NCT_ID,patient_id,patient_json,is_eligible,reasoning,unique_patient_id,eligibility_json
NCT00009971,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""recurrent extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""brain_mets"":""yes, treated with WBRT 14 months ago, asymptomatic"",""wbc"":4200,""platelets"":125000,""bilirubin_mgdl"":1.1,""ast_ul"":45,""creatinine_mgdl"":1.2,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",True,"Eligible: recurrent SCLC post-platinum, >3 weeks since chemo, ≤2 prior lines, brain mets treated & stable, all labs met, no disallowed meds or retinal disease.",NCT00009971_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent limited-stage SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":4,""brain_mets"":""none"",""wbc"":3100,""platelets"":85000,""bilirubin_mgdl"":0.9,""ast_ul"":38,""creatinine_mgdl"":0.8,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",True,"Eligible: meets all disease, line count, washout, and lab criteria; no brain mets, no exclusions triggered.",NCT00009971_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":3,""last_chemo_weeks_ago"":6,""brain_mets"":""none"",""wbc"":3800,""platelets"":98000,""bilirubin_mgdl"":1.3,""ast_ul"":52,""creatinine_mgdl"":1.4,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2}",False,Ineligible: received 3 prior chemotherapy regimens (protocol allows max 2).,NCT00009971_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":2,""brain_mets"":""yes, asymptomatic, treated >12mo ago"",""wbc"":2900,""platelets"":72000,""bilirubin_mgdl"":1.0,""ast_ul"":40,""creatinine_mgdl"":1.1,""on_anticonvulsants"":true,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",False,Ineligible: only 2 weeks since last chemo (<3 weeks required) AND concurrent anticonvulsant use (explicitly disallowed).,NCT00009971_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P005,"{""age"":61,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""brain_mets"":""yes, new symptomatic lesions"",""wbc"":3500,""platelets"":110000,""bilirubin_mgdl"":1.2,""ast_ul"":48,""creatinine_mgdl"":1.3,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2}",False,Ineligible: symptomatic/uncontrolled brain metastases (explicit exclusion).,NCT00009971_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P006,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":5,""brain_mets"":""none"",""wbc"":2200,""platelets"":68000,""bilirubin_mgdl"":1.6,""ast_ul"":70,""creatinine_mgdl"":1.7,""on_anticonvulsants"":false,""retinal_disease"":true,""pregnant"":false,""ecog"":1}",False,"Ineligible: multiple violations – platelets <70k, bilirubin >1.5 mg/dL, AST >2×ULN, and pre-existing retinal degenerative disease.",NCT00009971_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P007,"{""age"":39,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""brain_mets"":""none"",""wbc"":5100,""platelets"":180000,""bilirubin_mgdl"":0.8,""ast_ul"":35,""creatinine_mgdl"":0.9,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":true,""ecog"":0}",False,Ineligible: currently pregnant (strict exclusion).,NCT00009971_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P008,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":4,""brain_mets"":""yes, stable >12mo"",""wbc"":3200,""platelets"":95000,""bilirubin_mgdl"":1.4,""ast_ul"":50,""creatinine_mgdl"":1.4,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":2,""recent_mi"":true}",False,Ineligible: myocardial infarction within past 6 months (cardiac exclusion).,NCT00009971_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P009,"{""age"":52,""gender"":""M"",""diagnosis"":""recurrent SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""brain_mets"":""yes, treated & stable"",""wbc"":4800,""platelets"":160000,""bilirubin_mgdl"":1.0,""ast_ul"":42,""creatinine_mgdl"":1.1,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",True,"Eligible: all inclusion criteria met, brain mets treated & stable, >3 weeks since chemo, ≤2 lines, labs adequate, no exclusions.",NCT00009971_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT00009971,P010,"{""age"":64,""gender"":""F"",""diagnosis"":""recurrent SCLC"",""prior_lines"":2,""last_chemo_weeks_ago"":3.5,""brain_mets"":""none"",""wbc"":3300,""platelets"":88000,""bilirubin_mgdl"":1.2,""ast_ul"":55,""creatinine_mgdl"":1.3,""on_anticonvulsants"":false,""retinal_disease"":false,""pregnant"":false,""ecog"":1}",True,"Eligible: exactly meets washout (≥3 weeks), max 2 prior lines, adequate labs and performance status.",NCT00009971_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': ['limited stage', 'extensive stage'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy regimen'], 'allowed': ['steroids'], 'disallowed': ['systemic retinoid or carotenoid therapy within 3 weeks'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 70000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previously treated brain metastases allowed if neurologically stable', 'Stable dose of steroids allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal degenerative disease', 'other malignancy within the past 5 years except localized nonmelanoma skin cancer or carcinoma in situ'], 'concurrent_medications_disallowed': ['anticonvulsants'], 'other_exclusions': ['Symptomatic or uncontrolled brain or leptomeningeal disease', 'Pre-existing retinal degenerative disease']}}"
NCT03836352,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":10,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":9,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.2,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",True,"Eligible: post-1L ovarian ca, MSI-H, >4w since chemo, >2w since RT, ECOG 1, measurable disease, no brain mets, no immune-related tox history, no disallowed conditions/meds.",NCT03836352_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P002,"{""age"":58,""gender"":""M"",""diagnosis"":""metastatic HCC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""HCC"",""ecog"":0,""life_expectancy_months"":12,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":6.1,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",True,"Eligible: post-1L HCC, MSI-H, adequate washouts, no exclusions apply.",NCT03836352_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":3,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""NSCLC"",""ecog"":1,""life_expectancy_months"":8,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":3.8,""egfr_alk_status"":""EGFR exon 19 del"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: NSCLC with known EGFR mutation (explicitly excluded regardless of MSI status).,NCT03836352_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P004,"{""age"":54,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":3,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""yes, active"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":10,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":6.8,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: active CNS metastases AND largest lesion >5 cm in ovarian cancer patient (two independent exclusions).,NCT03836352_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""urothelial carcinoma"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""last_immuno_weeks_ago"":5,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""urothelial"",""ecog"":1,""life_expectancy_months"":7,""active_autoimmune"":true,""on_steroids"":true,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.0,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: ongoing systemic steroid therapy/immunosuppression AND active autoimmune disease requiring treatment.,NCT03836352_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSS"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":9,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":true,""largest_lesion_cm"":4.5,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: MSS (not MSI-H) AND history of malignant bowel obstruction.,NCT03836352_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""NSCLC"",""ecog"":1,""life_expectancy_months"":6,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":true,""bowel_obstruction"":false,""largest_lesion_cm"":3.9,""egfr_alk_status"":""wild-type"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: history of non-infectious pneumonitis requiring steroids.,NCT03836352_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":2,""life_expectancy_months"":10,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.8,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: ECOG 2 (protocol requires ECOG 0–1).,NCT03836352_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P009,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic urothelial"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""urothelial"",""ecog"":0,""life_expectancy_months"":14,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":3.5,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":true,""live_vaccine_last_30d"":false,""pregnant"":false}",False,Ineligible: prior receipt of survivin-based vaccine (explicit exclusion).,NCT03836352_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT03836352,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""recurrent ovarian cancer"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":4,""brain_mets"":""none"",""msi_status"":""MSI-H"",""tumor_type"":""ovarian"",""ecog"":1,""life_expectancy_months"":11,""active_autoimmune"":false,""on_steroids"":false,""recent_pneumonitis"":false,""bowel_obstruction"":false,""largest_lesion_cm"":4.9,""egfr_alk_status"":""not NSCLC"",""survivin_vaccine"":false,""live_vaccine_last_30d"":false,""pregnant"":false}",True,"Eligible: post-1L ovarian ca, MSI-H, all washouts met, ECOG 1, largest lesion <5 cm, no exclusions triggered.",NCT03836352_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['Microsatellite instability high']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['first line therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Completion of pre-treatment tumour biopsy required', 'Radiologic and/or biochemical evidence of disease progression']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['survivin-based vaccine(s) and/or immunotherapies', 'autoimmune disease requiring treatment within the last two years', 'thyroiditis', 'non-infectious pneumonitis that required steroid therapy', 'allogenic tissue/solid organ transplant', 'cerebrovascular event within 6 months', 'myocardial infarction within 6 months'], 'concurrent_medications_disallowed': ['steroid therapy or other immunosuppressive', 'live attenuated vaccines'], 'other_exclusions': ['Concurrent second malignancy other than non-melanoma skin cancer, cervical carcinoma in situ, or controlled bladder cancer', 'Clinical ascites or pleural fluid that cannot be managed', 'Malignant bowel obstruction or recent history of bowel obstruction', 'For OvCa, subjects with any single lesion greater than 5 cm', 'Presence of a serious acute or chronic infection', 'GI condition that might limit absorption of oral agents', 'Acute or chronic skin and/or microvascular disorders', 'Edema or lymphedema in the lower limbs > grade 2', 'Severe hypersensitivity (≥ Grade 3) to pembrolizumab', 'For NSCLC subjects: Known EGFR mutations or ALK rearrangements']}}"
NCT04421352,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":12,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":20,""brain_mets"":""yes, treated with SRT 14 weeks ago, stable"",""ecog"":1,""life_expectancy_months"":5,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",True,"Eligible: post-1L platinum ES-SCLC, prior ICI-naïve, brain mets treated & stable >12w ago, ECOG 1, extracranial measurable lesion, no exclusions.",NCT04421352_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":16,""brain_mets"":""none"",""ecog"":0,""life_expectancy_months"":8,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",True,"Eligible: relapsed LS-SCLC post-platinum + radical RT, >12w since RT, ICI-naïve, ECOG 0, all criteria met.",NCT04421352_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_immuno_weeks_ago"":6,""last_radiation_weeks_ago"":18,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":4,""prior_ici"":true,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: prior immune checkpoint inhibitor therapy (explicitly disallowed).,NCT04421352_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":15,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":9,""brain_mets"":""yes, treated 9 weeks ago"",""ecog"":1,""life_expectancy_months"":6,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: brain metastases treated <12 weeks ago (requires ≥3 months stability post-RT).,NCT04421352_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":11,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":30,""brain_mets"":""yes, asymptomatic but new lesion"",""ecog"":2,""life_expectancy_months"":4,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: unstable/active brain metastases AND ECOG 2 (protocol requires ECOG 0–1).,NCT04421352_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":14,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":8,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":7,""prior_ici"":false,""active_autoimmune"":true,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: active autoimmune disease requiring treatment.,NCT04421352_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":20,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":25,""brain_mets"":""none"",""ecog"":1,""life_expectancy_months"":5,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":true,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: history of grade ≥3 radiation pneumonitis.,NCT04421352_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P008,"{""age"":53,""gender"":""F"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":13,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":22,""brain_mets"":""meningeal metastases"",""ecog"":1,""life_expectancy_months"":6,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: meningeal metastases (explicit exclusion).,NCT04421352_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P009,"{""age"":60,""gender"":""M"",""diagnosis"":""ES-SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":16,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":28,""brain_mets"":""yes, treated 20 weeks ago, stable"",""ecog"":0,""life_expectancy_months"":9,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":true,""allergic_asthma"":false,""pregnant"":false}",False,Ineligible: active chronic hepatitis C.,NCT04421352_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT04421352,P010,"{""age"":57,""gender"":""F"",""diagnosis"":""LS-SCLC relapsed"",""prior_lines"":1,""last_chemo_weeks_ago"":18,""last_immuno_weeks_ago"":null,""last_radiation_weeks_ago"":24,""brain_mets"":""yes, treated 18 weeks ago, stable"",""ecog"":1,""life_expectancy_months"":7,""prior_ici"":false,""active_autoimmune"":false,""radiation_pneumonitis_g3"":false,""hiv"":false,""hepatitis_b_c"":false,""allergic_asthma"":false,""pregnant"":false}",True,"Eligible: all criteria met – post-platinum relapse, ICI-naïve, brain mets stable >12w post-RT, ECOG 1, adequate organ function assumed.",NCT04421352_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited or extensive', 'stage_list': ['LS-SCLC', 'ES-SCLC'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['platinum-containing dual-drug chemotherapy'], 'allowed': ['radiotherapy'], 'disallowed': ['immune checkpoint proteins/antibody/medicine'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 12, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': 12, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least one extracranial measurable lesion', 'No radiotherapy contraindications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary CNS tumors', 'meningeal metastases', 'autoimmune diseases', 'HIV infection', 'active chronic hepatitis B or C', 'uncontrolled allergic asthma', 'alcoholism or drug abuse', 'grade 3 or above radiation pneumonitis'], 'concurrent_medications_disallowed': ['immune checkpoint proteins/antibody/medicine'], 'other_exclusions': ['Serious hypersensitive reaction to monoclonal antibodies']}}"
NCT01774526,P001,"{""age"":48,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",True,"Eligible: Asian never-smoker female with metastatic adenocarcinoma and malignant pleural effusion, ECOG 1, fit and willing for pleuroscopy and systemic therapy.",NCT01774526_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P002,"{""age"":52,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Malay"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":2,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",True,"Eligible: meets all strict demographic and disease criteria, ECOG 2 allowed.",NCT01774526_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P003,"{""age"":45,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Indian"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",True,"Eligible: Asian ethnicity (Indian), never-smoker, malignant pleural effusion, all other criteria satisfied.",NCT01774526_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P004,"{""age"":38,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":false,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: unwilling to undergo pleuroscopy and biopsy (explicit requirement).,NCT01774526_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Caucasian"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: non-Asian ethnicity (strict exclusion).,NCT01774526_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""ex-smoker 10 pack-years"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: smoking history (protocol restricted to never-smokers only).,NCT01774526_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P007,"{""age"":60,""gender"":""M"",""diagnosis"":""lung squamous cell carcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""squamous"",""stage"":""IV""}",False,"Ineligible: histology is squamous cell carcinoma, not adenocarcinoma.",NCT01774526_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P008,"{""age"":42,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":false,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: no malignant pleural effusion (mandatory for this trial).,NCT01774526_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P009,"{""age"":19,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Malay"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":1,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":true,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: age <21 years (minimum age 21 required).,NCT01774526_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01774526,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""ethnicity"":""Chinese"",""smoking_history"":""never-smoker"",""has_malignant_pleural_effusion"":true,""ecog"":3,""willing_pleuroscopy"":true,""suitable_palliative_chemo_tki"":false,""histology"":""adenocarcinoma"",""stage"":""IV""}",False,Ineligible: ECOG 3 AND deemed not suitable for palliative chemotherapy or EGFR-TKI.,NCT01774526_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 21, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung adenocarcinoma', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 1, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Asian ethnicity', 'Non-smoker', 'Fit to undergo pleuroscopy and biopsy', 'Agreeable for palliative chemotherapy and/or EGFR-TKI']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Non-Asian ethnicity', 'Smoker', 'Poor ECOG status', 'Unwilling to undergo pleuroscopy and biopsy', 'Not suitable to receive palliative chemotherapy or EGFR-TKI', 'All other histological subtypes and stages of disease']}}"
NCT01780675,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_radiation_weeks_ago"":8,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",True,"Eligible: LS-SCLC in remission after chemo-RT, no brain mets, no progression, fluent in Dutch, no prior brain RT, no systemic therapy planned during PCI.",NCT01780675_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":5,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",True,"Eligible: ES-SCLC in remission after chemo, no brain mets, no progression, Dutch fluent, all criteria met.",NCT01780675_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":4,""last_radiation_weeks_ago"":7,""brain_mets"":""yes, asymptomatic"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",False,"Ineligible: clinical evidence of brain metastases (strict exclusion, even if asymptomatic).",NCT01780675_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":2,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":true,""recent_malignancy"":false,""pregnant"":false}",False,Ineligible: planned systemic anticancer treatment during or within 3 weeks before PCI.,NCT01780675_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":10,""last_radiation_weeks_ago"":12,""brain_mets"":""none"",""progressive_extracranial_disease"":true,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",False,Ineligible: evidence of progressive extracranial disease (excludes PCI candidacy).,NCT01780675_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P006,"{""age"":48,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":false,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",False,Ineligible: insufficient proficiency in Dutch (mandatory for neurocognitive assessments).,NCT01780675_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":9,""last_radiation_weeks_ago"":10,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":true,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",False,Ineligible: prior radiotherapy to the brain (strict exclusion).,NCT01780675_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":6,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":true,""pregnant"":false}",False,Ineligible: previous malignancy within past 2 years (except allowed skin/cervical in situ).,NCT01780675_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P009,"{""age"":39,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":8,""last_radiation_weeks_ago"":9,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":true}",False,Ineligible: currently pregnant (explicit exclusion).,NCT01780675_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT01780675,P010,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""last_chemo_weeks_ago"":7,""last_radiation_weeks_ago"":null,""brain_mets"":""none"",""progressive_extracranial_disease"":false,""dutch_fluency"":true,""prior_brain_rt"":false,""systemic_treatment_planned_during_pci"":false,""recent_malignancy"":false,""pregnant"":false}",True,"Eligible: ES-SCLC in remission post-chemo, no brain mets, stable disease, fluent in Dutch, no exclusions apply.",NCT01780675_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': ['I', 'II', 'III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemo-radiotherapy or chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Sufficient proficiency in Dutch']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignancy within 2 years except basal cell carcinoma or carcinoma in situ of the cervix'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Prior radiotherapy to the brain', 'Evidence of progressive extracranial metastatic disease', 'Any systemic anticancer treatment during PCI or within 3 weeks before start PCI']}}"
NCT03231111,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",True,"Eligible: female, age >20, first-time Tarceva, stage IV NSCLC, Chinese-literate, has home computer with DVD, treated at Taipei Medical Center.",NCT03231111_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P002,"{""age"":65,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",True,Eligible: meets all criteria including first-time EGFR-TKI use and Chinese literacy.,NCT03231111_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P003,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":true,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: prior EGFR-TKI exposure (trial restricted to TKI-naïve patients).,NCT03231111_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P004,"{""age"":55,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: male patient (trial exclusively for women).,NCT03231111_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P005,"{""age"":19,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: age <20 years.,NCT03231111_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":false,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: no computer equipment at home to play multimedia disc.,NCT03231111_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P007,"{""age"":50,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""English only"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: cannot speak/read/write Chinese fluently.,NCT03231111_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P008,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Tarceva"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""dementia"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",False,Ineligible: cognitive impairment (excludes clear consciousness requirement).,NCT03231111_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""none"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Kaohsiung Hospital"",""pregnant"":false}",False,Ineligible: not receiving treatment at Taipei Medical Center.,NCT03231111_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT03231111,P010,"{""age"":63,""gender"":""F"",""diagnosis"":""stage III NSCLC"",""prior_egfr_tki"":false,""current_tki_planned"":""Iressa"",""has_home_computer"":true,""language"":""Chinese"",""cognitive_status"":""clear"",""treatment_center"":""Taipei Medical Center"",""pregnant"":false}",True,"Eligible: female, first-time Iressa, stage III allowed, all logistical and language criteria met.",NCT03231111_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 20, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'stage III or IV', 'stage_list': ['III', 'IV'], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Iressa', 'Tarceva'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Female patients', 'Treated at medical department or surgical clinic in Taipei Medical Center', 'Able to speak, write, and read Chinese with clear consciousness and no cognitive impairment']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT00447421,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":0,""life_expectancy_months"":6,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",True,"Eligible: treatment-naïve LS-SCLC, ECOG 0, no prior chemo/RT, adequate organ/pulmonary function assumed, no cardiac events, no exclusions.",NCT00447421_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":5,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",True,"Eligible: treatment-naïve SCLC (stage not restricted), ECOG 1, all key criteria met.",NCT00447421_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""prior_chemo"":true,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":4,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",False,Ineligible: prior chemotherapy (protocol requires completely treatment-naïve status).,NCT00447421_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":true,""ecog"":0,""life_expectancy_months"":7,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",False,Ineligible: prior thoracic radiotherapy (explicitly disallowed).,NCT00447421_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":2,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",False,Ineligible: life expectancy <12 weeks.,NCT00447421_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P006,"{""age"":68,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":2,""life_expectancy_months"":6,""recent_mi"":true,""significant_weight_loss"":true,""prior_lower_neck_abdominal_rt"":true,""concurrent_other_antitumor"":false,""pregnant"":false}",False,"Ineligible: multiple: ECOG 2, recent MI, significant weight loss, prior abdominal RT.",NCT00447421_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P007,"{""age"":17,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":8,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",False,Ineligible: age <18 years.,NCT00447421_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P008,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":9,""recent_mi"":false,""significant_weight_loss"":true,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",False,Ineligible: significant weight loss (≥10% in 3 months assumed).,NCT00447421_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":1,""life_expectancy_months"":10,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":true,""pregnant"":false}",False,Ineligible: concurrent administration of other antitumor therapy.,NCT00447421_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00447421,P010,"{""age"":64,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":0,""prior_chemo"":false,""prior_thoracic_rt"":false,""ecog"":0,""life_expectancy_months"":12,""recent_mi"":false,""significant_weight_loss"":false,""prior_lower_neck_abdominal_rt"":false,""concurrent_other_antitumor"":false,""pregnant"":false}",True,"Eligible: fully treatment-naïve LS-SCLC, ECOG 0, life expectancy ≥12 weeks, no exclusion criteria triggered.",NCT00447421_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate pulmonary function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other antitumor therapy'], 'other_exclusions': ['Prior radiotherapy to the lower neck or abdominal region', 'Significant weight loss']}}"
NCT00084487,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":1,""anc"":2200,""platelets"":165000,""hemoglobin"":10.2,""creatinine_clearance"":72,""bilirubin_mgdl"":1.1,""ast"":48,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",True,"Eligible: sensitive relapse after 1 prior regimen, stable treated brain mets (no steroids), ECOG 1, all labs and cardiac criteria met.",NCT00084487_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":0,""anc"":1900,""platelets"":140000,""hemoglobin"":9.8,""creatinine_clearance"":68,""bilirubin_mgdl"":0.9,""ast"":55,""nyha_class"":2,""active_infection"":false,""pregnant"":false}",True,"Eligible: sensitive relapse, no brain mets, ECOG 0, adequate organ function.",NCT00084487_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":2,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":1,""anc"":1800,""platelets"":120000,""hemoglobin"":10.5,""creatinine_clearance"":75,""bilirubin_mgdl"":1.0,""ast"":60,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",False,Ineligible: received 2 prior chemotherapy regimens (max 1 allowed).,NCT00084487_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""refractory"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":1,""anc"":2100,""platelets"":155000,""hemoglobin"":9.9,""creatinine_clearance"":70,""bilirubin_mgdl"":1.2,""ast"":50,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",False,Ineligible: refractory relapse (protocol requires sensitive relapse only).,NCT00084487_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, progressing, on steroids"",""ecog"":2,""anc"":1600,""platelets"":110000,""hemoglobin"":9.5,""creatinine_clearance"":65,""bilirubin_mgdl"":1.3,""ast"":70,""nyha_class"":3,""active_infection"":false,""pregnant"":false}",False,Ineligible: unstable/symptomatic brain mets requiring steroids AND NYHA class III heart disease.,NCT00084487_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P006,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable but on dexamethasone"",""ecog"":1,""anc"":1400,""platelets"":95000,""hemoglobin"":8.8,""creatinine_clearance"":58,""bilirubin_mgdl"":1.6,""ast"":110,""nyha_class"":1,""active_infection"":true,""pregnant"":false}",False,"Ineligible: multiple labs below threshold (ANC<1500, Plt<100k, Hb<9, CrCl<60) + steroid requirement for brain mets + active infection.",NCT00084487_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""none"",""ecog"":2,""anc"":3000,""platelets"":180000,""hemoglobin"":11.0,""creatinine_clearance"":80,""bilirubin_mgdl"":0.8,""ast"":40,""nyha_class"":4,""active_infection"":false,""pregnant"":true}",False,Ineligible: pregnant AND NYHA class IV heart failure.,NCT00084487_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P008,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":1,""anc"":1700,""platelets"":105000,""hemoglobin"":9.2,""creatinine_clearance"":62,""bilirubin_mgdl"":1.4,""ast"":90,""nyha_class"":2,""active_infection"":false,""pregnant"":false}",True,"Eligible: sensitive relapse, stable brain mets off steroids, all other criteria satisfied.",NCT00084487_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":false,""brain_mets"":""none"",""ecog"":1,""anc"":2500,""platelets"":200000,""hemoglobin"":10.8,""creatinine_clearance"":85,""bilirubin_mgdl"":1.0,""ast"":45,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",False,Ineligible: no measurable disease by protocol criteria.,NCT00084487_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT00084487,P010,"{""age"":57,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_lines"":1,""relapse_type"":""sensitive"",""measurable_disease"":true,""brain_mets"":""yes, stable, no steroids"",""ecog"":0,""anc"":2800,""platelets"":190000,""hemoglobin"":11.5,""creatinine_clearance"":90,""bilirubin_mgdl"":0.9,""ast"":50,""nyha_class"":1,""active_infection"":false,""pregnant"":false}",True,"Eligible: textbook sensitive relapse case with stable treated brain mets, excellent performance status and labs.",NCT00084487_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'limited or extensive', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['1 prior chemotherapy regimen'], 'allowed': ['prior radiotherapy'], 'disallowed': ['concurrent investigational agents', 'concurrent therapies for SCLC'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver involvement: AST/ALT ≤5×ULN allowed', 'Creatinine < 2.0 mg/dL']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['combination antiretroviral therapy for HIV-positive patients'], 'other_exclusions': ['Active or ongoing infection', 'Psychiatric illness or social situation precluding study compliance', 'NYHA class III or IV heart disease', 'Symptomatic congestive heart failure', 'Unstable angina pectoris', 'Cardiac arrhythmia']}}"
NCT05958199,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""EGFR-mutant NSCLC"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, stable >3mo, asymptomatic"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: EGFR-mutant NSCLC, refractory, ECOG 1, stable brain mets, no unresolved ≥G2 tox, no active autoimmune on high-dose steroids.",NCT05958199_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""triple-negative breast cancer"",""stage"":""IV"",""prior_lines"":4,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: TNBC metastatic, ECOG 0, all criteria met.",NCT05958199_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""renal cell carcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":2,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: ECOG 2 (protocol allows only 0–1).,NCT05958199_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""urothelial carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, progressing"",""unresolved_tox_gte2"":true,""autoimmune_on_steroids_gt10mg"":true,""prior_grade3_ir_pneumonitis"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: unstable brain mets + unresolved ≥G2 toxicity + active autoimmune requiring >10mg prednisone + prior G3 ir-pneumonitis/colitis.,NCT05958199_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""colorectal carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""none"",""unresolved_tox_gte2"":true,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: unresolved Grade ≥2 toxicity from prior treatment (except allowed exceptions).,NCT05958199_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P006,"{""age"":48,""gender"":""F"",""diagnosis"":""cervical cancer"",""stage"":""IVB"",""prior_lines"":2,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":true,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":false,""pregnant"":false}",False,Ineligible: active autoimmune disease requiring >10mg prednisone equivalent AND not using effective contraception.,NCT05958199_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""pancreatic adenocarcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: history of grade 3 immune-related pneumonitis or colitis.,NCT05958199_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""endometrial carcinoma"",""stage"":""IV"",""prior_lines"":3,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":true}",False,Ineligible: currently pregnant.,NCT05958199_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":4,""ecog"":1,""brain_mets"":""yes, stable"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: NSCLC (EGFR status not required), refractory, stable brain mets, ECOG 1, no exclusions.",NCT05958199_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT05958199,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""cholangiocarcinoma"",""stage"":""IV"",""prior_lines"":2,""ecog"":0,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""autoimmune_on_steroids_gt10mg"":false,""prior_grade3_ir_pneumonitis"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: metastatic CCA, ECOG 0, clean toxicity/autoimmune history, contraception compliant.",NCT05958199_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or recurrent', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to standard of care therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_clinically_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal bone marrow, kidney and liver function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['grade 3 immune-related pneumonitis or colitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicity of Grade ≥ 2 from previous anti-cancer treatment (except alopecia, chronic neuropathy > 6 months, or changes in skin pigmentation)', 'Known autoimmune disease requiring immunosuppressive treatment > 10 mg prednisone daily']}}"
NCT02015416,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""ovarian cancer"",""stage"":""recurrent platinum-resistant"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":10,""brain_mets"":""yes, stable >6mo"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":6,""recent_investigational_weeks_ago"":8,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",True,"Eligible: recurrent ovarian ca, NY-ESO-1+, low burden, ≥1 prior therapy, ECOG 1, stable brain mets, adequate washout.",NCT02015416_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P002,"{""age"":62,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":12,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":5,""recent_investigational_weeks_ago"":10,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",True,"Eligible: NSCLC with ≥2 prior systemic therapies, NY-ESO-1+, ECOG 0, low burden, washouts met.",NCT02015416_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P003,"{""age"":55,""gender"":""F"",""diagnosis"":""melanoma"",""stage"":""IV"",""prior_lines"":1,""ny_eso1_positive"":false,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":9,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":7,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",False,Ineligible: tumor does not express NY-ESO-1 (mandatory biomarker).,NCT02015416_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""breast cancer"",""stage"":""IV"",""prior_lines"":1,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":8,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":6,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",False,Ineligible: breast cancer with only 1 prior systemic therapy (requires ≥2 for breast cancer).,NCT02015416_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P005,"{""age"":48,""gender"":""F"",""diagnosis"":""sarcoma"",""stage"":""metastatic"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""high"",""rapid_progression"":true,""ecog"":1,""life_expectancy_months"":7,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":8,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",False,"Ineligible: rapidly progressive, high disease burden (protocol requires low/minimal burden).",NCT02015416_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P006,"{""age"":65,""gender"":""M"",""diagnosis"":""NSCLC"",""stage"":""IV"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":11,""brain_mets"":""yes, progressing"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":4,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":true,""active_infection"":true,""recent_mi"":true,""pregnant"":false}",False,Ineligible: unstable brain metastases + significant autoimmune + active infection + recent MI.,NCT02015416_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""ovarian cancer"",""stage"":""recurrent"",""prior_lines"":3,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":5,""brain_mets"":""none"",""prior_ny_eso1_therapy"":true,""recent_chemo_weeks_ago"":12,""recent_investigational_weeks_ago"":4,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",False,Ineligible: prior NY-ESO-1 directed therapy AND recent investigational agent <3 weeks.,NCT02015416_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P008,"{""age"":70,""gender"":""M"",""diagnosis"":""uveal melanoma"",""stage"":""IV"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":9,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":10,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",False,Ineligible: uveal melanoma (explicitly excluded).,NCT02015416_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P009,"{""age"":44,""gender"":""F"",""diagnosis"":""melanoma"",""stage"":""IV"",""prior_lines"":2,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":1,""life_expectancy_months"":14,""brain_mets"":""yes, stable"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":5,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":true}",False,Ineligible: currently pregnant.,NCT02015416_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT02015416,P010,"{""age"":59,""gender"":""M"",""diagnosis"":""breast cancer"",""stage"":""IV"",""prior_lines"":4,""ny_eso1_positive"":true,""disease_burden"":""low"",""rapid_progression"":false,""ecog"":0,""life_expectancy_months"":15,""brain_mets"":""none"",""prior_ny_eso1_therapy"":false,""recent_chemo_weeks_ago"":7,""recent_investigational_weeks_ago"":null,""significant_autoimmune"":false,""active_infection"":false,""recent_mi"":false,""pregnant"":false}",True,"Eligible: metastatic breast ca with ≥2 prior therapies, NY-ESO-1+, low burden, ECOG 0, all criteria met.",NCT02015416_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'unresectable, relapsed and/or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['NY-ESO-1 expression']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': ['inadequate response, relapse and/or unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 3, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ECG without evidence of clinically significant arrhythmia or ischemia', 'NY-ESO-1 expressing cancer']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other cancer within three years', 'uveal melanoma'], 'concurrent_medications_disallowed': ['vaccine or other therapy directed against NY-ESO-1'], 'other_exclusions': ['Significant immunosuppression', 'Significant autoimmune disease', 'Active, concurrent or recent infection, including tuberculosis, hepatitis B, hepatitis C or HIV', 'Inadequate hematology or chemistry profiles']}}"
NCT06607185,P001,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""kras_mutation"":""G12D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, treated SRT 4mo ago, asymptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",True,"Eligible: KRAS G12D PDAC, measurable disease, ECOG 1, stable treated brain mets, no exclusions.",NCT06607185_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12C"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",True,"Eligible: classic KRAS G12C NSCLC, ECOG 0, all criteria cleanly met.",NCT06607185_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""kras_mutation"":""G12V"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":true,""history_ild_pneumonitis"":true,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":true,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",False,Ineligible: unresolved ≥G2 toxicity + prior steroid-requiring ILD/pneumonitis + significant cardiac disease.,NCT06607185_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12C"",""ecog"":2,""measurable_disease"":true,""brain_mets"":""yes, active symptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",False,Ineligible: ECOG 2 AND active/symptomatic CNS metastases.,NCT06607185_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P005,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""kras_mutation"":""wild-type"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",False,Ineligible: no qualifying KRAS mutation (G12C/D/V/A/S or G13D required).,NCT06607185_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""metastatic appendiceal cancer"",""kras_mutation"":""G13D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":true,""significant_cardiac_disease"":false,""active_infection"":true,""other_malignancy"":""prostate ca in remission"",""can_swallow_tablets"":true,""pregnant"":false}",False,Ineligible: active hepatitis/HIV + active infection.,NCT06607185_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12A"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":true,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":false,""pregnant"":false}",False,Ineligible: significant cardiovascular disease + unable to swallow tablets.,NCT06607185_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P008,"{""age"":53,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""kras_mutation"":""G12S"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""breast ca, active"",""can_swallow_tablets"":true,""pregnant"":true}",False,Ineligible: second active malignancy + pregnant.,NCT06607185_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic cholangiocarcinoma"",""kras_mutation"":""G12D"",""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":true,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",False,Ineligible: history of steroid-requiring non-infectious pneumonitis/ILD.,NCT06607185_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06607185,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_mutation"":""G12V"",""ecog"":0,""measurable_disease"":true,""brain_mets"":""yes, treated, asymptomatic"",""unresolved_tox_g1"":false,""history_ild_pneumonitis"":false,""active_hepatitis_hiv"":false,""significant_cardiac_disease"":false,""active_infection"":false,""other_malignancy"":""none"",""can_swallow_tablets"":true,""pregnant"":false}",True,"Eligible: KRAS G12V NSCLC, stable CNS disease, ECOG 0, perfect candidate.",NCT06607185_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C/G12D/G12V/G12A/G12S/G13D mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to swallow tablets', 'Asymptomatic or treated CNS disease allowed']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': False, 'history_of': ['non-infectious pneumonitis/interstitial lung disease requiring steroids', 'clinically significant pneumonitis/interstitial lung disease', 'significant cardiovascular disease (unstable angina, acute coronary syndrome, MI, uncontrolled arrhythmias, heart failure)', 'active hepatitis B/C or untreated HIV infection', 'other active malignancy not in remission with life expectancy > 2 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unresolved toxicities > NCI CTCAE Grade 1 (except alopecia, hearing loss, peripheral neuropathy, controlled endocrinopathies)', 'Active uncontrolled systemic infection']}}"
NCT06725225,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""pembrolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",True,"Eligible: histologically confirmed lung cancer on active immunotherapy, good communication, no cognitive issues, consent signed.",NCT06725225_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""current_immunotherapy"":""atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",True,"Eligible: SCLC on immunotherapy, all criteria met.",NCT06725225_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""stage III NSCLC"",""current_immunotherapy"":""durvalumab"",""verbal_communication"":""good"",""cognitive_impairment"":true,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",False,Ineligible: cognitive impairment (explicit exclusion).,NCT06725225_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P004,"{""age"":17,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",False,Ineligible: age <18 years.,NCT06725225_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P005,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""none, last dose 8 weeks ago"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",False,Ineligible: not currently receiving immunotherapy.,NCT06725225_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""current_immunotherapy"":""nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",False,"Ineligible: diagnosis is melanoma, not lung cancer.",NCT06725225_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P007,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""pembrolizumab"",""verbal_communication"":""poor"",""cognitive_impairment"":false,""severe_comorbid_disease"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: poor verbal communication AND other severe comorbid disease.,NCT06725225_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC"",""current_immunotherapy"":""pembrolizumab + chemo"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":false,""pregnant"":false}",False,Ineligible: no informed consent signed.,NCT06725225_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P009,"{""age"":74,""gender"":""M"",""diagnosis"":""stage IV SCLC"",""current_immunotherapy"":""lurbinectedin + atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",True,"Eligible: extensive-stage SCLC on active IO, consent signed, no exclusions.",NCT06725225_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06725225,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""current_immunotherapy"":""nivolumab-ipilimumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""severe_comorbid_disease"":false,""informed_consent"":true,""pregnant"":false}",True,"Eligible: NSCLC on dual checkpoint blockade, fully eligible.",NCT06725225_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Currently receiving immunotherapy for lung cancer', 'Good verbal communication ability', 'Informed consent signed by the patient or family member']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Cognitive impairment or mental illness', 'Other severe diseases']}}"
NCT06079970,P001,"{""age"":68,""gender"":""M"",""lesion_location"":""RUL peripheral"",""solid_component_mm"":18,""largest_diameter_mm"":26,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",True,"Eligible: classic peripheral 26 mm RUL nodule with bronchus sign, solid >10 mm, no contraindications.",NCT06079970_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P002,"{""age"":62,""gender"":""F"",""lesion_location"":""LLL peripheral"",""solid_component_mm"":15,""largest_diameter_mm"":22,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",True,"Eligible: perfect candidate, all criteria met.",NCT06079970_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P003,"{""age"":70,""gender"":""M"",""lesion_location"":""RML"",""solid_component_mm"":20,""largest_diameter_mm"":28,""bronchus_sign"":false,""rebus_expected"":false,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: no bronchus sign AND low expected r-EBUS signal.,NCT06079970_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P004,"{""age"":59,""gender"":""F"",""lesion_location"":""RUL"",""solid_component_mm"":8,""largest_diameter_mm"":25,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: solid component <10 mm.,NCT06079970_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P005,"{""age"":66,""gender"":""M"",""lesion_location"":""LUL"",""solid_component_mm"":22,""largest_diameter_mm"":35,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: largest diameter >30 mm.,NCT06079970_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P006,"{""age"":64,""gender"":""F"",""lesion_location"":""RUL"",""solid_component_mm"":19,""largest_diameter_mm"":27,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":true,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":true,""hemodynamic_stable"":false,""hypoxemia"":true,""can_tolerate_ga"":false,""informed_consent"":true,""pregnant"":false}",False,Ineligible: multiple – visible endobronchial tumor + fluorescein allergy + hemodynamic instability + refractory hypoxemia + cannot tolerate GA.,NCT06079970_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P007,"{""age"":71,""gender"":""M"",""lesion_location"":""central hilum"",""solid_component_mm"":25,""largest_diameter_mm"":29,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":true,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: lesion reachable by linear EBUS (excludes peripheral definition).,NCT06079970_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P008,"{""age"":55,""gender"":""F"",""lesion_location"":""RLL peripheral"",""solid_component_mm"":16,""largest_diameter_mm"":24,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":true,""therapeutic_anticoagulation_stopped"":false,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":false}",False,Ineligible: ongoing doxorubicin (fluorescent) + therapeutic anticoagulation cannot be stopped.,NCT06079970_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P009,"{""age"":60,""gender"":""M"",""lesion_location"":""LUL peripheral"",""solid_component_mm"":21,""largest_diameter_mm"":29,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":false,""pregnant"":false}",False,Ineligible: no informed consent.,NCT06079970_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT06079970,P010,"{""age"":67,""gender"":""F"",""lesion_location"":""RUL peripheral"",""solid_component_mm"":17,""largest_diameter_mm"":28,""bronchus_sign"":true,""rebus_expected"":true,""endobronchial_tumor_visible"":false,""linear_ebus_reachable"":false,""on_fluorescent_chemo"":false,""therapeutic_anticoagulation_stopped"":true,""fluorescein_allergy"":false,""hemodynamic_stable"":true,""hypoxemia"":false,""can_tolerate_ga"":true,""informed_consent"":true,""pregnant"":true}",False,Ineligible: currently pregnant.,NCT06079970_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Peripheral pulmonary lesion beyond visible segmental bronchi', 'Solid part of lesion ≥10 mm', 'Largest dimension ≤30 mm on CT']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Therapeutic anticoagulants that cannot be withheld', 'Chemotherapy with fluorescent properties'], 'other_exclusions': ['Endobronchial visible malignancy', 'Target lesion within reach of linear EBUS scope', 'Known allergy to fluorescein', 'Hemodynamic instability', 'Refractory hypoxemia', 'Unable to tolerate general anesthesia']}}"
NCT02117024,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""yes, treated SRT 3mo ago, stable"",""last_chemo_or_rt_weeks_ago"":4,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: 3rd-line adenocarcinoma, progressing, ECOG 1, stable brain mets, adequate washout, no vaccine history.",NCT02117024_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P002,"{""age"":59,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":5,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: 2nd-line progressing adenocarcinoma, all criteria met.",NCT02117024_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""lung squamous carcinoma"",""prior_lines"":3,""histology"":""squamous"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":6,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: squamous histology (trial restricted to adenocarcinoma only).,NCT02117024_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":4,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":8,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: 4 prior lines (maximum 3 allowed).,NCT02117024_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":false,""ecog"":2,""brain_mets"":""yes, active leptomeningeal"",""last_chemo_or_rt_weeks_ago"":10,""prior_cancer_vaccine"":true,""hiv_hbv_hcv"":true,""immunosuppressive_therapy"":true,""leptomeningeal_disease"":true,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: no progression at entry + leptomeningeal disease + prior cancer vaccine + HIV/HBV/HCV + systemic immunosuppression.,NCT02117024_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P006,"{""age"":55,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":1,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: systemic therapy <14 days ago + second active malignancy.,NCT02117024_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P007,"{""age"":68,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":2,""brain_mets"":""yes, stable"",""last_chemo_or_rt_weeks_ago"":4,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: ECOG 2 allowed per protocol discretion, 3 prior lines, stable brain mets, all else clean.",NCT02117024_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P008,"{""age"":52,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":6,""prior_cancer_vaccine"":true,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":true}",False,Ineligible: prior cancer vaccine for this indication + pregnant.,NCT02117024_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P009,"{""age"":73,""gender"":""M"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":2,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""yes, unstable"",""last_chemo_or_rt_weeks_ago"":5,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":true,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: neurologically unstable brain mets + concurrent systemic immunosuppression.,NCT02117024_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT02117024,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""lung adenocarcinoma"",""prior_lines"":3,""histology"":""adenocarcinoma"",""progression_at_entry"":true,""ecog"":1,""brain_mets"":""none"",""last_chemo_or_rt_weeks_ago"":7,""prior_cancer_vaccine"":false,""hiv_hbv_hcv"":false,""immunosuppressive_therapy"":false,""leptomeningeal_disease"":false,""other_active_malignancy"":false,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: textbook 3rd-line progressing adenocarcinoma, ECOG 1, no exclusions.",NCT02117024_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Suitable for conventional single agent chemotherapy', 'Disease progression at study entry', 'ECOG=2 patients may be considered', 'Adequate laboratory parameters']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['immunodeficiency disorders', 'leptomeningeal disease', 'other active malignancies'], 'concurrent_medications_disallowed': ['concurrent systemic immunosuppressive therapy'], 'other_exclusions': ['Prior treatment with a cancer vaccine for this indication']}}"
NCT00494026,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":0,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",True,"Eligible: treatment-naïve LS-SCLC, ECOG 0, no weight loss, willing/able vitamins & steroids.",NCT00494026_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",True,"Eligible: classic LS-SCLC candidate, ECOG 1, all criteria met.",NCT00494026_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: extensive-stage disease (trial strictly limited-stage only).,NCT00494026_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P004,"{""age"":60,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":true,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: prior chemotherapy (protocol requires completely treatment-naïve).,NCT00494026_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P005,"{""age"":55,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":true,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: prior thoracic radiotherapy.,NCT00494026_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P006,"{""age"":68,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":2,""significant_weight_loss_6w"":true,""able_vitamins_corticosteroids"":false,""pregnant"":false}",False,Ineligible: ECOG 2 (protocol allows ≤1) + significant weight loss + unwilling/unable vitamins/steroids.,NCT00494026_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P007,"{""age"":17,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: age <18.,NCT00494026_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":false,""ecog"":1,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: no measurable disease.,NCT00494026_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":1,""significant_weight_loss_6w"":true,""able_vitamins_corticosteroids"":true,""pregnant"":false}",False,Ineligible: significant weight loss ≥10% in past 6 weeks.,NCT00494026_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT00494026,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":false,""prior_thoracic_rt"":false,""measurable_disease"":true,""ecog"":0,""significant_weight_loss_6w"":false,""able_vitamins_corticosteroids"":true,""pregnant"":true}",False,Ineligible: currently pregnant/breastfeeding.,NCT00494026_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'Limited Stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy', 'thoracic radiotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate bone marrow reserve', 'Adequate hepatic function', 'Adequate pulmonary function', 'Adequate renal function', 'Able to take vitamin supplementation', 'Able to take corticosteroids']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Significant weight loss over previous 6 weeks']}}"
NCT06963502,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"": ""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: KRAS G12C NSCLC, no other drivers, no prior G12C inhibitor, ECOG 1, clean exclusions.",NCT06963502_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic CRC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: KRAS G12C CRC, perfect candidate.",NCT06963502_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P003,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C + EGFR exon19del"",""other_drivers"":""EGFR"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: co-occurring EGFR mutation (locally approved targeted therapy exists).,NCT06963502_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":true,""ecog"":1,""measurable_disease"":true,""brain_mets"":""active symptomatic"",""unresolved_tox_gte2"":true,""uncontrolled_effusion"":true,""spinal_cord_compression"":true,""ild_history"":true,""active_autoimmune"":true,""severe_cardiac"":true,""child_pugh"":""C"",""can_swallow_pills"":false,""contraception_compliant"":false,""pregnant"":false}",False,Ineligible: multiple – prior G12C inhibitor + active brain mets + ≥G2 unresolved tox + uncontrolled effusion + spinal compression + ILD + autoimmune + severe cardiac + Child-Pugh C + cannot swallow.,NCT06963502_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic pancreatic"",""kras_status"":""G12D"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: KRAS G12D (only G12C allowed).,NCT06963502_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, untreated"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: active brain metastases.,NCT06963502_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P007,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic CRC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":2,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":true,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":true,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: ECOG 2 + ≥G2 unresolved toxicity + severe cardiovascular disease.,NCT06963502_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P008,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":true,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":true}",False,Ineligible: history of ILD + pregnant.,NCT06963502_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P009,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic appendiceal"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":true,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",False,Ineligible: uncontrolled pleural/ascites/pericardial effusion.,NCT06963502_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT06963502,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""metastatic NSCLC"",""kras_status"":""G12C"",""other_drivers"":""none"",""prior_kras_g12c_inhibitor"":false,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""unresolved_tox_gte2"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""ild_history"":false,""active_autoimmune"":false,""severe_cardiac"":false,""child_pugh"":""A"",""can_swallow_pills"":true,""contraception_compliant"":true,""pregnant"":false}",True,"Eligible: textbook KRAS G12C NSCLC, ECOG 0, no exclusions.",NCT06963502_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'advanced solid tumors', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12C mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['other KRAS G12C inhibitors'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to comply with protocol', 'Able to swallow oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other primary malignancies'], 'concurrent_medications_disallowed': ['glucocorticoids'], 'other_exclusions': ['Uncontrolled pleural/ascites/pericardial effusion', 'Spinal cord compression', 'Grade ≥2 toxicities from prior therapy', 'Tumors with locally approved targeted molecular alterations (except KRAS G12C)', 'Inadequate bone marrow reserve or organ functions', 'Abnormal cardiac examination', 'Severe/uncontrolled cardiovascular disorders', 'Diabetes ketoacidosis/hyperglycemia hyperosmolality', 'Uncontrolled hypertension', 'Severe bleeding symptoms', 'Severe arteriovenous thrombosis', 'Serious infection', 'Active infectious diseases', 'Hepatic encephalopathy/hepatorenal syndrome/≥Child Pugh B cirrhosis', 'Interstitial lung disease (ILD)', 'Serious neurological/mental disorders', 'Active autoimmune diseases']}}"
NCT00663689,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L platinum doublet"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""multiple asymptomatic, treated SRT >3mo ago, no symptoms"",""brain_mri_lesions_count"":5,""longest_brain_lesion_mm"":8,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",True,"Eligible: classic post-1L SD, asymptomatic treated brain mets, ECOG 1, no prior EGFR-TKI, all labs met.",NCT00663689_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":0,""brain_mets"":""3 asymptomatic untreated lesions"",""brain_mri_lesions_count"":3,""longest_brain_lesion_mm"":12,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",True,"Eligible: untreated asymptomatic brain mets allowed if truly asymptomatic, ≥3 lesions, all criteria met.",NCT00663689_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P003,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""squamous"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":9,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",True,Eligible: squamous histology allowed (no restriction in protocol).,NCT00663689_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""PD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":6,""longest_brain_lesion_mm"":7,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",False,Ineligible: extracranial progressive disease (must be SD after 1L).,NCT00663689_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":true,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":11,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",False,Ineligible: prior EGFR-TKI exposure (strictly forbidden).,NCT00663689_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""symptomatic (headache + seizures)"",""brain_mri_lesions_count"":8,""longest_brain_lesion_mm"":15,""unresolved_tox_gte2"":true,""gi_integrity"":""gastric bypass"",""can_swallow_pills"":false,""active_infection"":true,""nyha_class"":3,""recent_mi"":true,""other_malignancy_5y"":true,""pregnant"":false}",False,Ineligible: multiple – symptomatic brain mets + unresolved ≥G3 tox + malabsorption + active infection + NYHA 3 + recent MI + second malignancy.,NCT00663689_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":2,""longest_brain_lesion_mm"":6,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",False,Ineligible: age <18 + only 2 brain lesions (requires ≥3 appraisable lesions).,NCT00663689_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":3,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":5,""longest_brain_lesion_mm"":9,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":true}",False,Ineligible: ECOG 3 + pregnant.,NCT00663689_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV NSCLC + SCLC mixed"",""histology"":""mixed"",""extracranial_response"":""SD after 1L chemo"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""asymptomatic"",""brain_mri_lesions_count"":7,""longest_brain_lesion_mm"":10,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",False,Ineligible: mixed small-cell component (explicit exclusion).,NCT00663689_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT00663689,P010,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology"":""adenocarcinoma"",""extracranial_response"":""SD after 1L pemetrexed-cisplatin"",""prior_egfr_tki"":false,""ecog"":1,""brain_mets"":""4 asymptomatic lesions"",""brain_mri_lesions_count"":4,""longest_brain_lesion_mm"":11,""unresolved_tox_gte2"":false,""gi_integrity"":""intact"",""can_swallow_pills"":true,""active_infection"":false,""nyha_class"":1,""recent_mi"":false,""other_malignancy_5y"":false,""pregnant"":false}",True,"Eligible: ideal candidate – post-platinum SD, asymptomatic brain mets, ECOG 1, no prior TKI.",NCT00663689_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR-TKI', 'EGFR monoclonal antibody'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Able to comply with study and follow-up procedures', 'PT-INR/PTT < 1.2 x ULN']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another malignancy within the last 5 years'], 'concurrent_medications_disallowed': ['other concurrent anticancer therapy'], 'other_exclusions': ['Mixed small cell and non-small cell lung cancer histology', 'Unresolved toxicity > CTCAE grade 2', 'Lack of physical integrity of the upper gastrointestinal tract', 'Malabsorption syndrome', 'Inability to take oral medication', 'Active peptic ulcer disease', 'Unstable systemic disease', 'Significant cardiovascular event', 'Substance abuse or medical, psychological or social conditions interfering with study participation']}}"
NCT02772107,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PR"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, treated SRT 8wk ago, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",True,"Eligible: ES-SCLC after 4 cycles EP, within 3–7wk window, ECOG 1, stable treated brain mets, no lepto.",NCT02772107_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, SD"",""weeks_since_last_chemo"":5,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",True,"Eligible: textbook 6-cycle responder, perfect timing, ECOG 0.",NCT02772107_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PD"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",False,Ineligible: progressive disease after 1L (must have response or at least SD/CR/PR).,NCT02772107_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":9,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""yes"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",False,Ineligible: >7 weeks since last chemo + leptomeningeal involvement.,NCT02772107_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""limited-stage SCLC"",""prior_chemo"":""4 cycles EP + concurrent RT, CR"",""weeks_since_last_chemo"":5,""ecog"":1,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",False,Ineligible: limited-stage disease (trial is extensive-stage only).,NCT02772107_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P006,"{""age"":70,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":2,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, active"",""leptomeningeal"":""no"",""hiv_status"":""positive on HAART"",""uncontrolled_illness"":true,""pregnant"":false}",False,Ineligible: <3 weeks since chemo + HIV on HAART + uncontrolled illness.,NCT02772107_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P007,"{""age"":52,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""4 cycles EP, PR"",""weeks_since_last_chemo"":6,""ecog"":2,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":true}",False,Ineligible: ECOG 2 + pregnant.,NCT02772107_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P008,"{""age"":66,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, PR"",""weeks_since_last_chemo"":5,""ecog"":1,""measurable_disease"":false,""brain_mets"":""yes, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",False,"Ineligible: no measurable disease (brain mets can count, but protocol explicitly requires measurable disease which includes them – borderline, but safest call is ineligible without extracranial measurable).",NCT02772107_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P009,"{""age"":63,""gender"":""F"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""5 cycles EP, PR"",""weeks_since_last_chemo"":4,""ecog"":1,""measurable_disease"":true,""brain_mets"":""yes, stable"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",True,"Eligible: 4–6 cycles completed (5 is allowed), within window, stable brain mets OK.",NCT02772107_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT02772107,P010,"{""age"":59,""gender"":""M"",""diagnosis"":""extensive-stage SCLC"",""prior_chemo"":""6 cycles EP, CR"",""weeks_since_last_chemo"":7,""ecog"":0,""measurable_disease"":true,""brain_mets"":""none"",""leptomeningeal"":""no"",""hiv_status"":""negative"",""uncontrolled_illness"":false,""pregnant"":false}",True,"Eligible: complete responder at upper limit of timing window (7 weeks exactly), ECOG 0, ideal candidate.",NCT02772107_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'extensive-stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['AST/ALT ≤5×ULN allowed if liver function abnormalities are due to underlying malignancy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['Leptomeningeal involvement', 'AIDS or HIV-positive on combination antiretroviral therapy']}}"
NCT03313544,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab monotherapy"",""baseline_lvef_percent"":58,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",True,"Eligible: standard nivolumab candidate, normal LVEF, no cardiac history.",NCT03313544_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P002,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab 2nd-line"",""baseline_lvef_percent"":62,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",True,"Eligible: NSCLC on nivolumab, clean cardiac history.",NCT03313544_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P003,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab + ipilimumab"",""baseline_lvef_percent"":55,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",True,Eligible: combo IO allowed (trial includes all patients selected for nivolumab ± ipi in routine care).,NCT03313544_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":48,""history_cardiomyopathy"":true,""history_arrhythmia"":true,""prior_cardiotoxicity"":true,""known_cad"":true,""recent_stroke"":true,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",False,Ineligible: LVEF <50% + dilated cardiomyopathy + prior cardiotoxicity + known CAD + recent stroke.,NCT03313544_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P005,"{""age"":17,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":60,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",False,Ineligible: age <18 years.,NCT03313544_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P006,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":52,""history_cardiomyopathy"":false,""history_arrhythmia"":true,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":true,""willing_to_participate"":true}",False,Ineligible: permanent atrial fibrillation + adult under legal guardianship.,NCT03313544_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P007,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":54,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":true,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":false}",False,Ineligible: prior immune-related myocarditis + patient refuses participation.,NCT03313544_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":65,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":true,""under_guardianship"":false,""willing_to_participate"":true}",False,Ineligible: currently pregnant.,NCT03313544_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P009,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""planned_treatment"":""nivolumab"",""baseline_lvef_percent"":51,""history_cardiomyopathy"":true,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",False,Ineligible: hypertrophic cardiomyopathy (explicit exclusion).,NCT03313544_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT03313544,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""planned_treatment"":""nivolumab monotherapy"",""baseline_lvef_percent"":60,""history_cardiomyopathy"":false,""history_arrhythmia"":false,""prior_cardiotoxicity"":false,""known_cad"":false,""recent_stroke"":false,""pregnant"":false,""under_guardianship"":false,""willing_to_participate"":true}",True,Eligible: perfect cardio-clean patient starting nivolumab.,NCT03313544_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['nivolumab'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': 50, 'other_inclusions': []}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['cardiac arrhythmia', 'cardiac toxicity under another anti-cancer treatment', 'stroke less than 3 months old', 'known coronary disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['cardiomyopathy dilated, hypertrophic or restrictive', 'patient not wishing to participate in the study', 'vulnerable persons (adults under guardianship or guardianship, persons deprived of their liberty)']}}"
NCT02349412,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":4,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",True,"Eligible: classic advanced NSCLC, told incurable 4wk ago, ECOG 1, English-speaking, all care at site, eligible caregiver.",NCT02349412_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P002,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""weeks_since_informed_incurable"":3,""ecog"":2,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":false}",True,"Eligible: no caregiver required for patient enrollment, pancreatic ca allowed, told <8wk ago.",NCT02349412_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""stage IV SCLC"",""weeks_since_informed_incurable"":10,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",False,Ineligible: informed of incurable disease >8 weeks ago (strict temporal criterion).,NCT02349412_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P004,"{""age"":65,""gender"":""F"",""diagnosis"":""metastatic esophageal squamous cell"",""weeks_since_informed_incurable"":5,""ecog"":0,""language"":""Spanish only, needs interpreter"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",False,Ineligible: patient requires more than minimal interpreter assistance (protocol allows minimal help only).,NCT02349412_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P005,"{""age"":59,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":6,""ecog"":3,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",False,Ineligible: ECOG 3 (max allowed 2).,NCT02349412_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P006,"{""age"":72,""gender"":""F"",""diagnosis"":""metastatic gastric adenocarcinoma"",""weeks_since_informed_incurable"":2,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":false,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",False,Ineligible: plans some oncology care outside enrolling institution.,NCT02349412_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":4,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",False,Ineligible: age <18.,NCT02349412_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P008,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""weeks_since_informed_incurable"":5,""ecog"":1,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":false}",False,Ineligible: colorectal GI cancer explicitly excluded.,NCT02349412_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P009,"{""age"":67,""gender"":""F"",""diagnosis"":""malignant pleural mesothelioma"",""weeks_since_informed_incurable"":7,""ecog"":2,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":false,""caregiver_english_fluent"":true}",True,"Eligible: mesothelioma allowed, caregiver sees patient only once weekly → still eligible because patient enrollment does not require caregiver registration.",NCT02349412_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02349412,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""weeks_since_informed_incurable"":1,""ecog"":0,""language"":""English fluent"",""all_care_at_institution"":true,""has_family_caregiver"":true,""caregiver_lives_with_or_sees_2x_week"":true,""caregiver_english_fluent"":true}",True,"Eligible: ideal candidate – newly informed of incurable disease, ECOG 0, full caregiver support.",NCT02349412_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Informed of diagnosis of incurable disease within the previous 8 weeks', 'Planning to receive all medical care for cancer at the enrolling institution', 'Under the care of an oncologist']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT07090499,P001,"{""age"":64,""gender"":""M"",""diagnosis"":""metastatic urothelial carcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",True,"Eligible: bladder ca, ≤2 prior lines (Part 2), no prior topotecan/exatecan ADC, ECOG 1.",NCT07090499_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV squamous NSCLC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":0,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",True,"Eligible: lung cancer, Part 1 (no line limit), clean history.",NCT07090499_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent head & neck SCC"",""prior_lines_advanced"":3,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",False,Ineligible: 3 prior lines in advanced setting (Part 2 max = 2).,NCT07090499_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":true,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":true,""severe_pulmonary_disease"":true,""tissue_consent"":true}",False,Ineligible: prior sacituzumab govitecan (camptothecin payload) + active intestinal obstruction + severe ILD.,NCT07090499_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic SCLC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",False,Ineligible: small cell lung cancer not included (only NSCLC allowed in lung category).,NCT07090499_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""metastatic esophageal adenocarcinoma"",""prior_lines_advanced"":1,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":2,""measurable_disease"":true,""resolved_prior_tox"":false,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":false}",False,Ineligible: ECOG 2 + unresolved ≥Grade 2 prior toxicity + refuses tissue submission.,NCT07090499_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""prior_lines_advanced"":0,""part"":""Part 1"",""prior_camptothecin_adc"":false,""ecog"":0,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",True,Eligible: treatment-naïve advanced NSCLC in dose-escalation (Part 1 allows any number of prior lines).,NCT07090499_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""metastatic gallbladder carcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",False,"Ineligible: gallbladder not in allowed list (only esophageal, gastric, hepatic, biliary, pancreatic for non-lung GI).",NCT07090499_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""metastatic pancreatic adenocarcinoma"",""prior_lines_advanced"":2,""part"":""Part 2"",""prior_camptothecin_adc"":false,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",True,"Eligible: pancreatic ca, exactly 2 prior lines, perfect Part 2 candidate.",NCT07090499_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT07090499,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""recurrent HNSCC"",""prior_lines_advanced"":1,""part"":""Part 1"",""prior_camptothecin_adc"":true,""ecog"":1,""measurable_disease"":true,""resolved_prior_tox"":true,""active_gi_obstruction"":false,""severe_pulmonary_disease"":false,""tissue_consent"":true}",False,Ineligible: prior trastuzumab deruxtecan (camptothecin-class payload).,NCT07090499_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of acute effects of prior anticancer therapy to baseline or Grade 1', 'Consent to submit required pre-treatment tumor tissue as medically feasible']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Received prior treatment with an antibody drug conjugate with a camptothecin-class payload', 'Active anorexia, nausea or vomiting, and/or signs of intestinal obstruction', 'Pulmonary disease meeting protocol exclusion', 'Other unacceptable abnormalities as defined by protocol']}}"
NCT01075399,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.5,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":1.2,""ast_alt_xuln"":1.8,""serum_creat_xuln"":1.4,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",True,"Eligible: classic LA-HNSCC ≥3cm, tissue available, FDG-PET timed correctly, planned CRT, labs OK.",NCT01075399_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IIIB NSCLC adenocarcinoma"",""tumor_size_cm"":5.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""concurrent chemoradiation"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":2.1,""serum_creat_xuln"":1.1,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",True,"Eligible: NSCLC ≥3cm, all criteria cleanly met.",NCT01075399_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P003,"{""age"":66,""gender"":""M"",""diagnosis"":""locally advanced rectal adenocarcinoma"",""tumor_size_cm"":2.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""neoadjuvant chemoradiation"",""bilirubin_xuln"":1.0,""ast_alt_xuln"":2.3,""serum_creat_xuln"":1.5,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",False,Ineligible: primary tumor <3 cm.,NCT01075399_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV cervical squamous carcinoma"",""tumor_size_cm"":4.1,""tumor_tissue_available"":false,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""palliative chemotherapy"",""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.4,""serum_creat_xuln"":1.8,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",False,Ineligible: no archived tumor tissue available for HIF1α/CA-IX IHC.,NCT01075399_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P005,"{""age"":55,""gender"":""M"",""diagnosis"":""locally advanced pancreatic adenocarcinoma"",""tumor_size_cm"":3.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":false,""planned_treatment"":""FOLFIRINOX → chemoradiation"",""bilirubin_xuln"":3.1,""ast_alt_xuln"":4.2,""serum_creat_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",False,Ineligible: elevated bilirubin/AST (liver obstruction) + FDG-PET not within 14d window.,NCT01075399_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P006,"{""age"":70,""gender"":""F"",""diagnosis"":""HCC"",""tumor_size_cm"":6.0,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""TACE + sorafenib"",""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.2,""serum_creat_xuln"":1.6,""pregnant"":false,""recent_radioactive_study"":true,""can_comply"":false}",False,Ineligible: hepatocellular carcinoma not allowed (only liver metastases implicitly via other primaries) + recent Y-90 radioembolization + compliance concerns.,NCT01075399_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P007,"{""age"":17,""gender"":""M"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""chemoradiation"",""bilirubin_xuln"":0.8,""ast_alt_xuln"":1.5,""serum_creat_xuln"":1.0,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",False,Ineligible: age <18.,NCT01075399_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""stage III cervical cancer"",""tumor_size_cm"":5.5,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""cisplatin + RT"",""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.9,""serum_creat_xuln"":1.3,""pregnant"":true,""recent_radioactive_study"":false,""can_comply"":true}",False,Ineligible: currently pregnant.,NCT01075399_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""locally advanced NSCLC"",""tumor_size_cm"":3.9,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""no anticancer therapy planned"",""bilirubin_xuln"":1.0,""ast_alt_xuln"":2.0,""serum_creat_xuln"":1.5,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",False,"Ineligible: no planned chemotherapy, radiation, or chemoradiotherapy after imaging.",NCT01075399_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT01075399,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""locally advanced HNSCC"",""tumor_size_cm"":4.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""induction TPF → concurrent CRT"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.7,""serum_creat_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",True,"Eligible: ideal candidate – large HNSCC, tissue + timing + treatment plan all perfect.",NCT01075399_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histopathology', 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor size ≥3cm', 'Tumor tissue samples available', 'Scheduled for chemotherapy, radiation or chemoradiotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inability to comply with study procedures', 'Radioactive research procedure within 7 days', 'Condition interfering with data collection']}}"
NCT04964960,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":3,""max_lesion_size_cm"":2.1,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":15,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":21,""minor_surgery_days_ago"":5,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":8,""consent_capacity"":true}",True,"Eligible: NSCLC with asymptomatic brain mets, no driver mutations, lesions <3cm and <10 total, all exclusion criteria avoided.",NCT04964960_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P002,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC squamous cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":7,""max_lesion_size_cm"":2.8,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":12,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":30,""minor_surgery_days_ago"":7,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":7,""consent_capacity"":true}",True,"Eligible: Meets all criteria - asymptomatic brain mets, appropriate lesion characteristics, no exclusions.",NCT04964960_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":true,""num_brain_lesions"":4,""max_lesion_size_cm"":2.5,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":20,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":25,""minor_surgery_days_ago"":10,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":6,""consent_capacity"":true}",False,Ineligible: New neurological symptoms from brain metastases.,NCT04964960_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""NSCLC with EGFR mutation"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":5,""max_lesion_size_cm"":2.2,""oncogenic_mutations"":true,""optic_nerve_proximity_mm"":18,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":20,""minor_surgery_days_ago"":8,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":9,""consent_capacity"":true}",False,Ineligible: Presence of oncogenic driver mutation (EGFR).,NCT04964960_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P005,"{""age"":71,""gender"":""M"",""diagnosis"":""NSCLC large cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":12,""max_lesion_size_cm"":1.8,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":25,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":18,""minor_surgery_days_ago"":6,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":5,""consent_capacity"":true}",False,"Ineligible: Too many brain lesions (12, exceeds limit of <10).",NCT04964960_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P006,"{""age"":52,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":2,""max_lesion_size_cm"":3.5,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":8,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":22,""minor_surgery_days_ago"":9,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":7,""consent_capacity"":true}",False,Ineligible: Lesion too large (3.5cm > 3cm limit) and too close to optic nerve (8mm < 10mm limit).,NCT04964960_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""NSCLC squamous"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":6,""max_lesion_size_cm"":2.4,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":15,""leptomeningeal_involvement"":true,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":19,""minor_surgery_days_ago"":11,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":4,""consent_capacity"":true}",False,Ineligible: Leptomeningeal involvement present.,NCT04964960_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P008,"{""age"":48,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":4,""max_lesion_size_cm"":2.0,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":20,""leptomeningeal_involvement"":false,""midline_shift"":true,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":16,""minor_surgery_days_ago"":12,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":false,""organ_function_adequate"":true,""life_expectancy_months"":6,""consent_capacity"":true}",False,Ineligible: Midline shift present on imaging.,NCT04964960_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""NSCLC large cell"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":3,""max_lesion_size_cm"":2.2,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":22,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":true,""major_surgery_days_ago"":5,""minor_surgery_days_ago"":15,""mab_allergy"":true,""cardiovascular_disease"":true,""intercurrent_illness"":true,""psychiatric_issues"":false,""organ_function_adequate"":false,""life_expectancy_months"":2,""consent_capacity"":true}",False,"Ineligible: Multiple exclusions - recent major surgery, mAb allergy, cardiovascular disease, uncontrolled illness, poor organ function, short life expectancy.",NCT04964960_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT04964960,P010,"{""age"":65,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""brain_metastases"":true,""brain_met_symptoms"":false,""num_brain_lesions"":8,""max_lesion_size_cm"":2.7,""oncogenic_mutations"":false,""optic_nerve_proximity_mm"":25,""leptomeningeal_involvement"":false,""midline_shift"":false,""wound_healing_issues"":false,""neurocognitive_ability"":false,""major_surgery_days_ago"":28,""minor_surgery_days_ago"":20,""mab_allergy"":false,""cardiovascular_disease"":false,""intercurrent_illness"":false,""psychiatric_issues"":true,""organ_function_adequate"":true,""life_expectancy_months"":5,""consent_capacity"":false}",False,"Ineligible: Cannot complete neurocognitive testing, psychiatric issues limit compliance, questionable consent capacity.",NCT04964960_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': ['lacks oncogenic driver mutations']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': 2}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Fewer than ten intracranial lesions', 'Each lesion measures three centimeters or less', 'Absence of new onset neurological symptoms', 'Adequate organ and marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Presence of oncogenic driver mutations', 'Measurable lesion within 10mm of optic chiasm/nerve or brainstem', 'Known leptomeningeal involvement', 'Midline shift', 'Serious non-healing wound, ulcer or bone fracture', 'Major surgical procedure within 14 days', 'Non-CNS minor surgery within 3 days', 'Allergic reactions to monoclonal antibodies', 'Clinically significant cardiovascular disease', 'Psychiatric illness/social situations limiting compliance']}}"
NCT01951469,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR exon 19 deletion"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":12,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":24,""hgb_g_dl"":11.2,""anc_x10e9"":2.1,""platelets_x10e9"":150,""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.8,""crcl_ml_min"":75,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",True,"Eligible: Stage IV NSCLC with EGFR mutation, multiple brain mets, no prior CNS/EGFR therapy, good PS and organ function.",NCT01951469_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P002,"{""age"":42,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR L858R mutation"",""brain_metastases"":true,""num_brain_lesions"":2,""largest_brain_lesion_mm"":8,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":20,""hgb_g_dl"":10.5,""anc_x10e9"":1.8,""platelets_x10e9"":120,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.1,""crcl_ml_min"":68,""liver_metastases"":true,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",True,"Eligible: EGFR mutant NSCLC with 1-2 brain lesions >5mm, adequate organ function despite liver mets, meets all criteria.",NCT01951469_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P003,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR exon 21 mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":15,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":16,""hgb_g_dl"":11.8,""anc_x10e9"":2.3,""platelets_x10e9"":180,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":55,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Age 72 exceeds maximum age limit of 75.,NCT01951469_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P004,"{""age"":35,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":5,""largest_brain_lesion_mm"":10,""prior_brain_rt"":true,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":28,""hgb_g_dl"":12.1,""anc_x10e9"":2.5,""platelets_x10e9"":200,""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.2,""crcl_ml_min"":85,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Prior brain irradiation received (exclusion criterion #1).,NCT01951469_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P005,"{""age"":61,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":12,""prior_brain_rt"":false,""prior_egfr_tki"":true,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":18,""hgb_g_dl"":10.8,""anc_x10e9"":1.9,""platelets_x10e9"":130,""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.0,""crcl_ml_min"":70,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Prior EGFR TKI therapy received (exclusion criterion #3).,NCT01951469_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P006,"{""age"":47,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":2,""largest_brain_lesion_mm"":4,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":22,""hgb_g_dl"":11.5,""anc_x10e9"":2.2,""platelets_x10e9"":160,""bilirubin_xuln"":1.1,""ast_alt_xuln"":1.6,""crcl_ml_min"":78,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Largest brain lesion 4mm (must be >5mm per inclusion criterion #3).,NCT01951469_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P007,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":9,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""hgb_g_dl"":10.2,""anc_x10e9"":1.7,""platelets_x10e9"":110,""bilirubin_xuln"":1.6,""ast_alt_xuln"":2.4,""crcl_ml_min"":65,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":false,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Meningeal metastases present and intracranial pressure uncontrolled.,NCT01951469_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P008,"{""age"":63,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":4,""largest_brain_lesion_mm"":11,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":2,""life_expectancy_weeks"":20,""hgb_g_dl"":9.8,""anc_x10e9"":1.4,""platelets_x10e9"":95,""bilirubin_xuln"":1.7,""ast_alt_xuln"":3.0,""crcl_ml_min"":55,""liver_metastases"":true,""interstitial_pneumonia"":true,""effusions_controlled"":false,""cardiac_stable"":false,""ophthalmic_issues"":true,""gi_absorption_ok"":false,""icp_controlled"":true,""concurrent_meds_disallowed"":true,""contraception_used"":false,""oral_meds_ability"":false}",False,"Ineligible: Multiple violations - ECOG 2, low blood counts, elevated LFTs, interstitial pneumonia, uncontrolled effusions, cardiac issues, ophthalmic problems, GI issues, taking phenytoin, no contraception.",NCT01951469_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P009,"{""age"":59,""gender"":""F"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":6,""largest_brain_lesion_mm"":14,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":0,""life_expectancy_weeks"":10,""hgb_g_dl"":11.0,""anc_x10e9"":1.6,""platelets_x10e9"":105,""bilirubin_xuln"":1.2,""ast_alt_xuln"":1.9,""crcl_ml_min"":62,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Life expectancy 10 weeks < required 12 weeks.,NCT01951469_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT01951469,P010,"{""age"":44,""gender"":""M"",""diagnosis"":""stage IV NSCLC with EGFR mutation"",""brain_metastases"":true,""num_brain_lesions"":3,""largest_brain_lesion_mm"":7,""prior_brain_rt"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""meningeal_metastases"":false,""ecog_ps"":1,""life_expectancy_weeks"":16,""hgb_g_dl"":10.1,""anc_x10e9"":1.6,""platelets_x10e9"":102,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.4,""crcl_ml_min"":58,""liver_metastases"":false,""interstitial_pneumonia"":false,""effusions_controlled"":true,""cardiac_stable"":true,""ophthalmic_issues"":false,""gi_absorption_ok"":true,""icp_controlled"":true,""concurrent_meds_disallowed"":false,""contraception_used"":true,""oral_meds_ability"":true}",False,Ineligible: Platelets 102 < minimum 100 and creatinine clearance 58 < required 60 ml/min.,NCT01951469_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologic histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR activating mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['EGFR Tyrosine Kinase Inhibitor', 'EGFR monoclonal antibody', 'brain irradiation'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 12, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['At least three metastatic lesions in brain, or 1-2 intracranial lesions with longest diameter >5 mm', 'AST/ALT < 5 x ULN allowed if liver metastases', 'Able to receive oral medications']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['meningeal metastases'], 'concurrent_medications_disallowed': ['Phenytoin', 'carbamazepine', 'rifampicin', 'phenobarbital', ""St. John's Wort""], 'other_exclusions': ['Interstitial pneumonia', 'Uncontrolled pericardial effusion or pleural effusion', 'Uncontrolled hypertension', 'Unstable angina', 'Congestive heart failure', 'Serious cardiac arrhythmia requiring medication', 'Severe dry eye syndrome', 'Keratoconjunctivitis sicca', 'Sjogren syndrome', 'Severe exposure keratitis', 'Active peptic ulcer disease', 'Uncontrolled intracranial pressure after dehydration and cortisone treatment']}}"
NCT00094003,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""colorectal cancer with liver metastases"",""primary_cancer"":""colorectal"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":6,""ecog_ps"":1,""prior_chemo_weeks_ago"":6,""prior_radiation_weeks_ago"":7,""prior_surgery_weeks_ago"":4,""prior_investigational_drug_weeks_ago"":35,""anc"":1800,""hgb_g_dl"":10.2,""platelets"":125000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.5,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.8,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",True,"Eligible: Liver mets from colorectal primary, adequate washout periods, meets all lab criteria including amylase/lipase, no exclusions.",NCT00094003_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""breast cancer with liver metastases"",""primary_cancer"":""breast"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":0,""prior_chemo_weeks_ago"":5,""prior_radiation_weeks_ago"":6,""prior_surgery_weeks_ago"":5,""prior_investigational_drug_weeks_ago"":40,""anc"":2200,""hgb_g_dl"":11.5,""platelets"":150000,""serum_creat_xuln"":1.0,""bilirubin_xuln"":1.1,""ast_alt_xuln"":2.0,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.2,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",True,"Eligible: Ideal candidate - breast cancer liver mets, excellent performance status, all labs within range, no exclusion criteria.",NCT00094003_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P003,"{""age"":48,""gender"":""M"",""diagnosis"":""pancreatic cancer with liver metastases"",""primary_cancer"":""pancreatic"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":4,""ecog_ps"":1,""prior_chemo_weeks_ago"":8,""prior_radiation_weeks_ago"":9,""prior_surgery_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":45,""anc"":1600,""hgb_g_dl"":9.5,""platelets"":110000,""serum_creat_xuln"":1.3,""bilirubin_xuln"":2.8,""ast_alt_xuln"":4.5,""amylase_lipase_normal"":false,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.5,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":true,""nyha_class"":2,""intercurrent_illness_controlled"":false,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,"Ineligible: History of pancreatic disease, elevated bilirubin and AST/ALT, abnormal amylase/lipase, uncontrolled intercurrent illness.",NCT00094003_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""lung adenocarcinoma with liver metastases"",""primary_cancer"":""lung"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":true,""life_expectancy_months"":5,""ecog_ps"":1,""prior_chemo_weeks_ago"":7,""prior_radiation_weeks_ago"":8,""prior_surgery_weeks_ago"":7,""prior_investigational_drug_weeks_ago"":50,""anc"":1900,""hgb_g_dl"":10.8,""platelets"":130000,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.8,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.9,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: Brain metastases present (exclusion criterion).,NCT00094003_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P005,"{""age"":59,""gender"":""M"",""diagnosis"":""gastric cancer with liver metastases"",""primary_cancer"":""gastric"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":4,""ecog_ps"":1,""prior_chemo_weeks_ago"":3,""prior_radiation_weeks_ago"":10,""prior_surgery_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":55,""anc"":1700,""hgb_g_dl"":9.2,""platelets"":105000,""serum_creat_xuln"":1.4,""bilirubin_xuln"":1.2,""ast_alt_xuln"":2.2,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.1,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: Chemotherapy washout only 3 weeks (requires 4 weeks).,NCT00094003_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P006,"{""age"":71,""gender"":""F"",""diagnosis"":""hepatocellular carcinoma"",""primary_cancer"":""liver"",""liver_metastases"":false,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":6,""ecog_ps"":1,""prior_chemo_weeks_ago"":9,""prior_radiation_weeks_ago"":11,""prior_surgery_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":60,""anc"":2000,""hgb_g_dl"":10.5,""platelets"":120000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.6,""ast_alt_xuln"":3.2,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.3,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":true,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: Primary liver cancer (HCC) - study is for metastatic disease to liver only.,NCT00094003_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""melanoma with liver metastases"",""primary_cancer"":""melanoma"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":0,""prior_chemo_weeks_ago"":6,""prior_radiation_weeks_ago"":12,""prior_surgery_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":32,""anc"":1400,""hgb_g_dl"":8.8,""platelets"":95000,""serum_creat_xuln"":1.6,""bilirubin_xuln"":1.7,""ast_alt_xuln"":3.5,""amylase_lipase_normal"":true,""pt_ptt_normal"":false,""serum_calcium_mg_dl"":11.5,""ecg_normal"":false,""afebrile"":false,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":true,""anticoagulation_therapy"":true}",False,"Ineligible: Multiple violations - low ANC/HGB/platelets, elevated creatinine, abnormal PT/PTT, high calcium, abnormal ECG, febrile, egg yolk allergy, on anticoagulation.",NCT00094003_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""renal cell carcinoma with liver metastases"",""primary_cancer"":""renal"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":7,""ecog_ps"":2,""prior_chemo_weeks_ago"":8,""prior_radiation_weeks_ago"":15,""prior_surgery_weeks_ago"":11,""prior_investigational_drug_weeks_ago"":42,""anc"":2100,""hgb_g_dl"":11.2,""platelets"":140000,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_alt_xuln"":2.1,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.0,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":true,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: ECOG PS 2 (max allowed is 1) and prior radiation to >25% of bone marrow.,NCT00094003_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P009,"{""age"":52,""gender"":""M"",""diagnosis"":""neuroendocrine tumor with liver metastases"",""primary_cancer"":""neuroendocrine"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":8,""ecog_ps"":1,""prior_chemo_weeks_ago"":10,""prior_radiation_weeks_ago"":13,""prior_surgery_weeks_ago"":12,""prior_investigational_drug_weeks_ago"":38,""anc"":2300,""hgb_g_dl"":12.1,""platelets"":160000,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_alt_xuln"":1.8,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":9.7,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":false,""pregnant"":false,""contraception_used"":true,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: Significant emotional/psychiatric problems making compliance uncertain.,NCT00094003_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT00094003,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""ovarian cancer with liver metastases"",""primary_cancer"":""ovarian"",""liver_metastases"":true,""measurable_lesion"":true,""brain_metastases"":false,""life_expectancy_months"":5,""ecog_ps"":1,""prior_chemo_weeks_ago"":7,""prior_radiation_weeks_ago"":14,""prior_surgery_weeks_ago"":2,""prior_investigational_drug_weeks_ago"":44,""anc"":1950,""hgb_g_dl"":10.9,""platelets"":135000,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.3,""ast_alt_xuln"":2.4,""amylase_lipase_normal"":true,""pt_ptt_normal"":true,""serum_calcium_mg_dl"":10.2,""ecg_normal"":true,""afebrile"":true,""primary_liver_disease"":false,""pancreatic_disease_history"":false,""nyha_class"":1,""intercurrent_illness_controlled"":true,""psychiatric_stable"":true,""pregnant"":true,""contraception_used"":false,""bone_marrow_radiation"":false,""egg_yolk_allergy"":false,""anticoagulation_therapy"":false}",False,Ineligible: Currently pregnant and major surgery only 2 weeks ago (requires 3 weeks washout).,NCT00094003_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4.285714286, 'radiation': 4, 'major_surgery': 3}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Amylase and lipase ≤ ULN', 'PT and PTT < 1.5 times ULN', 'Serum calcium <11 mg/dL', 'ECG with no acute abnormalities', 'Afebrile (≤37.5C or 99.5F)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['pancreatic disease', 'allergy to egg yolk', 'radiation to >25% of total bone marrow', 'receiving low-molecular weight heparin for blood coagulation disorder'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Concomitant primary malignant and/or non-malignant liver disease', 'Mentally or legally incapacitated', 'Significant emotional or psychiatric problems', 'Clinically relevant systemic disease other than malignancy']}}"
NCT03699956,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive stage small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",True,"Eligible: SCLC with 3 prior lines including platinum and checkpoint inhibitor, no CNS mets, meets all inclusion/exclusion criteria.",NCT03699956_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":2,""prior_platinum"":true,""prior_checkpoint_inhibitor"":false,""checkpoint_contraindicated"":true,""measurable_disease"":true,""ecog_ps"":0,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",True,"Eligible: SCLC with 2 prior lines, checkpoint inhibitor contraindicated (allowed per criteria), all other requirements met.",NCT03699956_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P003,"{""age"":72,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":1,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,Ineligible: Only 1 prior line of therapy (requires ≥2 prior lines).,NCT03699956_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P004,"{""age"":61,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":false,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,Ineligible: No prior platinum treatment (required per inclusion criterion #2).,NCT03699956_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":true,""cns_symptoms"":true,""steroid_dose_increasing"":true,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,Ineligible: Symptomatic CNS metastases with increasing steroid dose (exclusion criterion #1).,NCT03699956_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":true,""current_breast_cancer"":true,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,"Ineligible: Presence of another primary malignancy (active breast cancer, excludes only cervical CIS and basal skin cancer).",NCT03699956_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":true,""current_topotecan"":true,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,"Ineligible: Currently receiving antineoplastic treatment for SCLC (exclusion criterion #3, only steroids allowed).",NCT03699956_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":true,""uncontrolled_diabetes"":true,""uncontrolled_hypertension"":true,""active_hepatitis_b"":true,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":false}",False,"Ineligible: Multiple significant comorbidities (uncontrolled diabetes, hypertension, Hepatitis B) and compliance limitations.",NCT03699956_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P009,"{""age"":57,""gender"":""M"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":1,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":true,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":false,""pleural_effusion"":false,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,Ineligible: History of allergic reaction to platinum-based regimen (exclusion criterion #5).,NCT03699956_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT03699956,P010,"{""age"":69,""gender"":""F"",""diagnosis"":""small cell lung cancer"",""biopsy_confirmed"":true,""prior_lines_therapy"":3,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""measurable_disease"":true,""ecog_ps"":2,""brain_metastases"":false,""cns_symptoms"":false,""second_primary_malignancy"":false,""current_antineoplastic_treatment"":false,""significant_comorbidities"":false,""platinum_allergy"":false,""platinum_toxicity_discontinuation"":false,""abnormal_labs_contraindication"":true,""elevated_lfts"":true,""pleural_effusion"":true,""symptomatic_effusion"":true,""pericardial_effusion"":false,""pregnant"":false,""consent_capacity"":true,""compliance_ability"":true}",False,"Ineligible: ECOG PS 2 (max allowed 1), abnormal LFTs suggesting contraindication, and symptomatic pleural effusion.",NCT03699956_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 80}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum treatment', 'checkpoint inhibitor'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Able to provide informed consent']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reaction to platinum-based regimen', 'another primary malignancy'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Uncontrolled or symptomatic pleural or pericardial effusion', 'Treatment of SCLC with any antineoplastic agent except steroids', 'Clinically significant illnesses compromising study participation']}}"
NCT00046787,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":5,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":15,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",True,"Eligible: Recurrent SCLC with 1 prior chemo line, adequate washout periods, small target lesion, controlled CNS disease, no SVC syndrome.",NCT00046787_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":6,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":18,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",True,"Eligible: Classic recurrent SCLC case - one prior chemo, adequate washout, small measurable lesion, no exclusions.",NCT00046787_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P003,"{""age"":67,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":2,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":4,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":12,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",False,Ineligible: Two prior lines of chemotherapy (maximum one prior treatment allowed).,NCT00046787_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P004,"{""age"":54,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":2,""chemo_side_effects_resolved"":false,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":16,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",False,Ineligible: Chemotherapy only 2 weeks ago (requires 3 weeks) and side effects not resolved.,NCT00046787_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P005,"{""age"":71,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":2,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":false,""target_tumor_size_mm"":14,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",False,Ineligible: Chest radiotherapy only 2 weeks ago (requires 3 weeks) and radiation side effects not resolved.,NCT00046787_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P006,"{""age"":49,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":true,""head_rt_days_ago"":7,""rt_side_effects_resolved"":false,""target_tumor_size_mm"":13,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":false,""superior_vena_cava_syndrome"":false}",False,"Ineligible: Head irradiation only 7 days ago (requires 10 days), radiation side effects not resolved, and CNS disease uncontrolled.",NCT00046787_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":5,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":25,""ct_scan_type"":""conventional"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",False,Ineligible: Target tumor 25mm (exceeds 20mm maximum for conventional CT).,NCT00046787_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P008,"{""age"":66,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":12,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":true}",False,Ineligible: Superior vena cava syndrome present (sole exclusion criterion).,NCT00046787_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P009,"{""age"":59,""gender"":""M"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":false,""prior_lines_therapy"":0,""chemo_weeks_ago"":null,""chemo_side_effects_resolved"":true,""prior_chest_rt"":true,""chest_rt_weeks_ago"":6,""prior_head_rt"":false,""head_rt_days_ago"":null,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":11,""ct_scan_type"":""spiral"",""brain_metastases"":false,""cns_involvement_history"":false,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",False,Ineligible: No prior chemotherapy (one prior chemotherapy treatment required).,NCT00046787_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT00046787,P010,"{""age"":55,""gender"":""F"",""diagnosis"":""recurrent small cell lung cancer"",""prior_chemotherapy"":true,""prior_lines_therapy"":1,""chemo_weeks_ago"":4,""chemo_side_effects_resolved"":true,""prior_chest_rt"":false,""chest_rt_weeks_ago"":null,""prior_head_rt"":true,""head_rt_days_ago"":12,""rt_side_effects_resolved"":true,""target_tumor_size_mm"":9,""ct_scan_type"":""spiral"",""brain_metastases"":true,""cns_involvement_history"":true,""cns_disease_controlled"":true,""superior_vena_cava_syndrome"":false}",True,"Eligible: Meets all criteria - one prior chemo, adequate head RT washout, small spiral CT lesion, controlled CNS disease.",NCT00046787_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'recurrent', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one target tumor ≤20 mm (or ≤10 mm on spiral CT-scan)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Superior vena cava syndrome']}}"
NCT02606149,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_proven"":true,""time_since_diag_weeks"":4,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",True,"Eligible: All inclusion criteria met (Stage IV lung cancer, recent diagnosis, no prior systemic therapy, eligible age, consent/social security OK).",NCT02606149_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""stage IV SCLC"",""histology_proven"":true,""time_since_diag_weeks"":7,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""mild CHF"",""consent_given"":true,""systemic_therapy_indicated"":true}",True,Eligible: All key criteria met. The trial specifies 'lung cancer' which includes SCLC. Mild CHF is not a contraindication if the investigator deems it compatible.,NCT02606149_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""stage IV lung squamous carcinoma"",""histology_proven"":true,""time_since_diag_weeks"":10,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""well-controlled diabetes"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,"Ineligible: Diagnosis was made 10 weeks ago, which exceeds the 'diagnosed during the last 8 weeks' inclusion window.",NCT02606149_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P004,"{""age"":68,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":3,""prior_systemic_therapy"":true,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,Ineligible: Patient received prior systemic therapy (chemotherapy) for their metastatic disease.,NCT02606149_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""stage IV colorectal cancer"",""histology_proven"":true,""time_since_diag_weeks"":5,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,"Ineligible: Diagnosis is colorectal cancer, not stage IV lung cancer.",NCT02606149_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P006,"{""age"":80,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":false,""time_since_diag_weeks"":6,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,"Ineligible: Diagnosis is not histologically proven (e.g., diagnosed by imaging/cytology only), which is a hard inclusion criterion.",NCT02606149_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P007,"{""age"":32,""gender"":""M"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":1,""prior_systemic_therapy"":false,""social_security"":false,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,"Ineligible: Patient is not affiliated with a social security scheme, a clear exclusion criterion.",NCT02606149_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P008,"{""age"":60,""gender"":""F"",""diagnosis"":""stage IV adenocarcinoma lung"",""histology_proven"":true,""time_since_diag_weeks"":2,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""severe, rapidly progressing COPD"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,Ineligible: Severe comorbidity (COPD) may be deemed 'not compatible with the inclusion' by the investigator.,NCT02606149_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P009,"{""age"":17,""gender"":""M"",""diagnosis"":""stage IV lung cancer"",""histology_proven"":true,""time_since_diag_weeks"":4,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""none"",""consent_given"":true,""systemic_therapy_indicated"":true}",False,"Ineligible: Patient is 17 years old, which is below the minimum age of 18 years.",NCT02606149_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT02606149,P010,"{""age"":50,""gender"":""F"",""diagnosis"":""stage IV NSCLC"",""histology_proven"":true,""time_since_diag_weeks"":6,""prior_systemic_therapy"":false,""social_security"":true,""comorbidities"":""controlled hypertension"",""consent_given"":false,""systemic_therapy_indicated"":true}",False,Ineligible: Patient has not given non-objection (consent_given: false) or is unable to give it.,NCT02606149_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic therapy for metastatic disease'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['diagnosed during the last 8 weeks']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['patient unaffiliated or not beneficiary of a social security scheme', 'patient has not given non-objection']}}"
NCT06838208,P001,"{""age"":68,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""stable treated"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",True,"Eligible: Meets all key criteria—ES-SCLC, PS 0, no prior therapy, measurable lesion, no major contraindications (ICI/autoimmune/recent drugs).",NCT06838208_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P002,"{""age"":75,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":false,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,Ineligible: Diagnosis is not histologically or cytologically confirmed.,NCT06838208_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":true,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,Ineligible: Received prior systemic therapy (carboplatin + etoposide) for ES-SCLC.,NCT06838208_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":2,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1.",NCT06838208_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""untreated symptomatic"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,"Ineligible: Has untreated, symptomatic brain metastasis, which is an exclusion.",NCT06838208_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":false,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,Ineligible: Lacks a measurable chest lesion suitable for the specified irradiation dose.,NCT06838208_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":true,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,"Ineligible: History of prior anti-PD-1 therapy, which is an exclusion criterion.",NCT06838208_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P008,"{""age"":45,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":0,""measurable_chest_lesion"":true,""organ_function_adequate"":false,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":false,""recent_antibiotics"":true}",False,"Ineligible: Received oral antibiotics for a respiratory infection 10 days prior to screening, violating the 2-week washout period.",NCT06838208_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P009,"{""age"":72,""gender"":""M"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":false,""autoimmune_history"":true,""recent_systemic_steroid"":true,""interstitial_lung_disease"":false,""recent_antibiotics"":false}",False,Ineligible: History of active rheumatoid arthritis (autoimmune disease) requiring systemic steroid treatment 10 days ago (violates <14 day rule).,NCT06838208_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT06838208,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""ES-SCLC"",""histology_proven"":true,""prior_systemic_therapy_sclc"":false,""ecog_ps"":1,""measurable_chest_lesion"":true,""organ_function_adequate"":true,""brain_metastases"":""none"",""prior_ici_therapy"":false,""recent_live_vaccine"":true,""autoimmune_history"":false,""recent_systemic_steroid"":false,""interstitial_lung_disease"":true,""recent_antibiotics"":false}",False,Ineligible: History of interstitial lung disease (ILD) and received a live shingles vaccine 3 weeks prior (violates 4-week washout).,NCT06838208_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'ES-SCLC', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic treatment for ES-SCLC'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable chest lesion capable of 15Gy/5f irradiation', 'Adequate hematologic and end organ function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['autoimmune diseases that may relapse', 'interstitial lung disease', 'non-infectious pneumonitis'], 'concurrent_medications_disallowed': ['live vaccine within 4 weeks', 'systemic corticosteroids or immunosuppressive medication within 14 days', 'therapeutic oral or IV antibiotics within 2 weeks'], 'other_exclusions': ['Severe chronic or active infections requiring systemic antibacterial, antifungal or antiviral therapy within 2 weeks prior to treatment']}}"
NCT03778814,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""advanced NSCLC"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":25,""killing_percent"":22,""prior_gene_therapy"":false,""tumor_size_cm"":12,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",True,"Eligible: Meets all critical criteria. Advanced NSCLC with obtainable biopsy, Child-Pugh <7, life expectancy >12wk, and T-cell product meets both 20% thresholds.",NCT03778814_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""advanced ovarian cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":20,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":15,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":8,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,Ineligible: T-cell product fails to meet the minimum 20% targeted TCR expression requirement.,NCT03778814_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic prostate cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":7,""organ_function_adequate"":true,""tcr_exp_percent"":30,""killing_percent"":35,""prior_gene_therapy"":false,""tumor_size_cm"":10,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,"Ineligible: Child-Pugh-Turcotte score is 7, which is not <7 (indicates inadequate liver function).",NCT03778814_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P004,"{""age"":65,""gender"":""F"",""diagnosis"":""advanced SCLC"",""biopsy_obtainable"":false,""life_expectancy_weeks"":16,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":28,""killing_percent"":20,""prior_gene_therapy"":false,""tumor_size_cm"":6,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,"Ineligible: Biopsy is not safely obtainable for establishing tumor organoids/TILs, violating a key requirement.",NCT03778814_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P005,"{""age"":42,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":10,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":40,""killing_percent"":50,""prior_gene_therapy"":false,""tumor_size_cm"":15,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,"Ineligible: Estimated life expectancy is only 10 weeks, which is less than the required >12 weeks.",NCT03778814_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P006,"{""age"":50,""gender"":""M"",""diagnosis"":""advanced lung squamous cell carcinoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":14,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":33,""killing_percent"":18,""prior_gene_therapy"":false,""tumor_size_cm"":14,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,Ineligible: T-cell product fails to meet the minimum 20% tumor cell killing requirement.,NCT03778814_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P007,"{""age"":68,""gender"":""F"",""diagnosis"":""advanced cervical cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":13,""child_pugh_score"":5,""organ_function_adequate"":true,""tcr_exp_percent"":30,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":26,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,"Ineligible: Tumor size is 26 cm, which exceeds the maximum allowed size of 25 cm.",NCT03778814_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P008,"{""age"":53,""gender"":""M"",""diagnosis"":""advanced mesothelioma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":35,""killing_percent"":30,""prior_gene_therapy"":true,""tumor_size_cm"":9,""active_infection"":false,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":false}",False,Ineligible: Patient previously accepted gene therapy for an unrelated condition.,NCT03778814_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P009,"{""age"":40,""gender"":""F"",""diagnosis"":""advanced renal cell carcinoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":22,""killing_percent"":22,""prior_gene_therapy"":false,""tumor_size_cm"":7,""active_infection"":true,""hiv_status"":""negative"",""lung_transplant_history"":false,""pregnant_or_lactating"":true,""high_dose_steroids"":false}",False,"Ineligible: Has active infectious disease (pneumonia) and is currently pregnant/lactating, violating two exclusion criteria.",NCT03778814_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03778814,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""advanced NSCLC"",""biopsy_obtainable"":true,""life_expectancy_weeks"":14,""child_pugh_score"":6,""organ_function_adequate"":true,""tcr_exp_percent"":28,""killing_percent"":25,""prior_gene_therapy"":false,""tumor_size_cm"":11,""active_infection"":false,""hiv_status"":""positive"",""lung_transplant_history"":false,""pregnant_or_lactating"":false,""high_dose_steroids"":true}",False,Ineligible: Known HIV positivity and is currently on high-dose systemic steroids for colitis (≥0.5 mg/kg/day prednisone equivalent).,NCT03778814_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'biopsy', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['gene therapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Child-Pugh-Turcotte score <7', 'Available autologous transduced T cells with ≥20% expression of targeted TCR sequences', 'Killing of tumor cells ≥20% in cytotoxicity assay']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['lung transplantation'], 'concurrent_medications_disallowed': ['systemic steroid treatment ≥0.5 mg prednisone equivalent/kg/day'], 'other_exclusions': ['Tumor size more than 25cm', 'Severe virus infection', 'Active infectious disease', 'Known HIV positivity']}}"
NCT03613753,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":45,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":2.1,""platelets_g_per_l"":150,""hemoglobin_g_per_l"":100,""ast_alt_xuln"":1.5,""bilirubin_xuln"":1.0,""creatinine_umol_per_l"":90,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",True,"Eligible: All inclusion criteria met, including relapsed SCLC, correct first-line regimen, sufficient washout, good labs, and PS 1.",NCT03613753_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":60,""life_expectancy_months"":5,""ecog_ps"":0,""neutrophils_g_per_l"":1.8,""platelets_g_per_l"":120,""hemoglobin_g_per_l"":95,""ast_alt_xuln"":1.8,""bilirubin_xuln"":1.1,""creatinine_umol_per_l"":100,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,"Ineligible: Age is 72 years, which is above the maximum allowed age of 70 years.",NCT03613753_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""doxorubicin + cyclophosphamide"",""time_since_flt_days"":35,""life_expectancy_months"":3,""ecog_ps"":1,""neutrophils_g_per_l"":2.5,""platelets_g_per_l"":180,""hemoglobin_g_per_l"":110,""ast_alt_xuln"":1.1,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":85,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,Ineligible: First-line chemotherapy was not Etoposide + Cisplatin/Carboplatin as required by the protocol.,NCT03613753_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":25,""life_expectancy_months"":6,""ecog_ps"":1,""neutrophils_g_per_l"":2.0,""platelets_g_per_l"":140,""hemoglobin_g_per_l"":105,""ast_alt_xuln"":1.3,""bilirubin_xuln"":1.0,""creatinine_umol_per_l"":95,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,Ineligible: Only 25 days since first-line therapy completion; minimum washout is 30 days.,NCT03613753_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P005,"{""age"":68,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":40,""life_expectancy_months"":2,""ecog_ps"":1,""neutrophils_g_per_l"":2.2,""platelets_g_per_l"":160,""hemoglobin_g_per_l"":102,""ast_alt_xuln"":1.6,""bilirubin_xuln"":1.2,""creatinine_umol_per_l"":105,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,"Ineligible: Expected life time is 2 months, which is less than the required minimum of 3 months.",NCT03613753_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P006,"{""age"":58,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":50,""life_expectancy_months"":4,""ecog_ps"":2,""neutrophils_g_per_l"":1.9,""platelets_g_per_l"":130,""hemoglobin_g_per_l"":98,""ast_alt_xuln"":1.4,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":88,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,"Ineligible: ECOG PS is 2 due to comorbid conditions (uncontrolled heart failure), which is explicitly excluded.",NCT03613753_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":70,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":1.4,""platelets_g_per_l"":75,""hemoglobin_g_per_l"":90,""ast_alt_xuln"":1.0,""bilirubin_xuln"":0.8,""creatinine_umol_per_l"":80,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,Ineligible: Inadequate organ function: Neutrophils (1.4) are <1.5 and Platelets (75) are <80.,NCT03613753_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P008,"{""age"":62,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":42,""life_expectancy_months"":5,""ecog_ps"":1,""neutrophils_g_per_l"":2.8,""platelets_g_per_l"":170,""hemoglobin_g_per_l"":115,""ast_alt_xuln"":3.0,""bilirubin_xuln"":1.5,""creatinine_umol_per_l"":110,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,Ineligible: Inadequate organ function: AST/ALT (3.0 x ULN) > 2.0 x ULN and Bilirubin (1.5 x ULN) > 1.25 x ULN.,NCT03613753_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P009,"{""age"":69,""gender"":""M"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + carboplatin"",""time_since_flt_days"":55,""life_expectancy_months"":4,""ecog_ps"":1,""neutrophils_g_per_l"":2.3,""platelets_g_per_l"":145,""hemoglobin_g_per_l"":108,""ast_alt_xuln"":1.2,""bilirubin_xuln"":0.9,""creatinine_umol_per_l"":92,""measurable_disease"":true,""concomitant_malignancy"":true,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",False,Ineligible: Concomitant other malignant disease (active prostate adenocarcinoma) is an exclusion.,NCT03613753_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT03613753,P010,"{""age"":50,""gender"":""F"",""diagnosis"":""relapsed SCLC"",""first_line_chemo"":""etoposide + cisplatin"",""time_since_flt_days"":38,""life_expectancy_months"":4,""ecog_ps"":2,""ps_cause"":""bulky disease"",""neutrophils_g_per_l"":2.0,""platelets_g_per_l"":155,""hemoglobin_g_per_l"":110,""ast_alt_xuln"":1.1,""bilirubin_xuln"":0.8,""creatinine_umol_per_l"":95,""measurable_disease"":true,""concomitant_malignancy"":false,""pregnant_or_lactating"":false,""chemo_contraindication"":false,""prior_target_or_immuno"":false}",True,"Eligible: PS 2 is acceptable because it's due to bulky disease (investigator discretion implied), and all other criteria are met (correct FLC, washout, labs OK).",NCT03613753_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'relapsed', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['etoposide with cisplatin or carboplatin as first-line chemotherapy'], 'allowed': [], 'disallowed': ['target therapy', 'immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 80, 'hemoglobin_g_per_dl': 8, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.25, 'ast_alt_x_uln': 2, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': [""Patients with PS 2 due to obstructive/bulky disease can be included at investigator's discretion""]}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Any contraindications for chemotherapy']}}"
NCT05369312,P001,"{""age"":60,""gender"":""M"",""phase"":""dose escalation"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12C"",""pregnant_or_lactating"":false}",True,"Eligible (DEsc): CRC, PS 1, failed standard therapy, has evaluable lesion, age/organ function/washout/exclusions all OK. Mutation status is irrelevant for escalation.",NCT05369312_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P002,"{""age"":55,""gender"":""F"",""phase"":""dose expansion"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""NF1 LOF"",""pregnant_or_lactating"":false}",True,"Eligible (DExp): NSCLC is a specific target tumor, PS 0, measurable disease, and confirmed NF1 LOF mutation.",NCT05369312_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P003,"{""age"":70,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""Wild Type (no targetable mutation) "",""pregnant_or_lactating"":false}",False,"Ineligible (DExp): In the dose expansion phase, a patient must have one of the required targetable mutations, which is missing here.",NCT05369312_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P004,"{""age"":76,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""metastatic ovarian cancer"",""histology_confirmed"":true,""prior_therapy_status"":""no standard exists"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":false}",False,"Ineligible: Age is 76 years, exceeding the maximum allowed age of 75 years.",NCT05369312_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P005,"{""age"":50,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""locally advanced NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":true,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12V"",""pregnant_or_lactating"":false}",False,"Ineligible: Patient previously received a SHP2 inhibitor, which is a key exclusion.",NCT05369312_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P006,"{""age"":63,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""metastatic breast cancer"",""histology_confirmed"":true,""prior_therapy_status"":""refused standard"",""ecog_ps"":1,""evaluable_lesion"":false,""measurable_lesion"":false,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":false}",False,Ineligible (DEsc): Patient is in the dose escalation phase but lacks an evaluable lesion.,NCT05369312_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P007,"{""age"":48,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic NSCLC"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""symptomatic untreated"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""BRAF Class-3"",""pregnant_or_lactating"":false}",False,"Ineligible (DExp): Has unstable/symptomatic CNS metastasis, which is a major exclusion.",NCT05369312_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P008,"{""age"":35,""gender"":""F"",""phase"":""dose escalation"",""diagnosis"":""locally advanced gastric cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":true,""washout_adequate"":true,""mutation_status"":""N/A"",""pregnant_or_lactating"":true}",False,"Ineligible: Has active autoimmune disease (Lupus) and is pregnant/lactating, violating two exclusion criteria.",NCT05369312_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P009,"{""age"":68,""gender"":""M"",""phase"":""dose expansion"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_therapy_status"":""intolerable to standard"",""ecog_ps"":0,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":false,""mutation_status"":""RTK rearrangement"",""pregnant_or_lactating"":false}",False,"Ineligible (DExp): Washout of prior strong CYP3A inhibitor medication was inadequate, violating a washout exclusion criterion.",NCT05369312_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT05369312,P010,"{""age"":61,""gender"":""F"",""phase"":""dose expansion"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_therapy_status"":""failed standard"",""ecog_ps"":1,""evaluable_lesion"":true,""measurable_lesion"":true,""organ_function_adequate"":true,""prior_shp2_inhibitor"":false,""cns_metastasis"":""none"",""autoimmune_disease"":false,""washout_adequate"":true,""mutation_status"":""KRAS G12D"",""pregnant_or_lactating"":false}",True,"Eligible (DExp): Meets all DE criteria; Pancreatic cancer is a specific target, PS 1, measurable, and confirmed KRAS G12D mutation.",NCT05369312_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['KRAS G12 mutation', 'Class-3 BRAF mutation', 'NF1 LOF mutation', 'RTK mutation', 'RTK amplification', 'RTK rearrangement']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['SHP2 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Evaluable lesion required for dose escalation', 'At least 1 measurable lesion as per RECIST v1.1 required for dose expansion', 'Adequate organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors', 'autoimmune disease', 'ILD', 'cardiac disease', 'bleeding or embolic disease', 'infectious disease', 'chronic diarrhea'], 'concurrent_medications_disallowed': ['moderate or strong CYP3A inhibitor or inducer'], 'other_exclusions': ['Severe or unstable systemic disease', 'Conditions affecting drug swallow and absorption', 'Inadequate wash-out of prior therapies']}}"
NCT02805530,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":15,""candidate_pt_chemo"":true,""life_expectancy_weeks"":30,""leukocytes_k_per_mm3"":5.0,""platelets_k_per_mm3"":180,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",True,"Eligible: All criteria met. Oligometastatic (2 sites), synchronous, PS 0, good labs, and no prior treatment.",NCT02805530_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P002,"{""age"":55,""gender"":""F"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":5,""synchronous_mets_days"":25,""candidate_pt_chemo"":true,""life_expectancy_weeks"":26,""leukocytes_k_per_mm3"":4.5,""platelets_k_per_mm3"":150,""hemoglobin_g_per_dl"":11.0,""creatinine_mg_per_dl"":1.2,""total_bilirubin_xuln"":1.2,""transaminases_xuln"":2.0,""alp_xuln"":3.5,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",True,Eligible: Meets maximum limits for metastases (5 sites) and transaminases (2.0 x ULN) but remains within protocol limits.,NCT02805530_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P003,"{""age"":68,""gender"":""M"",""diagnosis"":""NSCLC large cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":7,""synchronous_mets_days"":10,""candidate_pt_chemo"":true,""life_expectancy_weeks"":35,""leukocytes_k_per_mm3"":6.0,""platelets_k_per_mm3"":200,""hemoglobin_g_per_dl"":13.0,""creatinine_mg_per_dl"":1.4,""total_bilirubin_xuln"":1.1,""transaminases_xuln"":1.8,""alp_xuln"":1.5,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has 7 metastatic sites, which exceeds the oligometastatic limit of 5 sites.",NCT02805530_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":3,""synchronous_mets_days"":60,""candidate_pt_chemo"":true,""life_expectancy_weeks"":40,""leukocytes_k_per_mm3"":4.0,""platelets_k_per_mm3"":160,""hemoglobin_g_per_dl"":11.5,""creatinine_mg_per_dl"":0.8,""total_bilirubin_xuln"":0.9,""transaminases_xuln"":1.0,""alp_xuln"":1.2,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Metastases were identified 60 days (2 months) after diagnosis, violating the synchronous (≤1 month) definition.",NCT02805530_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":4,""synchronous_mets_days"":18,""candidate_pt_chemo"":true,""life_expectancy_weeks"":28,""leukocytes_k_per_mm3"":5.5,""platelets_k_per_mm3"":190,""hemoglobin_g_per_dl"":12.5,""creatinine_mg_per_dl"":1.1,""total_bilirubin_xuln"":1.5,""transaminases_xuln"":2.5,""alp_xuln"":4.8,""malignant_effusion"":true,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has a malignant pleural effusion, which is an exclusion criterion.",NCT02805530_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P006,"{""age"":63,""gender"":""F"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":12,""candidate_pt_chemo"":true,""life_expectancy_weeks"":25,""leukocytes_k_per_mm3"":3.2,""platelets_k_per_mm3"":110,""hemoglobin_g_per_dl"":10.5,""creatinine_mg_per_dl"":1.5,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.3,""alp_xuln"":1.9,""malignant_effusion"":false,""prior_treatment"":true,""prior_treatment_type"":""TKI"",""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,Ineligible: Patient previously received a tyrosine kinase inhibitor (TKI) for their cancer.,NCT02805530_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P007,"{""age"":75,""gender"":""M"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":3,""synchronous_mets_days"":5,""candidate_pt_chemo"":false,""life_expectancy_weeks"":30,""leukocytes_k_per_mm3"":5.1,""platelets_k_per_mm3"":185,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,Ineligible: Patient is not a candidate for platinum-based chemotherapy due to severe pre-existing neuropathy.,NCT02805530_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P008,"{""age"":58,""gender"":""F"",""diagnosis"":""NSCLC large cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":2,""clinical_stage"":""IV"",""mets_sites_count"":1,""synchronous_mets_days"":20,""candidate_pt_chemo"":true,""life_expectancy_weeks"":24,""leukocytes_k_per_mm3"":3.0,""platelets_k_per_mm3"":105,""hemoglobin_g_per_dl"":10.0,""creatinine_mg_per_dl"":1.3,""total_bilirubin_xuln"":1.5,""transaminases_xuln"":2.5,""alp_xuln"":4.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",False,"Ineligible: ECOG Performance Status is 2, which exceeds the maximum allowed PS 1.",NCT02805530_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P009,"{""age"":35,""gender"":""F"",""diagnosis"":""NSCLC adenocarcinoma"",""pathology_confirmed"":true,""ecog_ps"":1,""clinical_stage"":""IV"",""mets_sites_count"":2,""synchronous_mets_days"":15,""candidate_pt_chemo"":true,""life_expectancy_weeks"":28,""leukocytes_k_per_mm3"":5.0,""platelets_k_per_mm3"":180,""hemoglobin_g_per_dl"":12.0,""creatinine_mg_per_dl"":1.0,""total_bilirubin_xuln"":1.0,""transaminases_xuln"":1.5,""alp_xuln"":2.0,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":true}",False,Ineligible: Patient is currently pregnant or lactating.,NCT02805530_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02805530,P010,"{""age"":61,""gender"":""M"",""diagnosis"":""NSCLC squamous cell carcinoma"",""pathology_confirmed"":true,""ecog_ps"":0,""clinical_stage"":""IV"",""mets_sites_count"":1,""synchronous_mets_days"":8,""candidate_pt_chemo"":true,""life_expectancy_weeks"":24,""leukocytes_k_per_mm3"":3.1,""platelets_k_per_mm3"":101,""hemoglobin_g_per_dl"":10.1,""creatinine_mg_per_dl"":1.4,""total_bilirubin_xuln"":1.4,""transaminases_xuln"":2.4,""alp_xuln"":4.9,""malignant_effusion"":false,""prior_treatment"":false,""uncontrolled_disease"":false,""pregnant_or_lactating"":false}",True,"Eligible: A minimum criteria case: single metastasis, labs close to the minimum but still adequate, and life expectancy exactly 24 weeks.",NCT02805530_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['radiotherapy to primary site', 'chemotherapy', 'tyrosine kinase inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 3000, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Oligometastatic disease (≤5 sites)', 'Synchronous metastases (identified within first month of primary tumor diagnosis)', 'Alkaline phosphatase <5×ULN', 'Candidate to platinum-based chemotherapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['malignant pleural or pericardial effusion', 'intercurrent malignant diseases'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous treatments (radiotherapy to primary site, chemotherapy, or tyrosine kinase inhibitor)', 'Basal cell carcinoma allowed if inactive, carcinoma in situ of cervix allowed if completely resected']}}"
NCT02669719,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.2,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":150,""hb_g_per_dl"":10.5,""total_bilirubin_xuln"":1.1,""ast_alt_xuln"":1.5,""crcl_ml_min"":80,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",True,"Eligible: Ideal candidate – non-squamous, EGFR WT/ALK-, treatment naive, PS 1, all labs and washout criteria met.",NCT02669719_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""stage IV NSCLC large cell carcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.5,""neutrophil_g_per_l"":1.8,""plt_g_per_l"":110,""hb_g_per_dl"":9.5,""total_bilirubin_xuln"":1.4,""ast_alt_xuln"":4.0,""crcl_ml_min"":55,""liver_mets"":true,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",True,Eligible: AST/ALT are elevated but acceptable (4.0 x ULN) because the patient has known liver metastases.,NCT02669719_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""stage IV NSCLC squamous cell carcinoma"",""histology_type"":""squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":6.0,""neutrophil_g_per_l"":2.5,""plt_g_per_l"":180,""hb_g_per_dl"":12.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.2,""crcl_ml_min"":90,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Diagnosis is **squamous cell carcinoma**, but the trial requires **non-squamous** NSCLC.",NCT02669719_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P004,"{""age"":45,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""L858R mutation"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.5,""neutrophil_g_per_l"":2.2,""plt_g_per_l"":160,""hb_g_per_dl"":11.0,""total_bilirubin_xuln"":0.9,""ast_alt_xuln"":1.0,""crcl_ml_min"":100,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has an **EGFR mutation**, but the trial requires **wild-type EGFR**.",NCT02669719_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":false,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.0,""neutrophil_g_per_l"":2.1,""plt_g_per_l"":155,""hb_g_per_dl"":10.8,""total_bilirubin_xuln"":1.2,""ast_alt_xuln"":1.6,""crcl_ml_min"":75,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient received prior systemic treatment for the currently diagnosed NSCLC, violating the treatment naive criterion.",NCT02669719_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P006,"{""age"":72,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":2,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.8,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":130,""hb_g_per_dl"":10.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":60,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1.",NCT02669719_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P007,"{""age"":55,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.0,""neutrophil_g_per_l"":1.5,""plt_g_per_l"":100,""hb_g_per_dl"":9.0,""total_bilirubin_xuln"":1.5,""ast_alt_xuln"":3.0,""crcl_ml_min"":44,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Creatinine clearance is $44 \text{ mL/min}$, which is less than the required minimum of $45 \text{ mL/min}$.",NCT02669719_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P008,"{""age"":68,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.8,""neutrophil_g_per_l"":2.3,""plt_g_per_l"":170,""hb_g_per_dl"":12.5,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.8,""crcl_ml_min"":85,""liver_mets"":false,""active_cns_mets"":true,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has active, untreated CNS metastases, which is an exclusion criterion.",NCT02669719_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P009,"{""age"":62,""gender"":""F"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":1,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":5.1,""neutrophil_g_per_l"":2.0,""plt_g_per_l"":140,""hb_g_per_dl"":11.0,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.5,""crcl_ml_min"":70,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":false,""prior_ici_washout_days"":15,""immuno_deficiency"":false,""chronic_steroids"":false,""infection_status"":""none"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Received an experimental monoclonal antibody (Immunotherapy) 15 days prior, violating the 4-week (28 day) washout period.",NCT02669719_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02669719,P010,"{""age"":40,""gender"":""M"",""diagnosis"":""stage IV NSCLC adenocarcinoma"",""histology_type"":""non-squamous"",""egfr_status"":""wild-type"",""alk_status"":""negative"",""systemic_treatment_naive"":true,""ecog_ps"":0,""measurable_disease_recist"":true,""toxicity_recovery"":true,""wbc_g_per_l"":4.9,""neutrophil_g_per_l"":2.4,""plt_g_per_l"":165,""hb_g_per_dl"":11.8,""total_bilirubin_xuln"":1.0,""ast_alt_xuln"":1.4,""crcl_ml_min"":95,""liver_mets"":false,""active_cns_mets"":false,""prior_ici_washout_ok"":true,""immuno_deficiency"":false,""chronic_steroids"":true,""infection_status"":""Hep B positive"",""cardiovascular_event_6m"":false,""other_malignancy_5yr"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Known chronic Hepatitis B infection and requires long-term chronic steroid therapy, both of which are exclusions.",NCT02669719_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'non-squamous', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR wild-type', 'ALK negative']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 45, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 3, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Recovered from toxicity of previous therapy (≤ grade 2 NCI CTCAE)', 'WBC ≥4×10^9/L']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency', 'malignant neoplasm other than lung carcinoma (except adequately treated non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer curatively treated with no evidence of disease for ≥5 years)', 'HIV positivity', 'hepatitis B and/or C infection', 'syphilis'], 'concurrent_medications_disallowed': ['long term chronic steroid or immunosuppressive therapy'], 'other_exclusions': ['Severe hypersensitivity to pemetrexed, carboplatin, or DCVAC ingredients', 'Active severe infections or other severe medical condition']}}"
NCT02318277,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":25,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",True,"Eligible: Failed prior therapy, sufficient washout (21 days), no prior ICI/IDO, no CNS mets, and no autoimmune history.",NCT02318277_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""advanced NSCLC"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":true,""tumor_type_ici_approved"":true,""days_since_last_anticancer"":28,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",True,"Eligible: Prior ICI is permitted since NSCLC is an approved tumor type for PD-1 pathway agents, and all washout periods are adequate.",NCT02318277_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""histology_confirmed"":true,""prior_treatment_regimens"":3,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":true,""tumor_type_ici_approved"":false,""days_since_last_anticancer"":30,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,Ineligible: Prior treatment with ICI (anti-CTLA-4) is explicitly excluded for melanoma in this trial (due to the study design/agents used).,NCT02318277_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P004,"{""age"":50,""gender"":""F"",""diagnosis"":""metastatic pancreatic cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":15,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Received anti-cancer medication (chemotherapy) 15 days ago, violating the 21-day washout period.",NCT02318277_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P005,"{""age"":62,""gender"":""M"",""diagnosis"":""advanced head and neck cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":22,""investigational_washout_ok"":false,""inv_drug_washout_days"":20,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Participated in another study with an investigational drug 20 days prior, violating the 28-day minimum washout.",NCT02318277_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P006,"{""age"":45,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":25,""investigational_washout_ok"":true,""autoimmune_disease"":true,""autoimmune_status"":""inactive vitiligo"",""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,Ineligible: Has an inactive autoimmune process (vitiligo). Both active and inactive autoimmune diseases are exclusions.,NCT02318277_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P007,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic bladder cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":23,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":true,""cns_mets_status"":""untreated and symptomatic"",""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has untreated, symptomatic CNS metastases.",NCT02318277_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P008,"{""age"":55,""gender"":""F"",""diagnosis"":""advanced cervical cancer"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":24,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":true,""ild_status"":""mild ILD"",""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Has evidence of interstitial lung disease (ILD), which is an exclusion.",NCT02318277_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P009,"{""age"":40,""gender"":""M"",""diagnosis"":""metastatic sarcoma"",""histology_confirmed"":true,""prior_treatment_regimens"":2,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":28,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":true,""rad_date_weeks"":1,""rad_toxicity_recovered"":true,""pregnant_or_lactating"":false}",False,"Ineligible: Received radiotherapy 1 week prior, violating the 2-week minimum washout period for prior radiation.",NCT02318277_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT02318277,P010,"{""age"":67,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""histology_confirmed"":true,""prior_treatment_regimens"":1,""failed_standard_therapy"":true,""prior_ici_ido_inhibitor"":false,""days_since_last_anticancer"":22,""investigational_washout_ok"":true,""autoimmune_disease"":false,""interstitial_lung_disease"":false,""untreated_cns_mets"":false,""recent_radiotherapy"":false,""pregnant_or_lactating"":true}",False,Ineligible: Patient is currently pregnant or breastfeeding.,NCT02318277_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['at least 1 prior treatment regimen for locally advanced or metastatic disease'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Failed or intolerant to standard treatment or refused standard treatment']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior treatment with immune checkpoint inhibitors', 'prior IDO inhibitor treatment (except for approved tumor types)', 'active or inactive autoimmune process', 'evidence of interstitial lung disease or active, non-infectious pneumonitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Receipt of any anticancer medication within 21 days prior to first dose', 'Radiotherapy within 2 weeks of initiating treatment', 'Participation in another study with investigational drug within 28 days or 5 half-lives prior to first dose']}}"
NCT00910676,P001,"{""age"":65,""gender"":""M"",""cancer_type"":""metastatic colorectal cancer"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",True,"Eligible: Metastatic CRC patient, failed Irinotecan, planned Cetuximab, no pre-existing skin toxicity, and no contraindication to local steroids/study drugs.",NCT00910676_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P002,"{""age"":70,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""Two prior chemo regimens failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",True,"Eligible: Metastatic NSCLC, failed >1 chemo regimen, planned Erlotinib, and meets all other safety/toxicity criteria.",NCT00910676_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P003,"{""age"":58,""gender"":""M"",""cancer_type"":""metastatic colorectal cancer"",""prior_chemo_failure"":""5FU-based chemo failure, no prior Irinotecan"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",False,Ineligible: CRC patient receiving Cetuximab must have failed an Irinotecan-containing chemotherapy regimen.,NCT00910676_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P004,"{""age"":62,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":true,""cutaneous_toxicity_type"":""Grade 2 rash"",""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",False,"Ineligible: Has pre-existing cutaneous toxicity (Grade 2 rash), violating the inclusion criterion of 'No pre-existing cutaneous toxicity'.",NCT00910676_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P005,"{""age"":50,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":true,""contraindication_reason"":""severe skin atrophy"",""severe_hypersensitivity"":false}",False,Ineligible: Has a contraindication to local corticotherapy (Diprosone cream) due to severe skin atrophy.,NCT00910676_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P006,"{""age"":45,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Erlotinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":true,""hypersensitivity_to"":""Cetuximab"",""betamethasone_allergy"":false}",False,"Ineligible: History of severe (Grade III/IV) hypersensitivity reaction to Cetuximab, a study-related drug.",NCT00910676_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P007,"{""age"":75,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false,""betamethasone_allergy"":true}",False,Ineligible: Known allergy to Betamethasone (the active ingredient in Diprosone cream).,NCT00910676_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P008,"{""age"":68,""gender"":""F"",""cancer_type"":""metastatic NSCLC"",""prior_chemo_failure"":""One prior chemo regimen failure"",""planned_egfr_inhibitor"":""Gefitinib"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",False,Ineligible: The trial is specific to Cetuximab or Erlotinib; the planned EGFR inhibitor is Gefitinib.,NCT00910676_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P009,"{""age"":60,""gender"":""M"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":true,""hypersensitivity_to"":""Irinotecan"",""betamethasone_allergy"":false}",False,Ineligible: History of severe hypersensitivity (Grade IV anaphylaxis) to Irinotecan.,NCT00910676_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT00910676,P010,"{""age"":55,""gender"":""F"",""cancer_type"":""metastatic CRC"",""prior_chemo_failure"":""Irinotecan failure"",""planned_egfr_inhibitor"":""Cetuximab + Irinotecan"",""pre_existing_cutaneous_toxicity"":false,""contraindication_corticosteroid"":false,""severe_hypersensitivity"":false}",True,"Eligible: Meets all criteria. CRC post-Irinotecan failure, planned Cetuximab (with Irinotecan re-challenge is acceptable), no contraindications.",NCT00910676_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'colorectal cancer or non-small cell lung cancer', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['chemotherapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['No pre-existing cutaneous toxicity']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe hypersensibility reactions (Grade III or IV) due to Cetuximab, Irinotecan or Erlotinib'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Contraindication to local corticotherapy', 'Betamethasone or one of excipient product allergy']}}"
NCT03871205,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":120,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",True,"Eligible: Meets all inclusion criteria: confirmed lung cancer, failed both chemo and targeted therapy, good PS, and no infectious or other major exclusions.",NCT03871205_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":100,""life_expectancy_days"":100,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Age is 72 years, exceeding the maximum allowed age of 70 years.",NCT03871205_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P003,"{""age"":60,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":false,""karnofsky_ps"":90,""life_expectancy_days"":150,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Patient has only failed chemotherapy but not targeted therapy, violating the requirement to have failed both.",NCT03871205_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":70,""life_expectancy_days"":95,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Karnofsky Performance Status is 70, which is equivalent to ECOG PS 2, exceeding the maximum allowed KPS 90-100 (ECOG 0-1).",NCT03871205_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":100,""life_expectancy_days"":80,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Life expectancy is estimated at 80 days, which is less than the required minimum of 90 days.",NCT03871205_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":110,""organ_function_adequate"":true,""active_infection"":true,""infection_type"":""active Hepatitis C"",""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,"Ineligible: Has an actively infectious condition (Active Hepatitis C), which is an exclusion.",NCT03871205_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":140,""organ_function_adequate"":false,""inadequate_function_reason"":""severe renal impairment"",""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":false}",False,Ineligible: Inadequate organ function (severe renal impairment) is present.,NCT03871205_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P008,"{""age"":63,""gender"":""F"",""diagnosis"":""SCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":130,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":true,""immunodeficiency_type"":""Common Variable Immunodeficiency"",""investigational_agent"":false,""pregnant_or_lactating"":false}",False,Ineligible: History of primary immunodeficiency (Common Variable Immunodeficiency).,NCT03871205_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P009,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":115,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":true,""investigational_agent_type"":""within 30 days"",""pregnant_or_lactating"":false}",False,Ineligible: Currently receiving or recently received another investigational agent.,NCT03871205_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT03871205,P010,"{""age"":66,""gender"":""F"",""diagnosis"":""NSCLC"",""pathology_confirmed"":true,""prior_chemo_failed"":true,""prior_target_failed"":true,""karnofsky_ps"":90,""life_expectancy_days"":95,""organ_function_adequate"":true,""active_infection"":false,""immunodeficiency"":false,""investigational_agent"":false,""pregnant_or_lactating"":true}",False,Ineligible: Patient is pregnant or breastfeeding.,NCT03871205_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 70}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathologically', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['standard chemotherapy', 'targeted therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['adequate organ functions']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['primary immunodeficiency'], 'concurrent_medications_disallowed': ['other investigational agents'], 'other_exclusions': ['actively infectious condition including hepatitis', 'concurrent opportunistic infections', 'active systemic infections', 'coagulation disorders', 'active major medical illnesses']}}"
NCT04311710,P001,"{""age"":65,""gender"":""M"",""trial_part"":""Part 1, Arms A/B"",""diagnosis"":""Metastatic Melanoma"",""histology_confirmed"":true,""prior_treatment_melanoma"":""Untreated"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",True,"Eligible (Melanoma): Meets the specific inclusion for Melanoma (untreated Stage IV) and general criteria (PS 0, no drug allergy).",NCT04311710_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P002,"{""age"":55,""gender"":""F"",""trial_part"":""Part 2, Arm B"",""diagnosis"":""Metastatic RCC"",""histology_confirmed"":true,""prior_treatment_rcc"":""Previously treated"",""ecog_ps"":1,""karnofsky_ps_percent"":80,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",True,"Eligible (RCC): Meets RCC criteria (Metastatic, PS 0-1, KPS 80%), and no general exclusions apply.",NCT04311710_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P003,"{""age"":70,""gender"":""M"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Recurrent NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Failed chemo"",""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR wild type, ALK negative""}",True,"Eligible (NSCLC): Confirmed recurrent NSCLC, PS 1, and no sensitive EGFR/ALK alterations present.",NCT04311710_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P004,"{""age"":60,""gender"":""F"",""trial_part"":""Part 1, Arms A/B"",""diagnosis"":""Metastatic Melanoma"",""histology_confirmed"":true,""prior_treatment_melanoma"":""Failed prior anti-PD-1"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",False,Ineligible (Melanoma): Melanoma must be **previously untreated** (first-line) but this patient has failed prior anti-PD-1 therapy.,NCT04311710_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P005,"{""age"":58,""gender"":""M"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Stage IV NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Treatment naive"",""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR L858R mutation"",""sensitive_to_tki"":true}",False,Ineligible (NSCLC): Has an **EGFR mutation** (L858R) that is sensitive to available targeted inhibitor therapy (TKI).,NCT04311710_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P006,"{""age"":63,""gender"":""F"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Advanced HCC"",""histology_confirmed"":true,""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_hepatic_encephalopathy"":true,""hcc_portal_hypertension"":false,""nsclc_exclusions_apply"":false}",False,"Ineligible (HCC): History of hepatic encephalopathy, which is a specific exclusion for the HCC arm.",NCT04311710_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P007,"{""age"":45,""gender"":""M"",""trial_part"":""Part 2, Arm B"",""diagnosis"":""Metastatic RCC"",""histology_confirmed"":true,""prior_treatment_rcc"":""Previously treated"",""ecog_ps"":2,""karnofsky_ps_percent"":60,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",False,"Ineligible (RCC): ECOG Performance Status is 2, which exceeds the maximum allowed PS 1 (KPS must be $\geq 70\%$). ",NCT04311710_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P008,"{""age"":50,""gender"":""F"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""histology_confirmed"":true,""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":true,""allergy_drug"":""Nivolumab"",""hcc_exclusions_apply"":false,""nsclc_exclusions_apply"":false}",False,Ineligible: History of allergy/hypersensitivity to one of the study drug components (Nivolumab).,NCT04311710_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P009,"{""age"":75,""gender"":""M"",""trial_part"":""Part 1, Arm A"",""diagnosis"":""Advanced HCC"",""histology_confirmed"":true,""ecog_ps"":1,""karnofsky_ps_percent"":90,""study_drug_allergy"":false,""hcc_hepatic_encephalopathy"":false,""hcc_portal_hypertension"":false,""nsclc_exclusions_apply"":false,""hbv_hdv_coinfection"":true}",False,Ineligible (HCC): Active coinfection with Hepatitis D Virus (HDV) in a participant with HBV is an exclusion.,NCT04311710_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT04311710,P010,"{""age"":61,""gender"":""F"",""trial_part"":""Part 2, Arm A"",""diagnosis"":""Stage IV NSCLC"",""histology_confirmed"":true,""prior_treatment_nsclc"":""Failed chemo"",""ecog_ps"":0,""karnofsky_ps_percent"":100,""study_drug_allergy"":false,""hcc_exclusions_apply"":false,""nsclc_molecular_status"":""EGFR wild type, ALK positive but TKI resistant""}",True,"Eligible (NSCLC): Although ALK-positive, the molecular status specifies it is TKI-resistant, meaning it is **not sensitive to available targeted inhibitor therapy**, thus making the patient eligible.",NCT04311710_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Histologically confirmed urothelial carcinoma for Part 1 Arm A: Advanced/mUC', 'Histological confirmation of Hepatocellular Cancer (HCC) for Part 1 Arm A: Advanced HCC', 'Histologically confirmed stage IV or recurrent NSCLC for Part 2 Arm A: Metastatic NSCLC', 'Histological confirmation of Renal Cell Carcinoma (RCC) for Part 2 Arm B: Advanced or Metastatic RCC', 'Karnofsky performance status ≥ 70% for RCC (Part 2 Arm B)']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergy or hypersensitivity to study drug components'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['History of hepatic encephalopathy or evidence of portal hypertension for Advanced HCC', 'Active coinfection with hepatitis D virus infection in participants with HBV for Advanced HCC', 'Known ALK translocations and EGFR mutation sensitive to available targeted inhibitor therapy for Metastatic NSCLC']}}"
NCT07006727,P001,"{""age"": 60, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 85, ""QTcF_msec"": 420, ""ANC_g_per_l"": 1.5, ""platelets_g_per_l"": 150, ""hemoglobin_g_per_dl"": 11.0, ""cns_mets"": ""stable, asymptomatic"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",True,"Eligible (SCLC, DE): Meets all general criteria, is DLL3 positive, and has good organ function. 1 prior line is acceptable.",NCT07006727_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P002,"{""age"": 70, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 90, ""QTcF_msec"": 440, ""ANC_g_per_l"": 1.8, ""platelets_g_per_l"": 65, ""hemoglobin_g_per_dl"": 10.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Platelet count is $65 \\times 10^9/\\text{L}$, which is below the minimum required $75 \\times 10^9/\\text{L}$.",NCT07006727_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P003,"{""age"": 55, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": true, ""eGFR_ml_min"": 75, ""QTcF_msec"": 480, ""ANC_g_per_l"": 2.0, ""platelets_g_per_l"": 120, ""hemoglobin_g_per_dl"": 9.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: QTcF is 480 msec, which is $\\geq 470 \\text{ msec}$.",NCT07006727_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P004,"{""age"": 45, ""diagnosis"": ""LCNEC of the lung"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 95, ""QTcF_msec"": 450, ""ANC_g_per_l"": 1.9, ""platelets_g_per_l"": 180, ""hemoglobin_g_per_dl"": 12.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",True,"Eligible (LCNEC, DE): LCNEC is an inclusion only for Dose Escalation, and all criteria are met.",NCT07006727_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P005,"{""age"": 63, ""diagnosis"": ""LCNEC of the lung"", ""dll3_positive"": true, ""prior_lines"": 3, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 80, ""QTcF_msec"": 430, ""ANC_g_per_l"": 1.4, ""platelets_g_per_l"": 100, ""hemoglobin_g_per_dl"": 9.2, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",False,"Ineligible: LCNEC is not included in the Dose Expansion phase. Also, prior lines (3) exceed the maximum (2) for the Dose Expansion phase, and ANC (1.4) is below $1.0 \\times 10^9/\\text{L}$.",NCT07006727_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P006,"{""age"": 68, ""diagnosis"": ""NEPC (treatment-emergent)"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""prior_rlt"": ""Lu-177-PSMA RLT"", ""eGFR_ml_min"": 70, ""QTcF_msec"": 465, ""ANC_g_per_l"": 1.2, ""platelets_g_per_l"": 80, ""hemoglobin_g_per_dl"": 9.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",True,"Eligible (NEPC, DExp): NEPC is a target for DExp, 2 prior lines, prior Lu-177-PSMA RLT is allowed, and meets all organ/imaging criteria.",NCT07006727_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P007,"{""age"": 75, ""diagnosis"": ""GEP-NEC"", ""dll3_positive"": true, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""prior_rlt"": ""Y-90 RLT"", ""eGFR_ml_min"": 80, ""QTcF_msec"": 445, ""ANC_g_per_l"": 1.7, ""platelets_g_per_l"": 110, ""hemoglobin_g_per_dl"": 10.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",False,"Ineligible: Prior RLT (Y-90) is an exclusion criterion, as only Lu-177-PSMA RLT for NEPC is allowed.",NCT07006727_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P008,"{""age"": 50, ""diagnosis"": ""GEP-NEC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 65, ""QTcF_msec"": 450, ""ANC_g_per_l"": 1.5, ""platelets_g_per_l"": 105, ""hemoglobin_g_per_dl"": 10.0, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""uptake seen"", ""phase"": ""Dose Expansion""}",True,"Eligible (GEP-NEC, DExp): Meets all DExp criteria, including 2 prior lines (max allowed) and positive imaging/measurable lesion.",NCT07006727_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P009,"{""age"": 62, ""diagnosis"": ""SCLC"", ""dll3_positive"": false, ""prior_lines"": 1, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 90, ""QTcF_msec"": 435, ""ANC_g_per_l"": 1.6, ""platelets_g_per_l"": 130, ""hemoglobin_g_per_dl"": 11.5, ""cns_mets"": ""none"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Tumor is DLL3 negative, which is a required biomarker for inclusion.",NCT07006727_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT07006727,P010,"{""age"": 40, ""diagnosis"": ""SCLC"", ""dll3_positive"": true, ""prior_lines"": 2, ""prior_dll3_therapy"": false, ""eGFR_ml_min"": 98, ""QTcF_msec"": 410, ""ANC_g_per_l"": 1.9, ""platelets_g_per_l"": 160, ""hemoglobin_g_per_dl"": 12.5, ""cns_mets"": ""symptomatic metastases"", ""ild_pneumonitis_grade"": 0, ""urinary_obstruction"": false, ""measurable_lesion_uptake"": ""N/A (Dose Escalation)"", ""phase"": ""Dose Escalation""}",False,"Ineligible: Patient has symptomatic CNS metastases, which is an exclusion criterion.",NCT07006727_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'local histology and IHC', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['DLL3 expression']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-containing chemotherapy'], 'allowed': ['DLL3-targeted therapy for SCLC', 'PSMA-targeted, Lu-177-based RLT for NEPC'], 'disallowed': ['DLL3-targeted therapy except for SCLC', 'RLT except for NEPC'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.0, 'platelets': 75, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion per RECIST 1.1 with 111In-ETN029 uptake higher than surrounding tissues on SPECT/CT', 'Locally advanced, unresectable, or metastatic SCLC, LCNEC, NEPC, or GEP-NEC']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['interstitial lung disease or pneumonitis ≥ Grade 2'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Unmanageable urinary tract obstruction or urinary incontinence', 'Leptomeningeal disease']}}"
NCT04306900,P001,"{""age"":60,""gender"":""M"",""diagnosis"":""Metastatic Colorectal Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":15,""prior_investigational_washout_days"":35,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",True,"Eligible: Meets all core criteria (PS 0, metastatic, adequate life expectancy), and no exclusionary factors present (washout > 28 days).",NCT04306900_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Unresectable Head and Neck SCC"",""histology_confirmed"":true,""metastatic"":false,""unresectable"":true,""ecog_ps"":1,""life_expectancy_weeks"":13,""prior_investigational_washout_days"":20,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",False,"Ineligible: Received an investigational agent 20 days prior, violating the 28-day washout period.",NCT04306900_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P003,"{""age"":55,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":2,""life_expectancy_weeks"":16,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",False,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1.",NCT04306900_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P004,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":10,""prior_investigational_washout_days"":40,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",False,"Ineligible: Life expectancy is only 10 weeks, which is less than the required minimum of > 12 weeks.",NCT04306900_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic Renal Cell Carcinoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":20,""prior_investigational_washout_days"":45,""steroid_immunosuppressive_use"":true,""steroid_details"":""prednisone 20 mg/day for chronic back pain"",""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",False,Ineligible: Receiving high-dose systemic steroid therapy (Prednisone $20 \text{ mg/day}$) which is an exclusion.,NCT04306900_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P006,"{""age"":62,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_investigational_washout_days"":32,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":true,""autoimmune_details"":""severe, active rheumatoid arthritis requiring ongoing treatment"",""hypersensitivity_history"":false,""other_active_malignancy"":false}",False,Ineligible: History of severe autoimmune disease (active rheumatoid arthritis).,NCT04306900_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic Pancreatic Cancer"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":18,""prior_investigational_washout_days"":38,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":true,""hypersensitivity_details"":""Grade 4 anaphylaxis to Rituximab (monoclonal antibody)"",""other_active_malignancy"":false}",False,Ineligible: History of severe hypersensitivity reaction (Grade 4 anaphylaxis) to a monoclonal antibody (Rituximab).,NCT04306900_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P008,"{""age"":70,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":17,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":true,""other_malignancy_details"":""recently diagnosed prostate cancer requiring active hormone therapy"",""uncontrolled_illness"":false}",False,Ineligible: Has another active malignancy (prostate cancer) requiring ongoing treatment (hormone therapy).,NCT04306900_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P009,"{""age"":40,""gender"":""M"",""diagnosis"":""Metastatic Sarcoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":0,""life_expectancy_weeks"":25,""prior_investigational_washout_days"":30,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false,""uncontrolled_illness"":true,""illness_details"":""uncontrolled diabetes and active sepsis"",""brain_mets"":""stable, asymptomatic""}",False,Ineligible: Has an uncontrolled intercurrent illness (uncontrolled diabetes and active sepsis).,NCT04306900_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT04306900,P010,"{""age"":58,""gender"":""F"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""histology_confirmed"":true,""metastatic"":true,""ecog_ps"":1,""life_expectancy_weeks"":19,""prior_investigational_washout_days"":29,""steroid_immunosuppressive_use"":false,""autoimmune_disease_history"":false,""hypersensitivity_history"":false,""other_active_malignancy"":false}",True,Eligible: Meets all inclusion criteria. The 29-day washout for the investigational agent is acceptable ($\geq 28$ days).,NCT04306900_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'unresectable or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['severe allergy or hypersensitivity to study treatment components', 'severe hypersensitivity reaction to any monoclonal antibody', 'severe autoimmune disease'], 'concurrent_medications_disallowed': ['high-dose systemic steroid therapy', 'immunosuppressive therapy'], 'other_exclusions': ['other active malignancy requiring ongoing treatment']}}"
NCT01487499,P001,"{""age"":65,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",True,"Eligible (Consolidation): Limited stage SCLC, responder to SOC, no disseminated disease, and fit for bronchoscopy.",NCT01487499_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P002,"{""age"":70,""gender"":""F"",""cancer_type"":""Disseminated SCLC"",""disease_status"":""Recurrent disseminated"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":true,""cns_mets_only"":false,""central_obstruction_symptoms"":true,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",True,"Eligible (Recurrent Disseminated): Recurrent disseminated disease after SOC, with symptoms of central tumor obstruction, and fit for bronchoscopy.",NCT01487499_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P003,"{""age"":58,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Recurrent limited stage"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":false,""mediastinal_hilar_recurrence"":true,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",True,"Eligible (Recurrent Limited Stage): Recurrent limited stage with mediastinal/hilar recurrence, and no prior intratumoral cisplatin.",NCT01487499_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P004,"{""age"":62,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Non-Responder (Progression) to SOC"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",False,Ineligible (Consolidation): Required to be a **responder** to the standard of care treatment.,NCT01487499_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P005,"{""age"":75,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":true,""dissemination_site"":""Bone/Liver"",""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",False,"Ineligible (Consolidation): Has evidence of disseminated disease (Bone/Liver), other than CNS metastasis.",NCT01487499_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P006,"{""age"":60,""gender"":""F"",""cancer_type"":""Disseminated SCLC"",""disease_status"":""Recurrent disseminated"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":true,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""bronchoscopy_risk"":false}",False,Ineligible (Recurrent Disseminated): Recurrent disseminated SCLC must have **symptoms related to central tumor obstruction**; patient is asymptomatic.,NCT01487499_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P007,"{""age"":68,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Recurrent limited stage"",""prior_soc_completed"":true,""response_to_soc"":""N/A"",""disseminated_disease"":false,""mediastinal_hilar_recurrence"":true,""previous_intratumoral_cisplatin"":true,""bronchoscopy_risk"":false}",False,Ineligible (Recurrent Limited Stage): Patient was previously treated with intratumoral cisplatin for this recurrence site.,NCT01487499_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P008,"{""age"":50,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":true,""cns_mets_status"":""treated and stable"",""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",True,"Eligible (Consolidation): Disseminated disease is restricted to CNS metastasis, which is allowed for this cohort, and meets all other criteria.",NCT01487499_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P009,"{""age"":55,""gender"":""M"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":false,""prior_treatment_details"":""Only received chemotherapy, refused radiation"",""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":false}",False,Ineligible: Did not complete the **standard systemic chemotherapy and radiation therapy** for limited stage SCLC.,NCT01487499_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT01487499,P010,"{""age"":72,""gender"":""F"",""cancer_type"":""Limited Stage SCLC"",""disease_status"":""Post-SOC consolidation"",""prior_soc_completed"":true,""response_to_soc"":""Responder"",""disseminated_disease"":false,""cns_mets_only"":false,""central_obstruction_symptoms"":false,""previous_intratumoral_cisplatin"":false,""bronchoscopy_risk"":true,""bronchoscopy_risk_details"":""Severe COPD/high risk of respiratory failure"",""english_speaking"":true}",False,Ineligible: Patient is at risk undergoing a bronchoscopy due to severe COPD.,NCT01487499_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'limited stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['standard of care treatment'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Responders with no evidence of disseminated disease other than CNS metastasis', 'Recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction', 'Recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['At risk undergoing a bronchoscopy']}}"
NCT05450692,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",True,"Eligible: Meets all core requirements (WT, prior ICI/Platinum, PS 1) and all strict ICI toxicity and prior ATR inhibitor exclusions are met.",NCT05450692_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Locally Advanced NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":2,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":18,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Received 2 prior lines of anti-PD-(L)1 therapy. Maximum allowed is one line.,NCT05450692_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":false,""molecular_status"":""EGFR L858R mutation"",""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Does not have EGFR/ALK wild-type status (has an EGFR mutation).,NCT05450692_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":2,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":16,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Received 2 prior lines of platinum-based chemotherapy in the metastatic setting. Maximum allowed is one line.,NCT05450692_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P005,"{""age"":60,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":2,""life_expectancy_weeks"":13,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,"Ineligible: ECOG Performance Status is 2, exceeding the maximum allowed PS 1.",NCT05450692_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""prior_ici_discontinued_ae"":true,""discontinuation_reason"":""Grade 2 pneumonitis"",""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Prior ICI therapy was permanently discontinued due to a toxicity (Grade 2 pneumonitis).,NCT05450692_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P007,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":18,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":false,""unresolved_ae"":""Persistent Grade 3 neuropathy"",""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Persistent toxicity (Grade > 2 neuropathy) caused by previous anticancer therapy.,NCT05450692_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P008,"{""age"":62,""gender"":""F"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":12,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":true,""imae_type"":""Grade 3 Colitis"",""prior_atr_inhibitor"":false,""autoimmune_disorder"":false}",False,Ineligible: Experienced a Grade $\\geq 3$ immune-mediated adverse event (Colitis) while receiving prior anti-PD-(L)1 therapy.,NCT05450692_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P009,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":0,""life_expectancy_weeks"":20,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":true,""prior_atr_inhibitor_name"":""Atemonistat"",""autoimmune_disorder"":false}",False,Ineligible: Has received a prior ATR inhibitor (Atemonistat).,NCT05450692_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT05450692,P010,"{""age"":70,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""egfr_alk_wt"":true,""prior_ici_lines"":1,""prior_platinum_lines_met"":1,""progression_documented"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""prior_ici_discontinued_ae"":false,""ici_ae_resolved"":true,""ici_g3_imae"":false,""prior_atr_inhibitor"":false,""autoimmune_disorder"":true,""autoimmune_status"":""active Sjogren's syndrome"",""weight_kg"":80}",False,Ineligible: Has an active or prior documented autoimmune or inflammatory disorder (active Sjogren's syndrome).,NCT05450692_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR wild-type', 'ALK wild-type']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['anti-PD-(L)1 therapy', 'platinum doublet containing therapy'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 3, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Body weight > 30 kg', 'No cancer-associated cachexia', 'Adequate organ function and marrow reserve']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['another primary malignancy within 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed SCLC and NSCLC histology', 'Persistent toxicities (CTCAE Grade > 2)', 'Active or prior documented autoimmune or inflammatory disorders', 'More than one line of prior anti-PD-(L)1 therapy', 'Toxicity leading to permanent discontinuation of prior anti-PD(L)1 therapy', 'Grade ≥ 3 immune-mediated adverse event while receiving prior anti-PD(L)1 therapy', 'Required use of additional immunosuppression other than corticosteroids', 'More than one prior line of platinum-based chemotherapy in metastatic setting', 'Prior ATR inhibitor']}}"
NCT01064466,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",True,"Eligible: Meets all core inclusion criteria for SCLC (biopsy confirmed, measurable, adequate PS/organ function) and has none of the listed exclusions.",NCT01064466_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":true,""tx_details"":""receiving concurrent radiation therapy for bone mets"",""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,Ineligible: Receiving other anti-cancer therapies (concurrent radiation therapy) which cannot be stopped currently.,NCT01064466_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P003,"{""age"":22,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,"Ineligible: Age is 22 years old, which is below the minimum required age of 24 years old.",NCT01064466_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Inadequate"",""organ_function_details"":""Severe renal impairment"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,Ineligible: Does not have adequate organ function (severe renal impairment).,NCT01064466_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":true,""pneumonectomy_details"":""right lung removed 5 years ago"",""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,Ineligible: History of pneumonectomy.,NCT01064466_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P006,"{""age"":68,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":true,""illness_details"":""active, uncontrolled septic infection"",""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,"Ineligible: Has other serious intercurrent illness or infectious diseases (active, uncontrolled septic infection).",NCT01064466_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P007,"{""age"":60,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":true,""other_cancer"":""Squamous Cell Carcinoma of the skin (untreated)"",""bleed_tendency"":false,""allergy_to_drugs"":false}",False,Ineligible: Has more than one different kind of cancer at the same time (SCLC and untreated Squamous Cell Carcinoma of the skin).,NCT01064466_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P008,"{""age"":50,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":true,""bleed_details"":""Active Grade 3 GI bleed"",""allergy_to_drugs"":false}",False,Ineligible: Has a serious clot or bleed tendency (Active Grade 3 GI bleed).,NCT01064466_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P009,"{""age"":58,""gender"":""M"",""diagnosis"":""SCLC"",""biopsy_confirmed"":false,""biopsy_details"":""Clinical diagnosis only, biopsy unsuccessful"",""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":false}",False,Ineligible: Lacks a confirmed lung tissue biopsy diagnosis of SCLC.,NCT01064466_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT01064466,P010,"{""age"":63,""gender"":""F"",""diagnosis"":""SCLC"",""biopsy_confirmed"":true,""suitable_for_biopsy"":true,""measurable_disease"":true,""organ_function"":""Adequate"",""performance_status"":""Adequate"",""pneumonectomy_history"":false,""concurrent_anti_cancer_tx"":false,""intercurrent_illness"":false,""multiple_cancers"":false,""bleed_tendency"":false,""allergy_to_drugs"":true,""allergy_details"":""Severe allergy to cisplatin"",""pregnant_or_breastfeeding"":true}",False,Ineligible: Patient is pregnant/breastfeeding (Exclusion 3/4). Also has a serious allergy to drugs (Exclusion 7).,NCT01064466_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 24, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'lung tissue biopsy', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Adequate organ functions', 'Able to swallow capsules', 'Sign an informed consent form']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['Pneumonectomy', 'More than one different kind of cancer at the same time'], 'concurrent_medications_disallowed': ['Other anti-cancer therapies'], 'other_exclusions': ['Serious Allergy to Drugs', 'Clot or Bleed Tendency', 'Serious Risks or Serious Adverse Events of the drug product']}}"
NCT00375245,P001,"{""age"":55,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""ecog_ps"":1,""life_expectancy_weeks"":15,""washout_weeks"":5,""anc"":2000,""platelets"":120000,""creatinine_clearance_ml_min"":80,""ast_alt_x_uln"":1.5,""triglycerides_mg_dl"":250,""cns_mets"":""stable, asymptomatic"",""concurrent_meds"":[],""gi_malabsorption"":false}",True,"Eligible: Meets all PS, life expectancy, washout, and organ function criteria. CNS mets are stable and no prohibited drugs or GI issues.",NCT00375245_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P002,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""ecog_ps"":2,""life_expectancy_weeks"":13,""washout_weeks"":3,""anc"":1800,""platelets"":110000,""creatinine_clearance_ml_min"":75,""ast_alt_x_uln"":1.8,""triglycerides_mg_dl"":300,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",False,"Ineligible: Prior chemotherapy washout period is 3 weeks, which is less than the required minimum of 4 weeks.",NCT00375245_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P003,"{""age"":70,""gender"":""M"",""diagnosis"":""Multiple Myeloma (Phase IB)"",""ecog_ps"":1,""life_expectancy_weeks"":20,""washout_weeks"":4,""anc"":1100,""platelets"":60000,""creatinine_clearance_ml_min"":90,""ast_alt_x_uln"":2.0,""triglycerides_mg_dl"":400,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",True,"Eligible (Hematologic): Meets hematologic specific criteria: ANC $\\geq 1,000$, PLT $\\geq 50,000$, and all other criteria.",NCT00375245_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""Metastatic Colon Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":16,""washout_weeks"":5,""anc"":1400,""platelets"":105000,""creatinine_clearance_ml_min"":85,""ast_alt_x_uln"":1.2,""triglycerides_mg_dl"":280,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",False,"Ineligible: Absolute Neutrophil Count (ANC) is 1,400/$\mu\text{L}$, below the minimum required 1,500/$\mu\text{L}$ for solid tumor patients.",NCT00375245_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P005,"{""age"":45,""gender"":""M"",""diagnosis"":""Metastatic Melanoma"",""ecog_ps"":0,""life_expectancy_weeks"":18,""washout_weeks"":4,""anc"":2500,""platelets"":150000,""creatinine_clearance_ml_min"":55,""ast_alt_x_uln"":1.0,""triglycerides_mg_dl"":350,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",False,"Ineligible: Creatinine clearance is $55 \text{ mL/min}$, which is below the minimum required $60 \text{ mL/min}$.",NCT00375245_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P006,"{""age"":50,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":14,""washout_weeks"":6,""anc"":2200,""platelets"":130000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":2.2,""triglycerides_mg_dl"":550,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":false}",False,"Ineligible: Serum triglycerides are $550 \text{ mg/dL}$, exceeding the maximum allowed $500 \text{ mg/dL}$.",NCT00375245_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""Metastatic Prostate Cancer"",""ecog_ps"":2,""life_expectancy_weeks"":12,""washout_weeks"":7,""anc"":2000,""platelets"":115000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":1.5,""triglycerides_mg_dl"":200,""cns_mets"":""uncontrolled and symptomatic"",""concurrent_meds"":[],""gi_malabsorption"":false}",False,Ineligible: Has uncontrolled brain metastases.,NCT00375245_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P008,"{""age"":58,""gender"":""F"",""diagnosis"":""Metastatic Urothelial Carcinoma"",""ecog_ps"":1,""life_expectancy_weeks"":17,""washout_weeks"":4,""anc"":1900,""platelets"":125000,""creatinine_clearance_ml_min"":80,""ast_alt_x_uln"":1.0,""triglycerides_mg_dl"":300,""cns_mets"":""none"",""concurrent_meds"":[""Ketoconazole""],""gi_malabsorption"":false}",False,Ineligible: Concurrent use of Ketoconazole is an explicit exclusion.,NCT00375245_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P009,"{""age"":66,""gender"":""M"",""diagnosis"":""Metastatic Gastric Cancer"",""ecog_ps"":1,""life_expectancy_weeks"":15,""washout_weeks"":5,""anc"":2100,""platelets"":140000,""creatinine_clearance_ml_min"":75,""ast_alt_x_uln"":1.8,""triglycerides_mg_dl"":450,""cns_mets"":""none"",""concurrent_meds"":[],""gi_malabsorption"":true,""gi_issue"":""partial small bowel obstruction"",""immuno_deficient"":false}",False,Ineligible: Has a gastrointestinal malabsorption issue (partial small bowel obstruction) which interferes with oral medication absorption.,NCT00375245_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00375245,P010,"{""age"":52,""gender"":""F"",""diagnosis"":""Metastatic Endometrial Cancer"",""ecog_ps"":0,""life_expectancy_weeks"":19,""washout_weeks"":4,""anc"":2000,""platelets"":135000,""creatinine_clearance_ml_min"":70,""ast_alt_x_uln"":1.1,""triglycerides_mg_dl"":290,""cns_mets"":""none"",""concurrent_meds"":[""Diltiazem""],""gi_malabsorption"":false}",False,Ineligible: Concurrent use of Diltiazem is prohibited (due to the grapefruit juice component of the study).,NCT00375245_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'metastatic or unresectable', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': 60, 'bilirubin_x_uln': None, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['ANC ≥1,000/μL for patients with hematologic malignancies', 'PLT ≥50,000/μL for patients with hematologic malignancies', 'Serum triglycerides ≤500 mg/dl']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['allergic reactions attributed to compounds of similar chemical or biologic composition to rapamycin'], 'concurrent_medications_disallowed': ['ketoconazole', 'cyclosporine', 'tacrolimus', 'diltiazem', 'rifampin', 'calcium channel blockers with grapefruit juice', 'terfenadine with grapefruit juice', 'astemizole with grapefruit juice', 'cisapride with grapefruit juice', 'propafenone with grapefruit juice', 'cyclosporine with grapefruit juice', 'midazolam with grapefruit juice', 'triazolam with grapefruit juice', 'quinidine with grapefruit juice', 'theophylline with grapefruit juice'], 'other_exclusions': ['Gastrointestinal malabsorption syndromes', 'partial small bowel obstruction', 'severe immunodeficient states', 'HIV-positive patients receiving combination antiretroviral therapy', 'enzyme-inducing anticonvulsants']}}"
NCT00475657,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",True,"Eligible: Meets all requirements for first-line extended-stage SCLC (PS 1, treatment-naïve, measurable disease, adequate organ function, and no specific exclusions).",NCT00475657_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":true,""tx_details"":""Received 2 cycles of Carboplatin/Etoposide"",""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":14,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":0,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,Ineligible: Has received previous systemic chemotherapy (Carboplatin/Etoposide) for SCLC. The trial requires treatment-naïve status.,NCT00475657_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P003,"{""age"":55,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":3,""life_expectancy_weeks"":12,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":8,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,"Ineligible: ECOG Performance Status is 3, exceeding the maximum allowed PS 2.",NCT00475657_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":16,""adequate_organ_function"":false,""organ_details"":""Severe Renal Failure"",""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,"Ineligible: Has severe renal failure, which is an explicit exclusion.",NCT00475657_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P005,"{""age"":50,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":18,""adequate_organ_function"":true,""discontinue_nsaids"":false,""nsaids_details"":""Unable to stop daily Aspirin for cardiac history"",""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":2,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,Ineligible: Unable to discontinue administration of NSAID agents (daily Aspirin).,NCT00475657_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P006,"{""age"":75,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":2,""life_expectancy_weeks"":13,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":true,""fluid_details"":""Large pleural effusion requiring drainage"",""weight_loss_6wks_percent"":5,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,Ineligible: Has clinically relevant fluid accumulation in the third space (large pleural effusion).,NCT00475657_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P007,"{""age"":58,""gender"":""F"",""diagnosis"":""Mixed SCLC/NSCLC"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":17,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":3,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,Ineligible: Mixed histologic diagnosis of SCLC and NSCLC is an exclusion criterion.,NCT00475657_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P008,"{""age"":68,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":15,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":12,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,Ineligible: Significant weight loss (12%) within 6 weeks prior to trial inclusion (threshold is $\geq 10\%$).,NCT00475657_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P009,"{""age"":62,""gender"":""F"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":0,""life_expectancy_weeks"":16,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":false,""cannot_take_details"":""Inability to take Folic Acid supplements"",""third_space_fluid"":false,""weight_loss_6wks_percent"":1,""cns_mets_status"":""none"",""prior_pemetrexed_trial"":false}",False,"Ineligible: Inability or unwillingness to take folic acid and vitamin B12 supplements, which are required co-medications for Pemetrexed.",NCT00475657_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT00475657,P010,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC, Extended Stage"",""histology_confirmed"":true,""prior_systemic_tx"":false,""measurable_lesion"":true,""ecog_ps"":1,""life_expectancy_weeks"":19,""adequate_organ_function"":true,""discontinue_nsaids"":true,""can_take_supplements_corticoids"":true,""third_space_fluid"":false,""weight_loss_6wks_percent"":3,""cns_mets_status"":""Treated and Stable, requires 5 mg daily dexamethasone"",""prior_pemetrexed_trial"":false}",True,"Eligible: Treated and stable CNS metastases are allowed, and the required steroid dose (5 mg Dexamethasone/equivalent) is low enough not to be considered 'concurrent corticoid therapy' required for the CNS mets exclusion.",NCT00475657_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['systemic chemotherapy', 'immunotherapy', 'biologic therapy'], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Previous bone marrow radiotherapy less than 25% is allowed', 'Patient must be compliant and located close to the trial area', 'Able to take folic acid and vitamin B12 supplements', 'Able to take corticoids']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['previous malignant process other than SCLC'], 'concurrent_medications_disallowed': ['vaccine against yellow fever', 'non-steroidal anti-inflammatory (NSAIDS) agents'], 'other_exclusions': ['Mixed histologic diagnosis of SCLC and NSCLC', 'Severe cardiac disease', 'Severe renal failure', 'Clinically relevant fluid accumulation in the third space', 'Significant weight loss (greater than or equal to 10%) within 6 weeks prior to trial inclusion', 'Concurrent administration of any other anti-tumor treatment', 'Having received treatment for the last 30 days with a drug that has not obtained regulatory approval', 'Having participated in a previous pemetrexed trial']}}"
NCT01944137,P001,"{""age"":55,""diagnosis"":""Stage II Breast Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",True,"Eligible: Meets all criteria—newly diagnosed Stage II Breast Cancer, scheduled for neoadjuvant chemotherapy, and no prior cycles of the current regimen.",NCT01944137_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P002,"{""age"":60,""diagnosis"":""Stage IV Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for palliative chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",False,Ineligible: Stage IV (metastatic) disease is excluded. Only Stage I-III is allowed.,NCT01944137_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P003,"{""age"":72,""diagnosis"":""Stage III NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":1,""english_speaking"":true}",False,Ineligible: Has already received 1 cycle of chemotherapy for the current regimen (Exclusion: already received $\geq 1$ cycle).,NCT01944137_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P004,"{""age"":45,""diagnosis"":""Stage I Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":false}",False,Ineligible: Unable to respond to questions in English.,NCT01944137_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P005,"{""age"":68,""diagnosis"":""Stage II Prostate Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",False,"Ineligible: Prostate cancer is not one of the eligible tumor types (only CRC, NSCLC, or Breast Cancer).",NCT01944137_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P006,"{""age"":50,""diagnosis"":""Stage I Breast Cancer"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for neoadjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",True,Eligible: Meets all criteria. Stage I Breast Cancer is an allowed type and stage.,NCT01944137_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P007,"{""age"":35,""diagnosis"":""Stage II NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",True,Eligible: Meets all criteria. Stage II NSCLC is an allowed type and stage.,NCT01944137_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P008,"{""age"":78,""diagnosis"":""Stage III Colorectal Cancer"",""newly_diagnosed"":true,""chemo_status"":""Completed 3 cycles of chemo 6 months ago"",""prior_chemo_cycles"":3,""english_speaking"":true}",False,Ineligible: Although the patient is newly diagnosed (within the trial context of having a cancer directed therapy) they have already completed 3 cycles of chemotherapy for the current regimen.,NCT01944137_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P009,"{""age"":25,""diagnosis"":""Stage II Breast Cancer"",""newly_diagnosed"":false,""chemo_status"":""Scheduled for neoadjuvant chemo (recurrence) "",""prior_chemo_cycles"":0,""english_speaking"":true}",False,"Ineligible: Not a newly diagnosed case of Stage I-III cancer. The chemotherapy is for a recurrence, not the initial therapy setting.",NCT01944137_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT01944137,P010,"{""age"":63,""diagnosis"":""Stage III NSCLC"",""newly_diagnosed"":true,""chemo_status"":""Scheduled for adjuvant chemo"",""prior_chemo_cycles"":0,""english_speaking"":true}",True,"Eligible: Meets all criteria. Stage III NSCLC, scheduled for adjuvant chemo, and no prior cycles.",NCT01944137_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'I-III', 'stage_list': ['I', 'II', 'III'], 'metastatic': False, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['chemotherapy for current regimen'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Scheduled for neoadjuvant or adjuvant chemotherapy', 'Able to respond to questions in English']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Already received 1 or more cycles of chemotherapy for the current regimen', 'Unwilling or unable to participate in the study']}}"
NCT03501056,P001,"{""age"":65,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":15,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",True,"Eligible: Meets age, disease (MUC1+ advanced lung cancer), measurable disease, washout, survival, and exclusion criteria (no CNS mets, normal coag, no autoimmune/HIV).",NCT03501056_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P002,"{""age"":70,""diagnosis"":""Advanced SCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":false,""washout_details"":""Received last dose of chemo 3 weeks ago"",""expected_survival_weeks"":13,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",False,Ineligible: Did not complete the required $\\geq 4$ weeks washout from prior anti-tumor drugs (chemotherapy).,NCT03501056_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P003,"{""age"":76,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":16,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",False,"Ineligible: Age is 76 years, which is above the maximum allowed age of 75 years.",NCT03501056_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P004,"{""age"":55,""diagnosis"":""Advanced Lung Adenocarcinoma"",""muc1_positive"":false,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":14,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",False,"Ineligible: The tumor is MUC1 negative, but MUC1 positive status is required for inclusion.",NCT03501056_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P005,"{""age"":60,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":false,""surgery_details"":""Major surgery 8 weeks ago"",""expected_survival_weeks"":18,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",False,"Ineligible: Major surgical treatment time is 8 weeks ago, which is less than the required $\\geq 3$ months (12 weeks) washout.",NCT03501056_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P006,"{""age"":58,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":16,""autoimmune_hiv_history"":true,""hiv_status"":""HIV positive, receiving combination antiretroviral therapy"",""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",False,Ineligible: Patient is positive for HIV antibody (an exclusion).,NCT03501056_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P007,"{""age"":62,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":12,""autoimmune_hiv_history"":false,""coagulation_normal"":false,""coag_details"":""INR 2.5"",""cns_mets"":false,""ascites_level"":""None""}",False,"Ineligible: Coagulant function abnormality (INR $2.5$), violating the $\\text{INR} < 2$ limit.",NCT03501056_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P008,"{""age"":50,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":15,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":true,""cns_mets_details"":""Multiple brain metastases"",""ascites_level"":""None""}",False,Ineligible: Has brain or dura mater metastases.,NCT03501056_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P009,"{""age"":68,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":13,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""Moderate"",""other_cancer"":false}",False,Ineligible: Presence of medium or above (moderate) ascites.,NCT03501056_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT03501056,P010,"{""age"":40,""diagnosis"":""Advanced NSCLC"",""muc1_positive"":true,""measurable_lesion"":true,""tolerates_soc"":false,""washout_4wks"":true,""surgery_3mos"":true,""expected_survival_weeks"":20,""autoimmune_hiv_history"":false,""coagulation_normal"":true,""cns_mets"":false,""ascites_level"":""None""}",True,"Eligible: Meets all requirements (young, MUC1+, adequate washouts, no critical exclusions).",NCT03501056_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['MUC1 positive']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': 4, 'major_surgery': 12}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Tumor measurable by RECIST criteria', 'Unable to tolerate systemic or local therapies']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['T cell lymphoma', 'myeloma', 'gastrointestinal bleeding in past 6 months'], 'concurrent_medications_disallowed': ['immunosuppressants', 'hormone therapy', 'thrombolytics', 'anticoagulation therapy', 'antiplatelet therapy'], 'other_exclusions': ['Moderate or above ascites', 'Second primary tumor or multiple primary cancer', 'Systemic autoimmune diseases or immunocompromised', 'Active bleeding or coagulant function abnormality', 'Severe stomach/esophageal varices needing intervention', 'Abdominal fistula, gastrointestinal perforation or abdominal abscess within 4 weeks', 'HIV antibody positive', 'Allergic to CT or MRI contrast agents', 'Received experimental drugs or pilot medical apparatus within 4 weeks']}}"
NCT00759824,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2500,""platelets"":150000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":1.5,""creatinine_mg_dl"":1.0,""lvef_percent"":60,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",True,"Eligible: Refractory SCLC to Platinum/Etoposide. No prior ACV components. Meets all PS, hematologic, organ function, and cardiac criteria.",NCT00759824_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P002,"{""age"":70,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":true,""prior_acv_details"":""Received Vincristine (Vinca-Alkaloid) in a prior regimen"",""karnofsky_ps"":70,""polynuclear_cells"":2200,""platelets"":120000,""bilirubin_mg_dl"":0.8,""transaminases_x_normal"":1.1,""creatinine_mg_dl"":1.2,""lvef_percent"":55,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,Ineligible: Was previously treated with a Vinca-Alkaloid derivative (Vindesine component is prohibited if used previously).,NCT00759824_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":50,""polynuclear_cells"":2300,""platelets"":130000,""bilirubin_mg_dl"":1.1,""transaminases_x_normal"":1.6,""creatinine_mg_dl"":1.3,""lvef_percent"":65,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Karnofsky Performance Status is 50, which is below the minimum required 60.",NCT00759824_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P004,"{""age"":62,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":70,""polynuclear_cells"":1800,""platelets"":110000,""bilirubin_mg_dl"":0.9,""transaminases_x_normal"":1.0,""creatinine_mg_dl"":1.0,""lvef_percent"":58,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Polynuclear cells are 1,800/$\text{mm}^3$, below the minimum required 2,000/$\text{mm}^3$.",NCT00759824_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P005,"{""age"":50,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2400,""platelets"":140000,""bilirubin_mg_dl"":1.8,""transaminases_x_normal"":1.4,""creatinine_mg_dl"":1.1,""lvef_percent"":62,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Serum bilirubin is $1.8 \text{ mg/dL}$, exceeding the maximum allowed $1.5 \text{ mg/dL}$.",NCT00759824_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P006,"{""age"":75,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":60,""polynuclear_cells"":2100,""platelets"":105000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":2.5,""creatinine_mg_dl"":1.4,""lvef_percent"":45,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Left Ventricular Ejection Fraction (LVEF) is 45%, below the minimum required 50%.",NCT00759824_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P007,"{""age"":45,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Secondary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":2800,""platelets"":160000,""bilirubin_mg_dl"":1.2,""transaminases_x_normal"":1.8,""creatinine_mg_dl"":1.0,""lvef_percent"":60,""recent_mi"":false,""active_epilepsy"":true,""epilepsy_status"":""Active epilepsy treated with Carbamazepine"",""prohibited_meds"":true}",False,"Ineligible: Active epilepsy needing specific treatment AND concomitant treatment with Carbamazepine, which is a prohibited medication.",NCT00759824_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P008,"{""age"":60,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":true,""prior_acv_details"":""Received Cyclophosphamide in a prior regimen"",""karnofsky_ps"":70,""polynuclear_cells"":2200,""platelets"":120000,""bilirubin_mg_dl"":1.0,""transaminases_x_normal"":1.5,""creatinine_mg_dl"":1.0,""lvef_percent"":55,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Patient was previously treated with Cyclophosphamide, which is an explicit exclusion.",NCT00759824_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P009,"{""age"":68,""gender"":""M"",""diagnosis"":""SCLC"",""refractory_status"":""Recurrence 4 months after end of treatment"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":80,""polynuclear_cells"":3000,""platelets"":180000,""bilirubin_mg_dl"":0.9,""transaminases_x_normal"":0.8,""creatinine_mg_dl"":0.9,""lvef_percent"":65,""recent_mi"":false,""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Disease recurrence occurred 4 months after treatment, classifying the patient as 'sensitive' and not 'refractory' (refractory requires recurrence $< 3$ months).",NCT00759824_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00759824,P010,"{""age"":52,""gender"":""F"",""diagnosis"":""SCLC"",""refractory_status"":""Primary Refractory"",""prior_tx"":""Platinum/Etoposide"",""prior_acv"":false,""karnofsky_ps"":90,""polynuclear_cells"":3200,""platelets"":150000,""bilirubin_mg_dl"":0.7,""transaminases_x_normal"":0.9,""creatinine_mg_dl"":0.8,""lvef_percent"":60,""recent_mi"":true,""mi_time"":""2 months prior"",""active_epilepsy"":false,""prohibited_meds"":false}",False,"Ineligible: Suffered a recent myocardial infarction (2 months prior), which is within the 3-month exclusion period.",NCT00759824_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'small cell lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum derivatives (cisplatin or carboplatin) and etoposide'], 'allowed': [], 'disallowed': ['anthracyclin', 'vinca-alcaloid derivatives', 'cyclophosphamide'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 3, 'nyha_class_max': None, 'lvef_percent_min': 50}, 'contraception_required': True, 'other_inclusions': ['At least one evaluable or measurable lesion']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['prior malignant tumour (except non-melanoma skin cancer or in situ carcinoma)', 'prior HIV infection'], 'concurrent_medications_disallowed': ['IMAO', 'carbamazepine', 'mefloquine', 'phenobarbital', 'primidone', 'phenytoïn', 'lamotrigine', 'zidovudine'], 'other_exclusions': ['Active epilepsy needing specific treatment', 'Known allergy to valproic acid and/or doxorubicin, cyclophosphamide, vindesine', 'Serious medical or psychological factors preventing adherence to treatment schedule']}}"
NCT00621361,P001,"{""age"":65,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",True,"Eligible: Meets disease and stage requirements (Extensive-Stage SCLC where EP is standard), is treatment-naïve for advanced disease, and has a WHO PS of 1 with no exclusions.",NCT00621361_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P002,"{""age"":72,""diagnosis"":""Extensive-Stage NSCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":2,""brain_mets_status"":""treated and stable"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",True,"Eligible: Meets disease, stage, and PS criteria. Treated and stable CNS metastases are not explicitly excluded, only untreated/unstable are excluded.",NCT00621361_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P003,"{""age"":55,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":true,""tx_details"":""Received 2 cycles of Carboplatin/Etoposide 3 months ago"",""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",False,Ineligible: Has received prior chemotherapy for advanced lung cancer.,NCT00621361_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P004,"{""age"":68,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":true,""radiation_details"":""Completed palliative radiotherapy 1 week ago (within measurable field) "",""who_ps"":2,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",False,"Ineligible: Prior radiotherapy was completed only 1 week ago, violating the required $\\geq 2$ week washout period.",NCT00621361_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P005,"{""age"":60,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":3,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",False,"Ineligible: WHO Performance Status is 3, exceeding the maximum allowed PS 2.",NCT00621361_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P006,"{""age"":70,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""untreated and symptomatic brain mets"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",False,Ineligible: Has untreated unstable brain metastases.,NCT00621361_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P007,"{""age"":50,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":0,""brain_mets_status"":""none"",""bone_marrow_reserve"":""inadequate"",""bone_marrow_details"":""Platelets < 50,000/mm^3"",""lab_values"":""inappropriate""}",False,Ineligible: Has inadequate bone marrow reserve (inappropriate lab test values).,NCT00621361_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P008,"{""age"":58,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":true,""radiation_details"":""Completed prophylactic cranial irradiation (PCI) 3 weeks ago (outside measurable field) "",""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",True,Eligible: Prior radiotherapy (PCI) was outside the measurable field and completed 3 weeks ago ($\\geq 2$ weeks washout).,NCT00621361_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P009,"{""age"":45,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":0,""brain_mets_status"":""meningeal metastases"",""brain_mets_details"":""untreated and symptomatic"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",False,Ineligible: Has untreated unstable meningeal metastases.,NCT00621361_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT00621361,P010,"{""age"":75,""diagnosis"":""Extensive-Stage SCLC"",""prior_systemic_tx"":false,""prior_radiotherapy"":false,""who_ps"":1,""brain_mets_status"":""none"",""bone_marrow_reserve"":""adequate"",""lab_values"":""appropriate""}",True,Eligible: Meets all criteria. Advanced age is not an exclusion criterion for this trial.,NCT00621361_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histological or cytological', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': 'extensive stage', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 2}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': ['prior radiotherapy'], 'disallowed': ['prior chemotherapy or immunotherapy for advanced stage'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': 'excluded', 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Inadequate bone marrow reserve']}}"
NCT06749691,P001,"{""age"":65,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":15,""infection_status"":""none"",""oral_absorption_issues"":false}",True,"Eligible: Meets age, stage, and measurable disease criteria. Failed first-line, no prior VEGF/VEGFR inhibitors, and no infection or absorption issues.",NCT06749691_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P002,"{""age"":70,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":3,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":13,""infection_status"":""none"",""oral_absorption_issues"":false}",False,Ineligible: Has failed 3 prior lines of treatment. The trial is for patients who have failed first-line or second-line treatment (maximum 2 prior lines).,NCT06749691_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P003,"{""age"":58,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":true,""vegf_drug"":""Anlotinib"",""measurable_lesion"":true,""expected_survival_weeks"":14,""infection_status"":""none"",""oral_absorption_issues"":false}",False,Ineligible: Has previously received systemic treatment targeting VEGF/VEGFR (Anlotinib).,NCT06749691_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P004,"{""age"":76,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":16,""infection_status"":""none"",""oral_absorption_issues"":false}",False,"Ineligible: Age is 76 years, exceeding the maximum allowed age of 75 years.",NCT06749691_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P005,"{""age"":50,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":11,""infection_status"":""none"",""oral_absorption_issues"":false}",False,"Ineligible: Expected survival period is 11 weeks, which is below the minimum required 12 weeks.",NCT06749691_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P006,"{""age"":62,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":15,""infection_status"":""Active Severe Infection (CTCAE 3)"",""antibiotics_2wks"":true,""oral_absorption_issues"":false}",False,Ineligible: Active or uncontrolled severe infection (CTCAE $\\geq 2$) AND received antibiotic treatment within 2 weeks prior to enrollment.,NCT06749691_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P007,"{""age"":45,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":18,""infection_status"":""none"",""oral_absorption_issues"":true,""absorption_details"":""Intestinal obstruction"",""antibiotics_2wks"":false}",False,"Ineligible: Has intestinal obstruction, a factor that affects the absorption of oral medication (Apatinib).",NCT06749691_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P008,"{""age"":68,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":false,""measurable_details"":""only non-measurable bone lesions"",""expected_survival_weeks"":12,""infection_status"":""none"",""oral_absorption_issues"":false}",False,Ineligible: Does not have at least one measurable lesion according to RECIST V1.1.,NCT06749691_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P009,"{""age"":55,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":2,""prior_vegf_tx"":true,""vegf_drug"":""Ranibizumab (for diabetic retinopathy) 6 months ago"",""measurable_lesion"":true,""expected_survival_weeks"":17,""infection_status"":""none"",""oral_absorption_issues"":false}",False,"Ineligible: Has previously received systemic treatment targeting VEGF (Ranibizumab), regardless of the indication.",NCT06749691_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT06749691,P010,"{""age"":40,""diagnosis"":""Extensive-Stage SCLC"",""prior_lines"":1,""prior_vegf_tx"":false,""measurable_lesion"":true,""expected_survival_weeks"":20,""infection_status"":""Active mild infection (CTCAE 1) but no antibiotics in 2 weeks"",""oral_absorption_issues"":false}",True,"Eligible: Meets all criteria. While there is an infection, it is mild (CTCAE 1) and does not meet the $\\geq 2$ severity exclusion.",NCT06749691_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line or second-line treatment'], 'allowed': [], 'disallowed': ['any systemic treatment targeting VEGF or VEGFR'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['At least one measurable lesion according to RECIST V 1.1']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active or uncontrolled severe infection (CTCAE 5.0 ≥ 2)', 'Antibiotic treatment within 2 weeks prior to enrollment', 'Multiple factors that affect the absorption of oral medication', 'Inability to swallow, nausea and vomiting, chronic diarrhea, and intestinal obstruction']}}"
NCT01588821,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""Metastatic Renal Cell Carcinoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":15,""radiation_washout_days"":60,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",True,"Eligible: Solid tumor (non-Breast/Prostate), has bony mets, and meets all washout requirements (chemo $> 21$ days, TKI $> 14$ days, radiation $> 14$ days/bone).",NCT01588821_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P002,"{""age"":72,""gender"":""F"",""diagnosis"":""Metastatic Breast Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":30,""prior_tki_washout_days"":20,""radiation_washout_days"":40,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Primary tumor is Breast Cancer, which is explicitly excluded.",NCT01588821_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P003,"{""age"":58,""gender"":""M"",""diagnosis"":""Metastatic NSCLC"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":18,""prior_tki_washout_days"":20,""radiation_washout_days"":35,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Cytotoxic chemotherapy washout is 18 days, which is less than the required minimum of 3 weeks (21 days).",NCT01588821_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P004,"{""age"":60,""gender"":""F"",""diagnosis"":""Metastatic Ovarian Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":10,""prior_tki_half_life"":2,""radiation_washout_days"":60,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Small molecule kinase inhibitor washout is 10 days. This is less than the required 14 days and less than $5 \times$ half-lives ($5 \times 2 = 10$ days, so it is exactly 5 half-lives, but the rule is 14 days $\text{OR } 5 \times$ half-lives. Assuming the standard interpretation of the minimum of the two: 14 days is the minimum if the half-life is short, 10 days is the minimum if the half-life is long. Since 10 days is $\text{NOT} \geq 14$ days, and is the $5 \times$ half-lives limit, this is a borderline failure. Let's use 14 days as the strict minimum for TKI washout).",NCT01588821_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P005,"{""age"":70,""gender"":""M"",""diagnosis"":""Metastatic Colon Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":20,""radiation_washout_days"":10,""radiation_site"":""bone metastasis"",""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Radiation to bone metastasis was 10 days ago, violating the required $\\geq 14$ day washout.",NCT01588821_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P006,"{""age"":45,""gender"":""F"",""diagnosis"":""Metastatic Thyroid Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":30,""radiation_washout_days"":100,""prior_toxicities_resolved"":false,""unresolved_toxicity"":""CTCAE Grade 3 Peripheral Neuropathy"",""active_brain_mets"":false,""primary_brain_tumor"":false}",False,Ineligible: Has not recovered from toxicities due to prior therapies (unresolved Grade 3 Neuropathy).,NCT01588821_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P007,"{""age"":62,""gender"":""M"",""diagnosis"":""Metastatic Lung Adenocarcinoma"",""bony_metastases"":false,""bony_metastases_status"":""none"",""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":20,""radiation_washout_days"":50,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Does not have bony metastases, which is a required inclusion criterion.",NCT01588821_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P008,"{""age"":68,""gender"":""F"",""diagnosis"":""Metastatic Small Intestine Cancer"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":25,""prior_tki_washout_days"":20,""radiation_washout_days"":80,""radiation_site"":""GI Tract"",""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",False,"Ineligible: Radiation to the GI tract was 80 days ago, which is less than the required minimum of 3 months (approx 90-91 days) washout.",NCT01588821_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P009,"{""age"":50,""gender"":""M"",""diagnosis"":""Metastatic Melanoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":28,""prior_tki_washout_days"":20,""radiation_washout_days"":50,""prior_toxicities_resolved"":true,""active_brain_mets"":true,""active_brain_mets_details"":""Symptomatic and requires steroids"",""primary_brain_tumor"":false}",False,Ineligible: Has active brain metastases.,NCT01588821_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT01588821,P010,"{""age"":55,""gender"":""F"",""diagnosis"":""Metastatic Sarcoma"",""bony_metastases"":true,""refractory_status"":true,""prior_chemo_washout_days"":22,""prior_tki_washout_days"":15,""radiation_washout_days"":30,""prior_toxicities_resolved"":true,""active_brain_mets"":false,""primary_brain_tumor"":false}",True,Eligible: Meets all disease and treatment washout criteria. Sarcoma is a solid tumor (non-Breast/Prostate) and has bony mets.,NCT01588821_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologic or cytologic', 'cancer_type': 'solid tumor', 'histology_subtype': '', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['refractory to or progressed following standard therapies'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 4, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Bony metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Primary brain tumor', 'Allergy or hypersensitivity to components of the study treatment formulation', 'Not recovered from toxicities due to prior therapies']}}"
NCT03361228,P001,"{""age"":62,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":3,""prior_targeted_therapy_weeks_ago"":4,""prior_mab_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":1}",True,"Eligible: Phase 2 CRC with measurable disease, adequate washout periods, resolved toxicities, no exclusion criteria.",NCT03361228_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""advanced NSCLC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",True,"Eligible: Phase 2 NSCLC with excellent performance status, all washout periods met, no prior IDO1/arginase inhibitors.",NCT03361228_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P003,"{""age"":45,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":1,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",False,Ineligible: Chemotherapy only 1 week ago (requires 2-week washout).,NCT03361228_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P004,"{""age"":67,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":false,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":7,""prior_mab_weeks_ago"":3,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":true,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",False,"Ineligible: Toxicities not resolved to Grade 1, prior mAb only 3 weeks ago (requires 4 weeks), and prior IDO1 inhibitor.",NCT03361228_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P005,"{""age"":52,""gender"":""M"",""diagnosis"":""advanced SCCHN"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":2,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":6,""prior_targeted_therapy_weeks_ago"":8,""prior_mab_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",False,Ineligible: ECOG PS 2 (maximum allowed is 1).,NCT03361228_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P006,"{""age"":61,""gender"":""F"",""diagnosis"":""metastatic urothelial carcinoma"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":7,""prior_investigational_drug_weeks_ago"":1,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":true,""rheumatoid_arthritis_treatment"":true,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":1}",False,Ineligible: Active autoimmune disease requiring systemic treatment in past 2 years and investigational drug only 1 week ago.,NCT03361228_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P007,"{""age"":59,""gender"":""M"",""diagnosis"":""advanced SCLC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":8,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":true,""serotonin_syndrome_history"":true,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",False,Ineligible: Received live vaccine within 30 days and history of serotonin syndrome.,NCT03361228_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P008,"{""age"":64,""gender"":""F"",""diagnosis"":""metastatic gastric cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":4,""prior_targeted_therapy_weeks_ago"":5,""prior_mab_weeks_ago"":9,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":true,""gi_absorption_issue"":true,""crohns_disease"":true,""adequate_organ_function"":true,""neuropathy_grade"":0}",False,Ineligible: Urea cycle defect and gastrointestinal condition (Crohn's disease) that may affect drug absorption.,NCT03361228_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P009,"{""age"":56,""gender"":""M"",""diagnosis"":""metastatic CRC"",""phase_eligible"":""phase_2"",""measurable_lesion"":true,""ecog_ps"":1,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":3,""prior_targeted_therapy_weeks_ago"":4,""prior_mab_weeks_ago"":6,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":false,""elevated_ast_alt"":true,""neuropathy_grade"":2}",True,"Eligible: Phase 2 CRC with Grade 2 neuropathy allowed per protocol, all other criteria met including adequate organ function.",NCT03361228_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT03361228,P010,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""phase_eligible"":""phase_1"",""measurable_lesion"":true,""ecog_ps"":0,""prior_standard_therapy_failure"":true,""toxicity_resolved_grade1"":true,""prior_chemo_weeks_ago"":5,""prior_targeted_therapy_weeks_ago"":6,""prior_mab_weeks_ago"":10,""prior_investigational_drug_weeks_ago"":0,""prior_ido1_inhibitor"":false,""prior_arginase_inhibitor"":false,""autoimmune_disease"":false,""live_vaccine_30d"":false,""serotonin_syndrome_history"":false,""urea_cycle_defect"":false,""gi_absorption_issue"":false,""adequate_organ_function"":true,""neuropathy_grade"":0}",True,"Eligible: Phase 1 solid tumor (breast cancer) with all criteria met - adequate washouts, resolved toxicities, good PS.",NCT03361228_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['failed prior standard therapy'], 'allowed': [], 'disallowed': ['IDO1 or arginase 1 inhibitor'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 2, 'targeted_therapy': 2, 'immunotherapy': None, 'investigational': 2, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Resolution of all toxicities to Grade 1 or less (except alopecia)', 'Subjects with ≤ Grade 2 neuropathy are allowed']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': False, 'history_of': ['serotonin syndrome after receiving serotonergic drugs', 'gastrointestinal condition that may affect drug absorption', 'defect in the function of the urea cycle'], 'concurrent_medications_disallowed': ['live vaccine within 30 days before the first dose of study treatment', 'protocol-defined prior/concomitant therapy'], 'other_exclusions': ['Active autoimmune disease that has required systemic treatment in past 2 years']}}"
NCT02281214,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":8,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",True,"Eligible: Metastatic lung adenocarcinoma with EGFR mutation, no prior therapy, no brain mets, life expectancy >3 months, can consent.",NCT02281214_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P002,"{""age"":65,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":6,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",True,"Eligible: Treatment-naive metastatic EGFR+ adenocarcinoma, meets all simple inclusion/exclusion criteria.",NCT02281214_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P003,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":false,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: No EGFR mutation (required for adenocarcinoma patients in first-line TKI therapy).,NCT02281214_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P004,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic lung squamous cell carcinoma"",""histology"":""squamous"",""egfr_mutation"":false,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":5,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: Squamous histology (only adenocarcinoma specified for EGFR mutation testing and TKI therapy).,NCT02281214_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P005,"{""age"":54,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":true,""prior_systemic_therapy"":false,""life_expectancy_months"":9,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: Brain metastases present (explicit exclusion criterion).,NCT02281214_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P006,"{""age"":59,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":true,""prior_chemo"":true,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: Prior systemic therapy received (study is for first-line therapy only).,NCT02281214_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P007,"{""age"":47,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":2,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: Life expectancy ≤3 months (explicit exclusion criterion).,NCT02281214_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P008,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":8,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":true,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":false}",False,Ineligible: Psychiatric disorders preventing capacity to provide informed consent.,NCT02281214_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P009,"{""age"":56,""gender"":""F"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":6,""pregnant"":true,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":false,""health_insurance"":true,""consent_capacity"":true}",False,Ineligible: Currently pregnant (exclusion criterion).,NCT02281214_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT02281214,P010,"{""age"":68,""gender"":""M"",""diagnosis"":""metastatic lung adenocarcinoma"",""histology"":""adenocarcinoma"",""egfr_mutation"":true,""brain_metastases"":false,""prior_systemic_therapy"":false,""life_expectancy_months"":7,""pregnant"":false,""breastfeeding"":false,""psychiatric_disorders"":false,""legal_guardianship"":true,""health_insurance"":true,""consent_capacity"":false}",False,Ineligible: Under legal guardianship (explicit exclusion criterion).,NCT02281214_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': []}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Incapacity to sign consent due to psychiatric or behavioral disorders', 'Private individuals deprived of freedom or under guardianship']}}"
NCT05538130,P001,"{""age"":45,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""V600E"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":2.5,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",True,"Eligible: Substudy B melanoma with BRAF V600E mutation, measurable disease, prior progression, brain mets <4cm, no RVO/CK issues.",NCT05538130_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P002,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""substudy"":""C"",""braf_mutation"":""Class II non-V600"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",True,"Eligible: Substudy C solid tumor with BRAF Class II alteration, measurable disease, progressed after SOC, no exclusions.",NCT05538130_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P003,"{""age"":38,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""Class III"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":4.5,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",False,Ineligible: Brain metastasis 4.5cm > 4cm maximum allowed size.,NCT05538130_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P004,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""substudy"":""C"",""braf_mutation"":""Class II non-V600"",""measurable_disease"":true,""prior_treatment_progression"":false,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",False,Ineligible: No progression on prior standard therapy (required for all substudies).,NCT05538130_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P005,"{""age"":47,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""wild-type"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",False,Ineligible: No BRAF mutation (Substudy B requires BRAF V600 or Class II/III alteration).,NCT05538130_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P006,"{""age"":55,""gender"":""M"",""diagnosis"":""metastatic thyroid cancer"",""substudy"":""C"",""braf_mutation"":""V600E"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":true,""elevated_ck_neuromuscular"":false}",False,Ineligible: History of retinal vein occlusion (exclusion criterion).,NCT05538130_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P007,"{""age"":42,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""V600K"",""measurable_disease"":false,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":true}",False,Ineligible: No measurable disease by RECIST 1.1 and neuromuscular disorder with elevated CK.,NCT05538130_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P008,"{""age"":59,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""substudy"":""C"",""braf_mutation"":""Class III non-V600"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":false,""largest_brain_met_cm"":null,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",True,"Eligible: Substudy C solid tumor with appropriate BRAF Class III alteration, measurable disease, prior progression.",NCT05538130_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P009,"{""age"":50,""gender"":""F"",""diagnosis"":""glioblastoma"",""substudy"":""monotherapy_1a"",""braf_mutation"":""unknown"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":3.0,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",True,"Eligible: Phase 1a monotherapy for primary brain tumor, progressed after prior therapy, brain lesion <4cm.",NCT05538130_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT05538130,P010,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic melanoma"",""substudy"":""B"",""braf_mutation"":""Class II"",""measurable_disease"":true,""prior_treatment_progression"":true,""brain_metastases"":true,""largest_brain_met_cm"":2.0,""retinal_vein_occlusion_history"":false,""elevated_ck_neuromuscular"":false}",True,"Eligible: Substudy B melanoma with BRAF Class II mutation, all criteria met including appropriate brain met size.",NCT05538130_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': 'advanced/metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['BRAF V600 mutation or BRAF Class II/III alteration for Substudy B', 'BRAF founder alteration (non-V600 Class II/III BRAF alteration) for Substudy C']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['progressed during/following last prior treatment for monotherapy phase 1a dose escalation'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Disease progressed on, or with demonstrated intolerance to SOC for Substudy C']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['retinal vein occlusion (RVO)', 'concurrent neuromuscular disorder associated with elevated creatine kinase (CK)'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Brain metastasis larger than 4 cm']}}"
NCT00967577,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":6,""radiation_weeks_ago"":8,""investigational_weeks_ago"":7,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":185000,""anc"":2500,""hgb_g_dl"":11.2,""coagulation_normal"":true,""serum_creat_xuln"":1.8,""ast_xuln"":2.1,""bilirubin_xuln"":1.2,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",True,"Eligible: Metastatic RCC with progression, adequate washouts, tissue for PSMA, meets all hematologic/organ function criteria, no exclusions.",NCT00967577_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P002,"{""age"":55,""gender"":""M"",""diagnosis"":""recurrent head and neck cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":5,""radiation_weeks_ago"":9,""investigational_weeks_ago"":0,""tissue_available_psma"":true,""bisphosphonate_therapy"":true,""bisphosphonate_stable_4wk"":true,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":165000,""anc"":2200,""hgb_g_dl"":10.5,""coagulation_normal"":true,""serum_creat_xuln"":1.5,""ast_xuln"":1.8,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",True,"Eligible: Recurrent head/neck cancer with progression, stable bisphosphonates, all labs within range, meets all criteria.",NCT00967577_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P003,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":2,""radiation_weeks_ago"":10,""investigational_weeks_ago"":8,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":195000,""anc"":2800,""hgb_g_dl"":11.8,""coagulation_normal"":true,""serum_creat_xuln"":1.2,""ast_xuln"":1.5,""bilirubin_xuln"":0.9,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":7,""urgent_treatment_needed"":false}",False,Ineligible: Chemotherapy only 2 weeks ago (requires 4-week washout).,NCT00967577_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P004,"{""age"":67,""gender"":""M"",""diagnosis"":""advanced pancreatic cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":7,""radiation_weeks_ago"":5,""investigational_weeks_ago"":9,""tissue_available_psma"":false,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":175000,""anc"":2400,""hgb_g_dl"":10.8,""coagulation_normal"":true,""serum_creat_xuln"":1.6,""ast_xuln"":2.0,""bilirubin_xuln"":1.3,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":4,""urgent_treatment_needed"":false}",False,Ineligible: No archived or current tissue available for PSMA determination (required).,NCT00967577_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P005,"{""age"":59,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":8,""radiation_weeks_ago"":12,""investigational_weeks_ago"":10,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":true,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":145000,""anc"":1900,""hgb_g_dl"":9.8,""coagulation_normal"":true,""serum_creat_xuln"":1.4,""ast_xuln"":1.9,""bilirubin_xuln"":1.0,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",False,"Ineligible: Platelet transfusions within 4 weeks and platelet count 145,000 < 150,000 minimum.",NCT00967577_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P006,"{""age"":71,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":9,""radiation_weeks_ago"":15,""investigational_weeks_ago"":11,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":true,""skeletal_radiation_25pct"":true,""prior_radiopharmaceuticals"":true,""platelet_count"":160000,""anc"":1800,""hgb_g_dl"":10.2,""coagulation_normal"":true,""serum_creat_xuln"":2.2,""ast_xuln"":2.8,""bilirubin_xuln"":1.7,""active_infection"":true,""cardiac_issues"":true,""ecog_ps"":3,""dvt_pe_1month"":true,""serious_comorbidities"":true,""hiv_history"":true,""leukemia_mds"":false,""gadolinium_allergy"":true,""life_expectancy_months"":2,""urgent_treatment_needed"":true}",False,"Ineligible: Multiple exclusions - growth factors within 4wk, >25% skeletal radiation, prior radiopharmaceuticals, elevated creatinine/AST/bilirubin, active infection, cardiac issues, ECOG 3, recent DVT/PE, HIV, gadolinium allergy, short life expectancy, urgent treatment needed.",NCT00967577_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P007,"{""age"":53,""gender"":""F"",""diagnosis"":""metastatic colorectal cancer"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":6,""radiation_weeks_ago"":8,""investigational_weeks_ago"":12,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":125000,""anc"":1500,""hgb_g_dl"":8.9,""coagulation_normal"":false,""serum_creat_xuln"":1.3,""ast_xuln"":1.7,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":true,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",False,"Ineligible: Low platelets/ANC/HGB, abnormal coagulation, and history of myelodysplastic syndrome.",NCT00967577_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P008,"{""age"":64,""gender"":""M"",""diagnosis"":""prostate cancer"",""prostate_cancer"":true,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":10,""radiation_weeks_ago"":14,""investigational_weeks_ago"":15,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":180000,""anc"":2600,""hgb_g_dl"":11.5,""coagulation_normal"":true,""serum_creat_xuln"":1.5,""ast_xuln"":1.6,""bilirubin_xuln"":1.0,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":7,""urgent_treatment_needed"":false}",False,Ineligible: Prostate cancer explicitly excluded from study (except prostate cancer).,NCT00967577_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P009,"{""age"":57,""gender"":""F"",""diagnosis"":""metastatic esophageal cancer"",""prostate_cancer"":false,""progressive_disease"":false,""prior_therapy_recovery"":true,""chemo_weeks_ago"":7,""radiation_weeks_ago"":11,""investigational_weeks_ago"":13,""tissue_available_psma"":true,""bisphosphonate_therapy"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":170000,""anc"":2300,""hgb_g_dl"":10.8,""coagulation_normal"":true,""serum_creat_xuln"":1.4,""ast_xuln"":1.8,""bilirubin_xuln"":1.2,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":5,""urgent_treatment_needed"":false}",False,Ineligible: No progressive disease documented (required per inclusion criteria).,NCT00967577_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT00967577,P010,"{""age"":60,""gender"":""M"",""diagnosis"":""metastatic renal cell carcinoma"",""prostate_cancer"":false,""progressive_disease"":true,""prior_therapy_recovery"":true,""chemo_weeks_ago"":8,""radiation_weeks_ago"":16,""investigational_weeks_ago"":14,""tissue_available_psma"":true,""bisphosphonate_therapy"":true,""bisphosphonate_stable_4wk"":false,""contraception_used"":true,""pregnancy_test_negative"":true,""platelet_transfusions_4wk"":false,""growth_factors_4wk"":false,""skeletal_radiation_25pct"":false,""prior_radiopharmaceuticals"":false,""platelet_count"":190000,""anc"":2700,""hgb_g_dl"":11.3,""coagulation_normal"":true,""serum_creat_xuln"":1.3,""ast_xuln"":1.9,""bilirubin_xuln"":1.1,""active_infection"":false,""cardiac_issues"":false,""ecog_ps"":1,""dvt_pe_1month"":false,""serious_comorbidities"":false,""hiv_history"":false,""leukemia_mds"":false,""gadolinium_allergy"":false,""life_expectancy_months"":6,""urgent_treatment_needed"":false}",False,Ineligible: Bisphosphonate therapy started <4 weeks ago (requires stable dose >4 weeks prior).,NCT00967577_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'adult solid tumors', 'histology_subtype': '', 'stage': 'advanced', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': False, 'biomarker_required': ['PSMA determination']}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['recovered from acute toxicities'], 'allowed': ['bisphosphonate therapy or denosumab'], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': None, 'investigational': 4, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 2000, 'platelets': 150000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Archived or current tissue available for PSMA determination', 'Stable dose of bisphosphonate therapy or denosumab started > 4 weeks prior to protocol therapy']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['HIV', 'leukemia or myelodysplastic syndrome', 'allergic reaction to Gadolinium contrast'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Platelet transfusions within 4 weeks of treatment', 'Hematopoietic growth factors within 4 weeks of treatment', 'Prior radiation therapy encompassing >25% of skeleton', 'Prior treatment with 89Strontium or 153Samarium containing compounds', 'Active serious infection', 'Active angina pectoris or NY Heart Association Class III-IV', 'Deep vein thrombosis and/or pulmonary embolus within 1 month of enrollment', 'Life expectancy < 3 months']}}"
NCT02200081,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":true,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.2,""ldh_xuln"":1.3,""ap_xuln"":1.1,""ggt_xuln"":1.4,""albumin_normal"":true,""creatinine_xuln"":1.3,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.1,""alt_xuln"":1.9,""liver_metastases"":false,""anc_x10e9"":2.1,""platelets_x10e9"":125,""leukocytes_x10e9"":4.2,""lymphocytes_x10e9"":1.3,""hgb_g_dl"":10.5,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",True,"Eligible: ED-SCLC with PR after 4 platinum cycles, treated brain mets, all organ function and hematologic parameters within limits.",NCT02200081_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""CR"",""confirmed_response_4_cycles"":""CR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":0,""bilirubin_xuln"":0.9,""ldh_xuln"":1.1,""ap_xuln"":1.0,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.8,""alt_xuln"":1.6,""liver_metastases"":true,""ast_alt_liver_mets"":4.2,""anc_x10e9"":1.8,""platelets_x10e9"":110,""leukocytes_x10e9"":3.5,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.5,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",True,"Eligible: ED-SCLC with CR after 4 cycles, liver mets with appropriate AST/ALT limits, all criteria met.",NCT02200081_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P003,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":3,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.0,""alt_xuln"":1.8,""liver_metastases"":false,""anc_x10e9"":2.0,""platelets_x10e9"":120,""leukocytes_x10e9"":4.0,""lymphocytes_x10e9"":1.2,""hgb_g_dl"":10.2,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Only 3 cycles of platinum-based therapy completed (requires exactly 4 cycles).,NCT02200081_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":1,""prior_chemo_before_platinum"":true,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.0,""ldh_xuln"":1.1,""ap_xuln"":0.9,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.7,""alt_xuln"":1.5,""liver_metastases"":false,""anc_x10e9"":1.9,""platelets_x10e9"":115,""leukocytes_x10e9"":3.8,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.8,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Prior chemotherapy before platinum-based regimen (requires no other prior chemotherapy).,NCT02200081_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""SD"",""confirmed_response_4_cycles"":""SD"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.2,""ldh_xuln"":1.3,""ap_xuln"":1.1,""ggt_xuln"":1.4,""albumin_normal"":true,""creatinine_xuln"":1.3,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.2,""alt_xuln"":2.0,""liver_metastases"":false,""anc_x10e9"":2.1,""platelets_x10e9"":125,""leukocytes_x10e9"":4.1,""lymphocytes_x10e9"":1.3,""hgb_g_dl"":10.4,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Only stable disease after 4 cycles (requires confirmed PR or CR).,NCT02200081_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":true,""ecog_ps"":1,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.1,""alt_xuln"":1.9,""liver_metastases"":false,""anc_x10e9"":2.0,""platelets_x10e9"":120,""leukocytes_x10e9"":4.0,""lymphocytes_x10e9"":1.2,""hgb_g_dl"":10.1,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Brain metastases not irradiated and requiring continuous steroids/anticonvulsants.,NCT02200081_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":2,""bilirubin_xuln"":1.3,""ldh_xuln"":1.4,""ap_xuln"":1.2,""ggt_xuln"":1.5,""albumin_normal"":true,""creatinine_xuln"":1.4,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.3,""alt_xuln"":2.1,""liver_metastases"":false,""anc_x10e9"":1.4,""platelets_x10e9"":95,""leukocytes_x10e9"":2.8,""lymphocytes_x10e9"":0.8,""hgb_g_dl"":8.9,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,"Ineligible: ECOG PS 2 (max allowed 1), low ANC/platelets/leukocytes/lymphocytes/HGB, multiple lab parameters out of range.",NCT02200081_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P008,"{""age"":56,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":false,""mixed_histology"":true,""sclc_percentage"":75,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.0,""ldh_xuln"":1.1,""ap_xuln"":0.9,""ggt_xuln"":1.2,""albumin_normal"":true,""creatinine_xuln"":1.1,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":1.8,""alt_xuln"":1.6,""liver_metastases"":false,""anc_x10e9"":1.9,""platelets_x10e9"":115,""leukocytes_x10e9"":3.9,""lymphocytes_x10e9"":1.1,""hgb_g_dl"":9.9,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Mixed histology with only 75% SCLC (requires at least 80% SCLC component).,NCT02200081_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":false,""brain_mets_irradiated"":false,""steroids_anticonvulsants"":false,""ecog_ps"":1,""bilirubin_xuln"":1.7,""ldh_xuln"":1.8,""ap_xuln"":1.6,""ggt_xuln"":1.9,""albumin_normal"":true,""creatinine_xuln"":1.6,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.6,""alt_xuln"":2.4,""liver_metastases"":false,""anc_x10e9"":2.2,""platelets_x10e9"":130,""leukocytes_x10e9"":4.3,""lymphocytes_x10e9"":1.4,""hgb_g_dl"":10.6,""contraception_used"":true,""pregnancy_test_negative"":true,""consent_capacity"":true}",False,Ineligible: Elevated bilirubin/LDH/AP/GGT/creatinine >1.5x ULN and AST/ALT >2.5x ULN without liver metastases.,NCT02200081_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT02200081,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive disease small cell lung cancer"",""histology_pure_sclc"":true,""prior_platinum_cycles"":4,""prior_chemotherapy_lines"":0,""response_after_2_cycles"":""PR"",""confirmed_response_4_cycles"":""PR"",""brain_metastases"":true,""brain_mets_irradiated"":true,""steroids_anticonvulsants"":false,""ecog_ps"":0,""bilirubin_xuln"":1.1,""ldh_xuln"":1.2,""ap_xuln"":1.0,""ggt_xuln"":1.3,""albumin_normal"":true,""creatinine_xuln"":1.2,""electrolytes_normal"":true,""coagulation_normal"":true,""ast_xuln"":2.0,""alt_xuln"":1.8,""liver_metastases"":false,""anc_x10e9"":1.7,""platelets_x10e9"":105,""leukocytes_x10e9"":3.2,""lymphocytes_x10e9"":1.0,""hgb_g_dl"":9.2,""contraception_used"":false,""pregnant"":true,""consent_capacity"":true}",False,Ineligible: Currently pregnant and not using contraception (exclusion criteria).,NCT02200081_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'small cell', 'stage': 'extensive disease', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['platinum-based regimen'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': 0, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_treated_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Liver metastases: AST/ALT ≤5×ULN allowed', 'Tumor response after 2 cycles and confirmed PR or CR at end of 4 cycles']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': []}}"
NCT00570401,P001,"{""age"":62,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":4500,""hgb_g_dl"":10.2,""platelets"":150000,""bilirubin_mg_dl"":1.2,""ast_xuln"":2.1,""alt_xuln"":1.8,""creatinine_mg_dl"":1.4,""crcl_ml_min"":65,""qtc_ms"":420,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":5,""prior_rt_weeks_ago"":6,""concurrent_meds_disallowed"":false}",True,"Eligible: Advanced EGFR+ adenocarcinoma with acquired resistance to erlotinib, prior response, adequate organ function, no cardiac issues, meets all criteria.",NCT00570401_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P002,"{""age"":58,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":7,""prior_response"":""CR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":true,""corticosteroids_escalating"":false,""karnofsky_ps"":90,""wbc"":3800,""hgb_g_dl"":9.5,""platelets"":120000,""bilirubin_mg_dl"":1.8,""ast_xuln"":2.3,""alt_xuln"":2.1,""creatinine_mg_dl"":1.6,""crcl_ml_min"":60,""qtc_ms"":430,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":6,""prior_rt_weeks_ago"":7,""concurrent_meds_disallowed"":false}",True,"Eligible: EGFR+ adenocarcinoma with gefitinib resistance, asymptomatic brain mets, all labs within range including adequate renal function.",NCT00570401_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P003,"{""age"":67,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":false,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":9,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":4200,""hgb_g_dl"":10.8,""platelets"":140000,""bilirubin_mg_dl"":1.5,""ast_xuln"":2.2,""alt_xuln"":2.0,""creatinine_mg_dl"":1.3,""crcl_ml_min"":70,""qtc_ms"":440,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":8,""prior_rt_weeks_ago"":9,""concurrent_meds_disallowed"":false}",False,Ineligible: No documented EGFR mutation (required for inclusion).,NCT00570401_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P004,"{""age"":54,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":4,""prior_response"":""SD"",""acquired_resistance"":false,""progressive_disease"":false,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":4000,""hgb_g_dl"":10.5,""platelets"":130000,""bilirubin_mg_dl"":1.4,""ast_xuln"":2.1,""alt_xuln"":1.9,""creatinine_mg_dl"":1.5,""crcl_ml_min"":65,""qtc_ms"":425,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":7,""prior_rt_weeks_ago"":8,""concurrent_meds_disallowed"":false}",False,Ineligible: EGFR TKI duration only 4 months (requires ≥6 months) and no acquired resistance demonstrated.,NCT00570401_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P005,"{""age"":61,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":false,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":true,""corticosteroids_escalating"":true,""karnofsky_ps"":70,""wbc"":3500,""hgb_g_dl"":9.2,""platelets"":110000,""bilirubin_mg_dl"":2.2,""ast_xuln"":2.8,""alt_xuln"":2.6,""creatinine_mg_dl"":1.8,""crcl_ml_min"":50,""qtc_ms"":460,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":9,""prior_rt_weeks_ago"":10,""concurrent_meds_disallowed"":false}",False,"Ineligible: No prior biopsy of progressive disease, symptomatic brain mets requiring escalating steroids, elevated bilirubin, low CrCl, prolonged QTc.",NCT00570401_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P006,"{""age"":59,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":7,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":true,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":4100,""hgb_g_dl"":10.6,""platelets"":135000,""bilirubin_mg_dl"":1.6,""ast_xuln"":2.2,""alt_xuln"":2.0,""creatinine_mg_dl"":1.4,""crcl_ml_min"":68,""qtc_ms"":435,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":4,""prior_rt_weeks_ago"":11,""concurrent_meds_disallowed"":false}",False,Ineligible: Measurable lesions previously irradiated and chemotherapy only 4 weeks ago (requires 3-week washout).,NCT00570401_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P007,"{""age"":65,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":65,""wbc"":2800,""hgb_g_dl"":8.8,""platelets"":95000,""bilirubin_mg_dl"":1.9,""ast_xuln"":2.7,""alt_xuln"":2.5,""creatinine_mg_dl"":2.2,""crcl_ml_min"":48,""qtc_ms"":470,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":true,""ventricular_arrhythmia"":true,""heart_failure"":true,""recent_mi"":true,""unstable_angina"":true,""active_infection"":true,""uncontrolled_htn"":true,""prior_chemo_weeks_ago"":10,""prior_rt_weeks_ago"":12,""concurrent_meds_disallowed"":true}",False,"Ineligible: Multiple exclusions - low KPS, hematologic parameters out of range, elevated creatinine, prolonged QTc, cardiac history, active infection, uncontrolled HTN, taking amiodarone.",NCT00570401_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P008,"{""age"":57,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":6,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":80,""wbc"":3600,""hgb_g_dl"":9.8,""platelets"":105000,""bilirubin_mg_dl"":1.7,""ast_xuln"":2.4,""alt_xuln"":2.2,""creatinine_mg_dl"":1.7,""crcl_ml_min"":58,""qtc_ms"":445,""oral_meds_ability"":false,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":8,""prior_rt_weeks_ago"":13,""concurrent_meds_disallowed"":false}",False,Ineligible: Unable to take oral medications (required for dasatinib administration).,NCT00570401_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P009,"{""age"":63,""gender"":""F"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""gefitinib"",""tki_duration_months"":7,""prior_response"":""CR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":90,""wbc"":3900,""hgb_g_dl"":10.1,""platelets"":115000,""bilirubin_mg_dl"":1.3,""ast_xuln"":2.0,""alt_xuln"":1.8,""creatinine_mg_dl"":1.5,""crcl_ml_min"":62,""qtc_ms"":425,""oral_meds_ability"":true,""pregnant"":true,""contraception_used"":false,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":9,""prior_rt_weeks_ago"":14,""concurrent_meds_disallowed"":false}",False,Ineligible: Currently pregnant (exclusion criterion).,NCT00570401_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00570401,P010,"{""age"":60,""gender"":""M"",""diagnosis"":""advanced lung adenocarcinoma"",""egfr_mutation"":true,""prior_egfr_tki"":""erlotinib"",""tki_duration_months"":8,""prior_response"":""PR"",""acquired_resistance"":true,""progressive_disease"":true,""prior_biopsy_progressive"":true,""measurable_lesions"":true,""lesions_previously_irradiated"":false,""brain_metastases"":false,""corticosteroids_escalating"":false,""karnofsky_ps"":85,""wbc"":3700,""hgb_g_dl"":10.3,""platelets"":125000,""bilirubin_mg_dl"":1.4,""ast_xuln"":2.1,""alt_xuln"":1.9,""creatinine_mg_dl"":1.6,""crcl_ml_min"":60,""qtc_ms"":440,""oral_meds_ability"":true,""pregnant"":false,""contraception_used"":true,""long_qt_syndrome"":false,""ventricular_arrhythmia"":false,""heart_failure"":false,""recent_mi"":false,""unstable_angina"":false,""active_infection"":false,""uncontrolled_htn"":false,""prior_chemo_weeks_ago"":7,""prior_rt_weeks_ago"":15,""concurrent_meds_disallowed"":false}",True,"Eligible: EGFR+ adenocarcinoma with erlotinib resistance, meets all criteria including adequate washout periods and normal QTc.",NCT00570401_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': 'adenocarcinoma', 'stage': 'advanced', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': ['EGFR mutation']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': ['erlotinib hydrochloride or gefitinib'], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 3, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 3, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': 55, 'bilirubin_x_uln': 2, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 450, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to take oral medications', 'Previously underwent biopsy of progressive disease']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['congenital long QT syndrome', 'ventricular arrhythmia', 'congestive heart failure', 'recent myocardial infarction', 'unstable angina', 'active infection', 'uncontrolled hypertension'], 'concurrent_medications_disallowed': ['quinidine', 'procainamide', 'disopyramide', 'amiodarone', 'sotalol', 'ibutilide', 'dofetilide', 'erythromycin', 'clarithromycin', 'chlorpromazine', 'haloperidol', 'mesoridazine', 'thioridazine', 'pimozide', 'cisapride', 'bepridil', 'droperidol', 'methadone', 'arsenic', 'chloroquine', 'domperidone', 'halofantrine', 'levomethadyl', 'pentamidine', 'sparfloxacin', 'lidoflazine'], 'other_exclusions': []}}"
NCT00496860,P001,"{""age"":52,""gender"":""M"",""diagnosis"":""metastatic colorectal cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":6,""prior_chemo_weeks_ago"":7,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":10,""life_expectancy_months"":6,""ecog_ps"":1,""anc"":1800,""platelets"":125000,""hgb_g_dl"":10.5,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.1,""ast_xuln"":2.1,""alk_phos_xuln"":2.2,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":85,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",True,"Eligible: HLA-A2.1/p53+ metastatic cancer, adequate washouts, normal organ function, no cardiac/pulmonary issues, meets all criteria.",NCT00496860_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P002,"{""age"":48,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":8,""prior_chemo_weeks_ago"":9,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":12,""life_expectancy_months"":7,""ecog_ps"":0,""anc"":2200,""platelets"":150000,""hgb_g_dl"":11.2,""serum_creat_xuln"":1.0,""bilirubin_xuln"":0.9,""ast_xuln"":1.8,""alk_phos_xuln"":1.9,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":90,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",True,"Eligible: Ideal candidate - HLA-A2.1/p53+, excellent PS, all labs normal, no risk factors requiring stress test/PFT.",NCT00496860_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P003,"{""age"":61,""gender"":""M"",""diagnosis"":""metastatic pancreatic cancer"",""hla_a2_1_p53_positive"":false,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":7,""prior_chemo_weeks_ago"":8,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":11,""life_expectancy_months"":5,""ecog_ps"":1,""anc"":1900,""platelets"":130000,""hgb_g_dl"":10.8,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_xuln"":2.2,""alk_phos_xuln"":2.3,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":88,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",False,Ineligible: HLA-A2.1/p53 negative (required biomarker).,NCT00496860_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P004,"{""age"":55,""gender"":""F"",""diagnosis"":""metastatic ovarian cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":true,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":9,""prior_chemo_weeks_ago"":10,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":13,""life_expectancy_months"":6,""ecog_ps"":1,""anc"":2000,""platelets"":140000,""hgb_g_dl"":10.9,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_xuln"":2.0,""alk_phos_xuln"":2.1,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":86,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",False,Ineligible: Prior Proleukin therapy within one year (exclusion).,NCT00496860_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""metastatic NSCLC"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":true,""prior_rt_weeks_ago"":2,""prior_chemo_weeks_ago"":3,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":15,""life_expectancy_months"":4,""ecog_ps"":1,""anc"":1700,""platelets"":120000,""hgb_g_dl"":10.3,""serum_creat_xuln"":1.4,""bilirubin_xuln"":1.3,""ast_xuln"":2.3,""alk_phos_xuln"":2.4,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":87,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",False,Ineligible: Concurrent radiotherapy and chemotherapy only 2-3 weeks ago (requires 4-week washout).,NCT00496860_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P006,"{""age"":58,""gender"":""F"",""diagnosis"":""metastatic melanoma"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":10,""prior_chemo_weeks_ago"":11,""prior_nitrosoureas_weeks_ago"":5,""prior_mab_weeks_ago"":16,""life_expectancy_months"":5,""ecog_ps"":1,""anc"":1600,""platelets"":115000,""hgb_g_dl"":10.1,""serum_creat_xuln"":1.5,""bilirubin_xuln"":1.6,""ast_xuln"":2.6,""alk_phos_xuln"":2.7,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":89,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",False,Ineligible: Nitrosoureas only 5 weeks ago (requires 6-week washout) and elevated bilirubin/alk phos.,NCT00496860_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P007,"{""age"":63,""gender"":""M"",""diagnosis"":""metastatic gastric cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":12,""prior_chemo_weeks_ago"":13,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":17,""life_expectancy_months"":6,""ecog_ps"":2,""anc"":1400,""platelets"":95000,""hgb_g_dl"":9.8,""serum_creat_xuln"":1.7,""bilirubin_xuln"":1.8,""ast_xuln"":2.8,""alk_phos_xuln"":2.9,""pt_inr_normal"":false,""aptt_normal"":false,""antihypertensives_taperable"":false,""nyha_class"":3,""heart_failure_6mo"":true,""unstable_angina_6mo"":true,""mi_6mo"":true,""ventricular_arrhythmia_history"":true,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":true,""smoking_history"":true,""fev1_predicted"":70,""autoimmune_disease"":true,""hiv_positive"":true,""psychiatric_issues"":true,""cns_disease"":true,""active_infection"":true,""systemic_steroids"":true,""organ_allograft"":true,""investigational_agents"":true,""asthma_meds"":true,""pregnant"":false,""contraception_used"":true}",False,"Ineligible: Multiple exclusions - ECOG PS 2, low blood counts, elevated LFTs/creatinine, abnormal coagulation, cardiac issues, abnormal PFT, autoimmune disease, HIV, CNS disease, active infection, steroids, organ transplant, investigational drugs.",NCT00496860_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P008,"{""age"":59,""gender"":""F"",""diagnosis"":""metastatic breast cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":11,""prior_chemo_weeks_ago"":12,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":18,""life_expectancy_months"":7,""ecog_ps"":1,""anc"":2100,""platelets"":145000,""hgb_g_dl"":11.1,""serum_creat_xuln"":1.2,""bilirubin_xuln"":1.1,""ast_xuln"":2.1,""alk_phos_xuln"":2.2,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":true,""fev1_predicted"":80,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":true,""contraception_used"":false}",False,Ineligible: Currently pregnant (exclusion criterion).,NCT00496860_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P009,"{""age"":72,""gender"":""M"",""diagnosis"":""metastatic prostate cancer"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":13,""prior_chemo_weeks_ago"":14,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":19,""life_expectancy_months"":4,""ecog_ps"":1,""anc"":1900,""platelets"":135000,""hgb_g_dl"":10.7,""serum_creat_xuln"":1.3,""bilirubin_xuln"":1.2,""ast_xuln"":2.2,""alk_phos_xuln"":2.3,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":false,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":85,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",False,Ineligible: Age >50 requires normal cardiac stress test (not performed).,NCT00496860_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT00496860,P010,"{""age"":56,""gender"":""F"",""diagnosis"":""metastatic renal cell carcinoma"",""hla_a2_1_p53_positive"":true,""evaluable_disease"":true,""incurable"":true,""standard_therapy_refractory"":true,""prior_proleukin_1yr"":false,""concurrent_rt_chemo_immuno"":false,""prior_rt_weeks_ago"":14,""prior_chemo_weeks_ago"":15,""prior_nitrosoureas_weeks_ago"":0,""prior_mab_weeks_ago"":20,""life_expectancy_months"":8,""ecog_ps"":1,""anc"":2300,""platelets"":155000,""hgb_g_dl"":11.5,""serum_creat_xuln"":1.1,""bilirubin_xuln"":1.0,""ast_xuln"":1.9,""alk_phos_xuln"":2.0,""pt_inr_normal"":true,""aptt_normal"":true,""antihypertensives_taperable"":true,""nyha_class"":1,""heart_failure_6mo"":false,""unstable_angina_6mo"":false,""mi_6mo"":false,""ventricular_arrhythmia_history"":false,""cardiac_stress_test_normal"":true,""pulmonary_symptoms"":false,""smoking_history"":false,""fev1_predicted"":92,""autoimmune_disease"":false,""hiv_positive"":false,""psychiatric_issues"":false,""cns_disease"":false,""active_infection"":false,""systemic_steroids"":false,""organ_allograft"":false,""investigational_agents"":false,""asthma_meds"":false,""pregnant"":false,""contraception_used"":true}",True,"Eligible: HLA-A2.1/p53+ metastatic RCC, all washouts adequate, normal organ function and stress test, meets all criteria.",NCT00496860_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histologically or cytologically confirmed', 'cancer_type': 'malignancies', 'histology_subtype': '', 'stage': 'locally advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': None, 'biomarker_required': ['HLA-A2.1/p53 positive']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': ['Proleukin therapy within one year', 'concurrent radiotherapy', 'concurrent chemotherapy', 'concurrent immunotherapy'], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1500, 'platelets': 100000, 'hemoglobin_g_per_dl': 10, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': 6, 'nyha_class_max': 2, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Normal cardiac stress test required if over age 50, history of abnormal EKG, or symptoms of cardiac ischemia or arrhythmia', 'Normal pulmonary function test (FEV1 ≥ 75% of predicted value) if prolonged history of cigarette smoking or symptoms of respiratory dysfunction']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['ventricular arrhythmias', 'CNS disease', 'autoimmune disease', 'HIV positive', 'organ allograft'], 'concurrent_medications_disallowed': ['systemic steroid therapy', 'chronic medication for asthma', 'other investigational agents'], 'other_exclusions': ['psychiatric illness/social situations that would limit study compliance', 'active systemic infection requiring parental antibiotic therapy']}}"
NCT06400472,P001,"{""age"":58,""gender"":""F"",""diagnosis"":""epithelial ovarian cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":430,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",True,"Eligible: Ovarian cancer for dose escalation phase, no CNS mets, no significant comorbidities, QTcF within limits.",NCT06400472_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P002,"{""age"":62,""gender"":""F"",""diagnosis"":""endometrial cancer"",""phase"":""dose_optimization"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":445,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",True,"Eligible: Endometrial cancer for dose optimization phase, meets all exclusion criteria, no significant health issues.",NCT06400472_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P003,"{""age"":45,""gender"":""F"",""diagnosis"":""low grade serous ovarian cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":420,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",True,"Eligible: Low grade serous ovarian cancer for dose expansion phase, clean exclusion profile.",NCT06400472_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P004,"{""age"":54,""gender"":""M"",""diagnosis"":""non-small cell lung cancer"",""phase"":""dose_escalation"",""cns_metastases"":true,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":435,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",False,Ineligible: Known CNS metastases (exclusion criterion).,NCT06400472_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P005,"{""age"":49,""gender"":""F"",""diagnosis"":""triple negative breast cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":true,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":440,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",False,Ineligible: History of carcinomatous meningitis (exclusion criterion).,NCT06400472_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P006,"{""age"":67,""gender"":""F"",""diagnosis"":""cervical cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":true,""systemic_fungal_infection"":true,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":450,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",False,Ineligible: Active uncontrolled systemic infection (exclusion criterion).,NCT06400472_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""colorectal cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":true,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":425,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",False,Ineligible: Evidence of corneal keratopathy (exclusion criterion).,NCT06400472_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P008,"{""age"":59,""gender"":""F"",""diagnosis"":""pancreatic cancer"",""phase"":""dose_escalation"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":true,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":460,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":false,""breastfeeding"":false}",False,Ineligible: History of corneal transplant (exclusion criterion).,NCT06400472_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P009,"{""age"":55,""gender"":""F"",""diagnosis"":""endometrial cancer"",""phase"":""dose_optimization"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":true,""grade2_neuropathy"":true,""cardiovascular_disease"":true,""congestive_heart_failure"":true,""qtcf_ms"":480,""pneumonitis_history"":true,""interstitial_lung_disease"":true,""pregnant"":false,""breastfeeding"":false}",False,"Ineligible: Multiple exclusions - unresolved toxicities, cardiovascular disease, prolonged QTcF, history of pneumonitis/ILD.",NCT06400472_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT06400472,P010,"{""age"":42,""gender"":""F"",""diagnosis"":""cervical cancer"",""phase"":""dose_expansion"",""cns_metastases"":false,""carcinomatous_meningitis"":false,""active_infection"":false,""corneal_keratopathy"":false,""corneal_transplant"":false,""unresolved_toxicities"":false,""cardiovascular_disease"":false,""qtcf_ms"":440,""pneumonitis_history"":false,""interstitial_lung_disease"":false,""pregnant"":true,""breastfeeding"":false}",False,Ineligible: Currently pregnant (exclusion criterion).,NCT06400472_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': None, 'cancer_type': '', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': None}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': 470, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Ovarian (epithelial ovarian, primary peritoneal, and fallopian tube) cancer', 'endometrial cancer', 'cervical cancer', 'non-small cell lung cancer (NSCLC)', 'triple negative breast cancer (TNBC)', 'pancreatic cancer', 'colorectal cancer (CRC)']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis', 'corneal transplant', 'pneumonitis/interstitial lung disease'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Active uncontrolled systemic bacterial, viral, fungal, or parasitic infection', 'Significant cardiovascular disease', 'Serious unresolved toxicities from prior therapy']}}"
NCT07106528,P001,"{""age"":65,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":6,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",True,"Eligible: ES-SCLC with progression during first-line platinum therapy, tissue available for organoids, stable brain mets, adequate organ function.",NCT07106528_P001,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P002,"{""age"":58,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""within_6_months"",""tumor_tissue_available"":false,""malignant_effusion_available"":true,""pleural_effusion_sufficient"":true,""measurable_lesions"":true,""ecog_ps"":0,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":8,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",True,"Eligible: ES-SCLC with progression within 6 months, malignant effusion available for organoids, excellent PS, all criteria met.",NCT07106528_P002,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P003,"{""age"":62,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""after_6_months"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":7,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: Progression >6 months after first-line therapy completion (must be during or within 6 months).,NCT07106528_P003,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P004,"{""age"":59,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":false,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":5,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: No tumor tissue or malignant effusion available for organoid culture (required).,NCT07106528_P004,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P005,"{""age"":67,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":2,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":4,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: ECOG PS 2 (maximum allowed is 1).,NCT07106528_P005,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P006,"{""age"":54,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":true,""cns_stable"":false,""meningeal_metastases"":true,""life_expectancy_months"":5,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: Symptomatic/progressive brain metastases and meningeal metastases (exclusion criteria).,NCT07106528_P006,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P007,"{""age"":61,""gender"":""M"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":2,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":true,""prior_topotecan"":true,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: Prior second-line therapy received and life expectancy <3 months.,NCT07106528_P007,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P008,"{""age"":56,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":false,""low_platelets"":true,""elevated_creatinine"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":6,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":true,""active_breast_cancer"":true,""active_infection"":true,""severe_organ_dysfunction"":true,""follow_up_ability"":false,""consent_capacity"":true}",False,"Ineligible: Multiple exclusions - inadequate organ function, other active malignancy within 5 years, active infection, severe organ dysfunction, unable to complete follow-up.",NCT07106528_P008,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P009,"{""age"":63,""gender"":""M"",""diagnosis"":""mixed small cell and non-small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""during_first_line"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":1,""adequate_organ_function"":true,""brain_metastases"":false,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":7,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":true,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",False,Ineligible: Mixed tumor pathology (exclusion criterion).,NCT07106528_P009,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT07106528,P010,"{""age"":60,""gender"":""F"",""diagnosis"":""extensive-stage small cell lung cancer"",""stage_iv"":true,""prior_platinum_chemo"":true,""progression_timing"":""within_6_months"",""tumor_tissue_available"":true,""malignant_effusion_available"":false,""measurable_lesions"":true,""ecog_ps"":0,""adequate_organ_function"":true,""brain_metastases"":true,""cns_symptoms"":false,""cns_stable"":true,""meningeal_metastases"":false,""life_expectancy_months"":9,""contraception_used"":true,""pregnant"":false,""breastfeeding"":false,""mixed_pathology"":false,""prior_second_line"":false,""other_malignancy_5yr"":false,""active_infection"":false,""severe_organ_dysfunction"":false,""follow_up_ability"":true,""consent_capacity"":true}",True,"Eligible: ES-SCLC with progression within 6 months, tissue available, stable asymptomatic brain mets, excellent candidate.",NCT07106528_P010,"{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'small cell lung cancer', 'histology_subtype': 'extensive-stage', 'stage': 'Stage IV', 'stage_list': ['Stage IV'], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['first-line platinum-based systemic chemotherapy'], 'allowed': [], 'disallowed': ['second-line or higher systemic anti-tumor therapy'], 'max_lines_systemic': 1, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'allowed_if_asymptomatic_and_stable', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Sufficient tumor tissue or malignant serous effusion for organoid culture', 'Adequate bone marrow and organ function']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['other malignant tumors within the past 5 years'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Mixed tumor pathology or lack of histological confirmation', 'Active infections', 'Severe organ dysfunction', 'Inability to complete standardized clinical diagnosis/treatment or regular follow-up']}}"
NCT00009971,P011,"{""age"":65,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":35,""wbc_count"":4500,""platelet_count"":120000,""bilirubin_mg_dl"":0.8,""sgot_xuln"":1.1,""creatinine_mg_dl"":1.0,""creatinine_clearance_ml_min"":90,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":true,""prior_systemic_retinoid_weeks"":5,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":1}",true,"Eligible: Recurrent SCLC (extensive stage) after 1 prior regimen, measurable disease (>20mm), WBC/Platelets/Liver/Renal labs OK, no heart disease/retinal disease/recent cancer, prior chemo washout >3wks, stable treated brain mets allowed, no disallowed concurrent meds."
NCT00009971,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Recurrent limited stage SCLC"",""prior_chemo_regimens"":2,""measurable_disease_mm"":22,""wbc_count"":5200,""platelet_count"":150000,""bilirubin_mg_dl"":1.2,""sgot_xuln"":1.5,""creatinine_mg_dl"":1.2,""creatinine_clearance_ml_min"":85,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":true,""nonmelanoma_skin_cancer"":true,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":3,""contraception_used"":true,""pregnant"":false,""performance_status_zubrod"":0}",true,"Eligible: Recurrent SCLC (limited stage) after 2 prior regimens, measurable disease (>20mm), all labs OK, only prior nonmelanoma skin cancer allowed, prior systemic retinoid washout is exactly 3 weeks, uses contraception, good performance status."
NCT00009971,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":15,""wbc_count"":3100,""platelet_count"":75000,""bilirubin_mg_dl"":1.0,""sgot_xuln"":1.9,""creatinine_mg_dl"":1.4,""creatinine_clearance_ml_min"":70,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":6,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":2}",true,"Eligible: Recurrent SCLC, measurable disease (15mm with spiral CT scan is sufficient), all labs are within required limits (WBC/Platelet/Bilirubin/SGOT/Creatinine), Karnofsky 70 (Zubrod 2) is OK, no exclusion criteria met."
NCT00009971,P014,"{""age"":55,""gender"":""F"",""diagnosis"":""Recurrent limited stage SCLC"",""prior_chemo_regimens"":2,""measurable_disease_mm"":40,""wbc_count"":6000,""platelet_count"":200000,""bilirubin_mg_dl"":0.5,""sgot_xuln"":0.8,""creatinine_mg_dl"":1.1,""creatinine_clearance_ml_min"":95,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":true,""prior_systemic_retinoid_weeks"":4,""contraception_used"":true,""pregnant"":false,""performance_status_zubrod"":1}",true,"Eligible: Recurrent SCLC (limited stage), previously treated brain mets are stable, patient has 2 prior chemo regimens (max allowed), all organ function tests (Hematopoietic, Hepatic, Renal) are excellent, uses contraception."
NCT00009971,P015,"{""age"":38,""gender"":""M"",""diagnosis"":""Recurrent extensive stage SCLC"",""prior_chemo_regimens"":1,""measurable_disease_mm"":25,""wbc_count"":3500,""platelet_count"":90000,""bilirubin_mg_dl"":1.4,""sgot_xuln"":1.8,""creatinine_mg_dl"":1.3,""creatinine_clearance_ml_min"":80,""mi_past_6mo"":false,""retinal_disease"":false,""other_malignancy_past_5y"":false,""anticonvulsants"":false,""stable_brain_mets"":false,""prior_systemic_retinoid_weeks"":7,""contraception_used"":false,""pregnant"":false,""performance_status_zubrod"":0}",true,"Eligible: Recurrent SCLC after platinum-containing chemo, measurable disease, no prior systemic retinoids in the last 3 weeks, all lab values meet minimum requirements, no serious concurrent illness or exclusionary history."
NCT03836352,P011,"{""age"":58,""gender"":""F"",""cancer_type"":""Epithelial ovarian cancer"",""prior_therapy_type"":""first line chemotherapy"",""time_since_last_chemo_days"":35,""time_since_last_radiation_weeks"":5,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":3.5,""ecog_performance_status"":0,""life_expectancy_months"":12,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: Ovarian cancer progressed after first line therapy, chemo washout >28 days, measurable disease, ECOG 0, life expectancy >6mo, no prior anti-PD-1 toxicity, no CNS mets, no recent autoimmune/pneumonitis/MI/CVA history, no OvCa lesion >5cm."
NCT03836352,P012,"{""age"":68,""gender"":""M"",""cancer_type"":""Hepatocellular carcinoma"",""prior_therapy_type"":""first line targeted therapy"",""time_since_last_chemo_days"":50,""time_since_last_radiation_weeks"":3,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":8,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":true,""malignancy_type"":""controlled bladder cancer"",""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: HCC progressed after first line therapy, meets washout for chemo/radiation, ECOG 1, acceptable concurrent malignancy (controlled bladder cancer), no history of high-grade anti-PD-1 toxicity or other exclusions."
NCT03836352,P013,"{""age"":42,""gender"":""F"",""cancer_type"":""Non-small cell lung cancer"",""prior_therapy_type"":""first line immunotherapy (non-PD1/L1)"" ,""time_since_last_chemo_days"":45,""time_since_last_radiation_weeks"":8,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":10,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":""wild type"",""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: NSCLC (wild type/no EGFR/ALK), progressed after first line, no prior anti-PD-1/L1/L2, adequate washouts for chemo and radiation, ECOG 1, no excluded history (autoimmune, pneumonitis, transplant, etc.)."
NCT03836352,P014,"{""age"":75,""gender"":""M"",""cancer_type"":""Microsatellite instability high colon cancer"",""prior_therapy_type"":""first line chemotherapy"",""time_since_last_chemo_days"":60,""time_since_last_radiation_weeks"":4,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":0,""life_expectancy_months"":9,""prior_anti_pd1_toxicity_grade"":null,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":true,""malignancy_type"":""non-melanoma skin cancer"",""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":true,""replacement_therapy"":true,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: MSI-H solid tumor progressed after first line, meets all washouts, ECOG 0, NMSC allowed, history of autoimmune disease only on replacement therapy (allowed), no CNS mets or other exclusions."
NCT03836352,P015,"{""age"":62,""gender"":""F"",""cancer_type"":""Urothelial cancer"",""prior_therapy_type"":""first line chemo-immunotherapy"",""time_since_last_chemo_days"":28,""time_since_last_radiation_weeks"":2,""disease_status"":""progression"",""measurable_disease_recist11"":true,""single_ovca_lesion_cm"":null,""ecog_performance_status"":1,""life_expectancy_months"":7,""prior_anti_pd1_toxicity_grade"":2,""egfr_alk_status_nsclc"":null,""prior_survivin_vaccine"":false,""concurrent_malignancy"":false,""managed_ascites"":false,""bowel_obstruction_hx"":false,""autoimmune_treatment_past_2y"":false,""thyroiditis_hx"":false,""pneumonitis_hx"":false,""cns_mets"":false,""immunosuppressive_meds"":false,""hypersensitivity_pembro_grade"":0}",true,"Eligible: Urothelial cancer progressed after first line, washout times met (28 days for chemo/immuno, 2 weeks for rad), prior anti-PD-1 toxicity was Grade 2 (only G3+ is excluded), no GI issues, no CNS mets, no edema > grade 2."
NCT04421352,P011,"{""age"":68,""gender"":""M"",""sclc_stage"":""ES-SCLC (Extensive Stage)"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""liver"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":0,""life_expectancy_months"":6,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":false}",true,"Eligible: ES-SCLC progressed since 1st line platinum chemo, has an extracranial measurable lesion, ECOG 0, good life expectancy and organ function, no CNS mets, no history of autoimmune disease, prior immunotherapy, or high-grade radiation pneumonitis."
NCT04421352,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""LS-SCLC (Limited Stage)"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""chest wall"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":true,""progression_after_rad"":true,""time_since_rad_to_lesion_months"":5,""brain_metastases_status"":""treated and stable"",""brain_mets_rad_washout_months"":4,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":4,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":1,""contraception_agreed"":true}",true,"Eligible: LS-SCLC progressed after 1st line and radical chest RT, measurable lesion that progressed after RT, RT washout for lesion (>3mo) and brain mets (>3mo) met, ECOG 1, no excluded infections/history, agrees to contraception."
NCT04421352,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_chemo"":""carboplatin/etoposide"",""tumor_progression_site"":""adrenal gland"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":5,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":2,""contraception_agreed"":false}",true,"Eligible: ES-SCLC relapsed after platinum dual-drug, has measurable disease, ECOG 1, life expectancy >3mo, history of radiation pneumonitis is Grade 2 (only G3+ excluded), no prior immunotherapy, no radiotherapy contraindications."
NCT04421352,P014,"{""age"":61,""gender"":""M"",""sclc_stage"":""LS-SCLC"",""prior_chemo"":""cisplatin/etoposide"",""tumor_progression_site"":""bone"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""none"",""brain_mets_rad_washout_months"":null,""radiotherapy_contraindications"":false,""ecog_performance_status"":0,""life_expectancy_months"":10,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":false}",true,"Eligible: LS-SCLC progressed since 1st line platinum chemo, measurable disease outside CNS, excellent ECOG and organ function, no exclusions met (no active/unstable CNS mets, no prior immunotherapy, no severe pneumonitis, no active infections)."
NCT04421352,P015,"{""age"":49,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_chemo"":""platinum dual-drug"",""tumor_progression_site"":""lymph node"",""extracranial_measurable_lesion"":true,""prior_rad_to_target_lesion"":false,""brain_metastases_status"":""treated and stable"",""brain_mets_rad_washout_months"":8,""radiotherapy_contraindications"":false,""ecog_performance_status"":1,""life_expectancy_months"":7,""adequate_organ_function"":true,""autoimmune_disease_hx"":false,""prior_checkpoint_inhibitor"":false,""hiv_hcv_hbv_active"":false,""monoclonal_ab_hypersensitivity"":false,""rad_pneumonitis_grade"":0,""contraception_agreed"":true}",true,"Eligible: ES-SCLC relapsed after 1st line, measurable lesion, treated/stable brain mets with RT washout >3mo, ECOG 1, no history of drug abuse/alcoholism, no uncontrolled asthma, agrees to use contraception."
NCT01774526,P011,"{""age"":55,""gender"":""F"",""ethnicity"":""Chinese"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""chemo and EGFR-TKI"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, age > 21, metastatic lung adenocarcinoma with pleural effusion, good ECOG 1, fit and agreeable to required procedures and treatments, and no exclusionary histological subtypes or stages."
NCT01774526,P012,"{""age"":62,""gender"":""M"",""ethnicity"":""Indian"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":2,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""palliative chemotherapy only"",""other_histology_subtype"":false}",true,"Eligible: Asian male never-smoker, age > 21, confirmed lung adenocarcinoma with metastatic pleural effusion, ECOG 2, fit for pleuroscopy, and agreeable to palliative chemotherapy. All key inclusion criteria met."
NCT01774526,P013,"{""age"":78,""gender"":""F"",""ethnicity"":""Malay"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""EGFR-TKI only"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, >21 years old, metastatic adenocarcinoma, ECOG 1, willing and able to undergo biopsy, and agreeable to receiving EGFR-TKI. All required criteria for this molecular study are satisfied."
NCT01774526,P014,"{""age"":45,""gender"":""F"",""ethnicity"":""Filipino"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":2,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""chemo and EGFR-TKI"",""other_histology_subtype"":false}",true,"Eligible: Asian female never-smoker, metastatic adenocarcinoma with pleural effusion, ECOG 2 (acceptable status), fit for all procedures, and agreeable to both potential treatment options (chemo and TKI). Patient meets all inclusion criteria."
NCT01774526,P015,"{""age"":39,""gender"":""M"",""ethnicity"":""Thai"",""smoking_status"":""never-smoker"",""cancer_type"":""Lung adenocarcinoma"",""disease_stage"":""metastatic pleural effusion"",""ecog_performance_status"":1,""fit_for_pleuroscopy"":true,""agreeable_to_tx"":""palliative chemotherapy only"",""other_histology_subtype"":false}",true,"Eligible: Asian male never-smoker, age > 21, metastatic adenocarcinoma (specific histology and stage required), good ECOG 1, willing to undergo pleuroscopy/biopsy, and suitable for palliative treatment. No exclusion criteria met."
NCT01780675,P011,"{""age"":62,""gender"":""M"",""sclc_stage"":""Stage III"",""disease_status_after_tx"":""complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":4,""pregnant_lactating"":false}",true,"Eligible: Stage III SCLC with complete response after chemo-RT, candidate for PCI (Prophylactic Cranial Irradiation), no evidence of brain mets or progressive extracranial disease, no prior brain RT, sufficient Dutch proficiency, and adequate systemic treatment washout (>3 weeks)."
NCT01780675,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""Stage IV"",""disease_status_after_tx"":""partial remission after chemotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":8,""pregnant_lactating"":false}",true,"Eligible: Stage IV SCLC in remission after chemotherapy, no clinical or radiological brain metastases, no progressive extracranial disease, no prior brain RT, meets language requirement, and adequate washout from systemic treatment."
NCT01780675,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Stage II"",""disease_status_after_tx"":""near complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":true,""malignancy_type"":""basal cell carcinoma (treated)"" ,""washout_systemic_tx_weeks"":3.5,""pregnant_lactating"":false}",true,"Eligible: Stage II SCLC with remission post-chemo-RT, no evidence of brain mets or progression, prior malignancy was a treated basal cell carcinoma (allowed exclusion), washout >3 weeks, and proficient in Dutch. Candidate for PCI."
NCT01780675,P014,"{""age"":48,""gender"":""F"",""sclc_stage"":""Stage IV"",""disease_status_after_tx"":""complete remission after chemotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":5,""pregnant_lactating"":false}",true,"Eligible: Stage IV SCLC in complete remission after chemo, no brain mets, no active extracranial disease, no prior brain RT, and meets all other non-disease specific requirements like language, washout, and concurrent malignancy history."
NCT01780675,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Stage I"",""disease_status_after_tx"":""complete response after chemo-radiotherapy"",""extracranial_progression"":false,""brain_mets_clinical_radiological"":false,""prior_brain_rt"":false,""dutch_proficiency"":true,""prior_malignancy_past_2y"":false,""washout_systemic_tx_weeks"":10,""pregnant_lactating"":false}",true,"Eligible: Stage I SCLC in CR after chemo-RT, no progression/brain mets, no prior brain RT, long systemic treatment washout, and sufficient Dutch proficiency, making him an ideal PCI candidate."
NCT03231111,P011,"{""age"":55,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient >20 with Stage IV lung cancer, starting Iressa (first time targeted therapy), has home computer equipment, is proficient in Chinese (speak/write/read) with clear consciousness, and is treated at the specified Taipei location."
NCT03231111,P012,"{""age"":68,""gender"":""F"",""lung_cancer_stage"":""Stage III"",""target_drug_treatment_status"":""first time treatment with Tarceva"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Surgical Clinic)""}",true,"Eligible: Female patient >20 with Stage III lung cancer, initiating Tarceva as first targeted therapy, possesses computer equipment, meets all Chinese language and cognitive requirements, and is receiving treatment at the Taipei Surgical Clinic."
NCT03231111,P013,"{""age"":42,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient 42 (age >20), Stage IV lung cancer, is naive to targeted therapy (starting Iressa), has computer access, no cognitive impairment, and receives care at the required medical center in Taipei."
NCT03231111,P014,"{""age"":75,""gender"":""F"",""lung_cancer_stage"":""Stage III"",""target_drug_treatment_status"":""first time treatment with Tarceva"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Medical Department)""}",true,"Eligible: Female patient >20, Stage III lung cancer, starting Tarceva for the first time, meets the requirement for home computer equipment, is proficient in Chinese, and is treated at the Taipei Medical Center as specified."
NCT03231111,P015,"{""age"":60,""gender"":""F"",""lung_cancer_stage"":""Stage IV"",""target_drug_treatment_status"":""first time treatment with Iressa"",""home_computer_equipment"":true,""chinese_proficiency_speak_write_read"":true,""cognitive_impairment"":false,""treatment_location"":""Taipei Medical Center (Surgical Clinic)""}",true,"Eligible: Female patient >20, Stage IV, initiating first targeted drug (Iressa), meets all technical (computer) and communication (Chinese/cognition) requirements, and is being treated at the eligible location in Taipei."
NCT00447421,P011,"{""age"":65,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":20,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Newly diagnosed SCLC with measurable disease, no prior chemo/thoracic RT, ECOG 0, life expectancy >12wks, no MI/serious disorders/prior non-thoracic RT to neck/abdomen, and no significant weight loss."
NCT00447421,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":15,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Chemo- and RT-naïve SCLC patient, ECOG 1, measurable disease confirmed, adequate pulmonary and organ function, and none of the exclusion criteria (MI, serious disorder, prior RT to specified areas, weight loss) are present."
NCT00447421,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: New SCLC diagnosis, meets minimum age, life expectancy (12wks), and performance status (ECOG 1) requirements. No history of MI, no significant weight loss, and no prior exposure to chemotherapy or radiotherapy as excluded."
NCT00447421,P014,"{""age"":59,""gender"":""F"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: SCLC, measurable disease, ECOG 0 (excellent PS), no prior treatment, good organ and pulmonary function. All exclusionary conditions (cardiac event, significant weight loss, prior RT to excluded areas) are absent."
NCT00447421,P015,"{""age"":35,""gender"":""M"",""diagnosis"":""Small Cell Lung Cancer"",""measurable_disease"":true,""prior_chemotherapy"":false,""prior_thoracic_radiotherapy"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":40,""adequate_pulmonary_function"":true,""adequate_organ_function"":true,""mi_past_6mo"":false,""serious_systemic_disorder"":false,""prior_lower_neck_abdo_rt"":false,""significant_weight_loss"":false,""concurrent_antitumor_therapy"":false}",true,"Eligible: Young SCLC patient, treatment-naïve, measurable disease, ECOG 1, robust life expectancy. No serious systemic disorder and no concurrent antitumor therapy planned, meeting all inclusion and exclusion criteria."
NCT00084487,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_lesion_mm"":30,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":2000,""platelet_count"":150000,""hemoglobin_g_dl"":11.0,""ast_alt_xuln"":1.5,""bilirubin_mg_dl"":1.0,""creatinine_mg_dl"":1.2,""creatinine_clearance_ml_min"":80,""nyha_class"":2,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":1}",true,"Eligible: Limited SCLC relapsed after 1 prior regimen, measurable disease, all required labs (ANC, Plt, Hgb, LFTs, Renal) are adequate, NYHA Class II heart disease is allowed, no active brain mets or other major exclusions met."
NCT00084487,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":12,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":1800,""platelet_count"":120000,""hemoglobin_g_dl"":9.5,""ast_alt_xuln"":4.0,""liver_involvement"":true,""bilirubin_mg_dl"":1.2,""creatinine_mg_dl"":1.5,""creatinine_clearance_ml_min"":65,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":true,""brain_mets_stable"":true,""brain_mets_no_steroids"":true,""brain_mets_no_rt"":true,""pregnant"":false,""contraception_used"":true,""performance_status_ecog"":2}",true,"Eligible: Extensive SCLC, sensitive relapse after 1 prior chemo, measurable lesion (12mm by CT), LFTs up to 5xULN allowed due to liver mets, stable brain mets without RT/steroids allowed, ECOG 2, uses contraception, and meets all organ function cutoffs."
NCT00084487,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":25,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":3000,""platelet_count"":200000,""hemoglobin_g_dl"":12.5,""ast_alt_xuln"":2.0,""bilirubin_mg_dl"":0.8,""creatinine_mg_dl"":1.8,""creatinine_clearance_ml_min"":75,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":0}",true,"Eligible: Extensive SCLC, sensitive relapse, excellent organ function labs, ECOG 0 (Karnofsky 100%), no brain mets, no heart disease/infection/compliance issues, prior radiotherapy is allowed."
NCT00084487,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_lesion_mm"":20,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":2500,""platelet_count"":105000,""hemoglobin_g_dl"":10.0,""ast_alt_xuln"":2.4,""bilirubin_mg_dl"":1.5,""creatinine_mg_dl"":1.9,""creatinine_clearance_ml_min"":60,""nyha_class"":2,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":false,""pregnant"":false,""contraception_used"":true,""performance_status_ecog"":1}",true,"Eligible: Limited SCLC, sensitive relapse after 1 prior chemo, meets minimum measurable lesion size, all lab values are within the acceptable limits (Creatinine <2.0, CrCl ≥60, Bilirubin ≤1.5), NYHA II, and uses contraception."
NCT00084487,P015,"{""age"":78,""gender"":""M"",""sclc_stage"":""Extensive Stage"",""measurable_lesion_mm"":15,""prior_chemo_regimens"":1,""relapse_type"":""sensitive"",""anc_count"":1500,""platelet_count"":100000,""hemoglobin_g_dl"":9.0,""ast_alt_xuln"":1.0,""bilirubin_mg_dl"":0.5,""creatinine_mg_dl"":1.0,""creatinine_clearance_ml_min"":90,""nyha_class"":1,""unstable_angina"":false,""cardiac_arrhythmia"":false,""active_infection"":false,""compliant"":true,""brain_mets"":true,""brain_mets_stable"":true,""brain_mets_no_steroids"":true,""brain_mets_no_rt"":true,""pregnant"":false,""contraception_used"":false,""performance_status_ecog"":2}",true,"Eligible: Extensive SCLC, sensitive relapse after 1st line, measurable lesion (CT), treated and stable brain mets allowed if no steroids/RT, all hematologic and organ function labs meet minimum required thresholds (e.g., ANC ≥1500, Plt ≥100k, Hgb ≥9.0). Performance status ECOG 2 is acceptable."
NCT05958199,P011,"{""age"":60,""gender"":""F"",""cancer_type"":""NSCLC, EGFR mutant"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":0,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":3,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":true}",true,"Eligible: Recurrent NSCLC (EGFR mutant) refractory to SOC, ECOG 0, normal organ function, no unresolved Grade ≥2 non-exempt toxicity, no brain mets, no history of severe immune-related toxicity, and uses contraception."
NCT05958199,P012,"{""age"":52,""gender"":""M"",""cancer_type"":""Renal Cell Carcinoma"",""disease_status"":""metastatic, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""alopecia"",""chronic_neuropathy_months"":10,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""treated and stable"",""autoimmune_disease_steroids"":""prednisone 5mg daily"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Metastatic RCC refractory to SOC, ECOG 1, acceptable Grade 2 unresolved toxicity (alopecia is exempt), chronic neuropathy >6 months is exempt, clinically stable brain mets allowed, steroid dose for AI disease is ≤10mg prednisone daily (allowed)."
NCT05958199,P013,"{""age"":71,""gender"":""F"",""cancer_type"":""Colorectal Carcinoma"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":8,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":true}",true,"Eligible: CRC refractory to SOC, ECOG 1, no high-grade unresolved toxicity (chronic neuropathy is exempt), normal organ function, no known brain metastases, and no history of severe immune-related pneumonitis/colitis."
NCT05958199,P014,"{""age"":45,""gender"":""M"",""cancer_type"":""Triple Negative Breast Carcinoma"",""disease_status"":""metastatic, refractory to SOC"",""ecog_performance_status"":0,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""skin pigmentation changes"",""chronic_neuropathy_months"":2,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""treated and stable"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Metastatic TNBC refractory to SOC, ECOG 0, unresolved Grade 2 skin pigmentation changes are exempt from exclusion, clinically stable brain mets allowed, normal organ function, and no history of exclusionary autoimmune disease or immune-related toxicity."
NCT05958199,P015,"{""age"":67,""gender"":""M"",""cancer_type"":""Urothelial Carcinoma"",""disease_status"":""recurrent, refractory to SOC"",""ecog_performance_status"":1,""unresolved_toxicity_grade"":1,""chronic_neuropathy_months"":18,""bone_marrow_function"":""normal"",""kidney_function"":""normal"",""liver_function"":""normal"",""brain_mets_status"":""none"",""autoimmune_disease_steroids"":""none"",""history_grade3_pneumonitis_colitis"":false,""contraception_willing"":false}",true,"Eligible: Recurrent UCC refractory to SOC, ECOG 1, chronic neuropathy is well over 6 months (exempt), no brain metastases, meets normal organ function requirements, and has no other high-risk exclusionary conditions."
NCT02015416,P011,"{""age"":55,""gender"":""F"",""cancer_type"":""Ovarian Cancer"",""nyeso1_expression"":true,""disease_burden"":""minimal"",""prior_therapies_count"":1,""prior_therapy_outcome"":""relapsed"",""prior_investigational_washout_weeks"":4,""prior_chemo_washout_weeks"":5,""ecog_performance_status"":0,""life_expectancy_months"":12,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive Ovarian Cancer, unresectable/relapsed with minimal burden, 1 prior systemic therapy (meets minimum for OvCa/Melanoma/RCC), excellent performance status, adequate washouts, no cardiac/autoimmune/infection/lab exclusions."
NCT02015416,P012,"{""age"":68,""gender"":""M"",""cancer_type"":""Melanoma"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":1,""prior_therapy_outcome"":""inadequate response"",""prior_investigational_washout_weeks"":5,""prior_chemo_washout_weeks"":4,""ecog_performance_status"":1,""life_expectancy_months"":8,""cardiac_status"":""normal ecg, no mi past 6mo"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive Melanoma, unresectable with low burden, 1 prior therapy with inadequate response, ECOG 1, meets minimum cardiac requirements (no recent MI or HF III/IV), no prior NY-ESO-1 therapy, and no history of uveal melanoma."
NCT02015416,P013,"{""age"":72,""gender"":""F"",""cancer_type"":""Non-Small Cell Lung Cancer"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":2,""prior_therapy_outcome"":""unacceptable toxicity"",""prior_investigational_washout_weeks"":3.5,""prior_chemo_washout_weeks"":3,""ecog_performance_status"":1,""life_expectancy_months"":6,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive NSCLC, unresectable, minimal disease, required 2+ prior therapies met (minimum for NSCLC/Breast), chemo and investigational washout of ≥3 weeks met, ECOG 1, and no unstable brain metastases."
NCT02015416,P014,"{""age"":45,""gender"":""M"",""cancer_type"":""Sarcoma"",""nyeso1_expression"":true,""disease_burden"":""minimal"",""prior_therapies_count"":1,""prior_therapy_outcome"":""unacceptable toxicity"",""prior_investigational_washout_weeks"":6,""prior_chemo_washout_weeks"":4,""ecog_performance_status"":0,""life_expectancy_months"":10,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":true,""brain_mets_stable"":true}",true,"Eligible: NY-ESO-1 positive Sarcoma, unresectable, 1 prior therapy, ECOG 0, stable brain metastases allowed, all washouts met, no history of other recent cancer, and no evidence of active infection or significant autoimmune disease."
NCT02015416,P015,"{""age"":61,""gender"":""M"",""cancer_type"":""Renal Cell Cancer"",""nyeso1_expression"":true,""disease_burden"":""low"",""prior_therapies_count"":1,""prior_therapy_outcome"":""relapsed"",""prior_investigational_washout_weeks"":8,""prior_chemo_washout_weeks"":12,""ecog_performance_status"":1,""life_expectancy_months"":15,""cardiac_status"":""normal ecg"",""prior_nyeso1_vaccine"":false,""immunosuppression"":false,""autoimmune_disease"":false,""recent_infection"":false,""inadequate_labs"":false,""other_cancer_past_3y"":false,""unstable_brain_mets"":false,""pregnant"":false}",true,"Eligible: NY-ESO-1 positive RCC, relapsed after 1 prior therapy, low disease burden, excellent washouts from prior treatment, ECOG 1, and meets all other laboratory, cardiac, and infectious disease exclusions."
NCT06607185,P011,"{""age"":60,""gender"":""M"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""treated and asymptomatic"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12C mutant NSCLC, measurable disease, ECOG 0, stable treated CNS disease is allowed, unresolved toxicity is Grade 1 (acceptable), and no history of severe cardiac or pulmonary issues."
NCT06607185,P012,"{""age"":52,""gender"":""F"",""tumor_type"":""Colorectal Carcinoma"",""kras_mutation"":""G12D"",""disease_status"":""locally advanced, unresectable"",""measurable_disease_recist11"":true,""ecog_performance_status"":1,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""peripheral neuropathy"",""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12D mutant CRC, ECOG 1, unresolved Grade 2 peripheral neuropathy is exempt from exclusion, no active CNS disease, no significant cardiovascular disease, and no exclusionary infection/malignancy history."
NCT06607185,P013,"{""age"":71,""gender"":""M"",""tumor_type"":""Pancreatic Cancer"",""kras_mutation"":""G12V"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""controlled endocrinopathy (hypothyroidism)"" ,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":true,""other_malignancy_remission_years"":3,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12V mutant PDAC, ECOG 0, unresolved Grade 2 controlled endocrinopathy is exempt, history of other malignancy is $>2$ years in remission (allowed), and meets all other criteria, including being able to swallow tablets."
NCT06607185,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""Gastric Carcinoma"",""kras_mutation"":""G13D"",""disease_status"":""unresectable"",""measurable_disease_recist11"":true,""ecog_performance_status"":1,""cns_disease_status"":""asymptomatic, untreated"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":false,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G13D mutant Gastric Ca, ECOG 1, asymptomatic CNS disease is allowed, unresolved toxicity is $\le$ Grade 1, no active infections or history of pneumonitis, and can swallow the oral drug."
NCT06607185,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Cholangiocarcinoma"",""kras_mutation"":""G12S"",""disease_status"":""metastatic"",""measurable_disease_recist11"":true,""ecog_performance_status"":0,""cns_disease_status"":""none"",""able_to_swallow_tablets"":true,""unresolved_toxicity_grade"":1,""cardiovascular_disease"":true,""cardiac_history"":""stable atrial fibrillation (controlled)"" ,""active_hbv_hcv_hiv_untreated"":false,""other_active_malignancy"":false,""active_uncontrolled_infection"":false,""pneumonitis_history"":false,""pregnant_or_nursing"":false}",true,"Eligible: KRAS G12S mutant CCA, ECOG 0, stable controlled arrhythmia is not an exclusion, no unresolved toxicity $>$ Grade 1, no active CNS mets or history of pneumonitis requiring steroids."
NCT06725225,P011,"{""age"":55,""gender"":""F"",""lung_cancer_histology"":""NSCLC Adenocarcinoma"",""current_therapy"":""Pembrolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""mild, controlled hypertension"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Histologically confirmed NSCLC, age >18, currently on immunotherapy (Pembrolizumab), good verbal communication, no cognitive/mental illness, and comorbidity (hypertension) is not classified as severe disease."
NCT06725225,P012,"{""age"":72,""gender"":""M"",""lung_cancer_histology"":""Small Cell Lung Cancer"",""current_therapy"":""Durvalumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""Type 2 Diabetes (controlled)"" ,""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: SCLC, currently receiving Durvalumab (immunotherapy), good verbal ability, no cognitive impairment, and diabetes is well-controlled and not a severe disease, meeting all inclusion criteria."
NCT06725225,P013,"{""age"":65,""gender"":""F"",""lung_cancer_histology"":""NSCLC Squamous"",""current_therapy"":""Nivolumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""prior mastectomy (no evidence of recurrence)"" ,""consent_signed_by"":""family member"",""pregnant"":false}",true,"Eligible: Histologically confirmed NSCLC, currently on Nivolumab, good verbal communication, consent signed by a family member (allowed), and no cognitive impairment or other severe concurrent diseases."
NCT06725225,P014,"{""age"":48,""gender"":""M"",""lung_cancer_histology"":""Large Cell Lung Cancer"",""current_therapy"":""Atezolizumab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""none"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Lung cancer diagnosis, under immunotherapy (Atezolizumab), good verbal ability and no cognitive issues, excellent health status with no severe diseases, and consent signed by the patient."
NCT06725225,P015,"{""age"":61,""gender"":""F"",""lung_cancer_histology"":""Lung Carcinoid (Atypical)"" ,""current_therapy"":""Cemiplimab"",""verbal_communication"":""good"",""cognitive_impairment"":false,""mental_illness"":false,""other_severe_disease"":false,""comorbidities"":""mild osteoarthritis"",""consent_signed_by"":""patient"",""pregnant"":false}",true,"Eligible: Confirmed lung cancer, currently receiving Cemiplimab, good verbal communication, no cognitive/mental illness, and mild osteoarthritis is not considered a severe disease, meeting all enrollment criteria."
NCT06079970,P011,"{""age"":65,""gender"":""M"",""lesion_suspicion"":""malignant peripheral pulmonary nodule"",""lesion_location"":""peripheral (beyond segmental bronchi)"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":12,""lesion_long_axis_ct_mm"":15,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Suspected peripheral lung lesion (12x15mm, solid part $\ge$10mm, beyond visible bronchi), bronchus sign positive, no endobronchial component, lesion too peripheral for linear EBUS, no contraindications (fluorescein allergy, instability, hypoxemia, anticoagulants, fluorescent chemo)."
NCT06079970,P012,"{""age"":48,""gender"":""F"",""lesion_suspicion"":""suspect malignant nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":25,""lesion_long_axis_ct_mm"":28,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lung lesion 28mm (within $\le$30mm limit), solid part 25mm, indication for bronchoscopy, no visible endobronchial component, lesion out of linear EBUS reach, no fluorescein allergy, not on excluded chemotherapy, and able to tolerate anesthesia."
NCT06079970,P013,"{""age"":75,""gender"":""M"",""lesion_suspicion"":""indeterminate peripheral nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":false,""estimated_r_ebus_signal"":true,""solid_part_size_mm"":10,""lesion_long_axis_ct_mm"":11,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion (10x11mm, minimal size), estimated r-EBUS signal meets navigation criterion, no endobronchial disease, lesion is not linear EBUS accessible, all vital signs and safety criteria (no anticoagulants, no severe hypoxemia) are met."
NCT06079970,P014,"{""age"":59,""gender"":""F"",""lesion_suspicion"":""malignant peripheral nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":18,""lesion_long_axis_ct_mm"":30,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":true,""anticoagulant_can_be_withheld"":true,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":false,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion 30mm (max size allowed), solid part 18mm, appropriate lesion location and size, patient is on therapeutic anticoagulants but they can be withheld for the required interval (not excluded), and no fluorescent chemotherapy is ongoing."
NCT06079970,P015,"{""age"":62,""gender"":""M"",""lesion_suspicion"":""suspect malignant nodule"",""lesion_location"":""peripheral"",""bronchus_sign_or_rebus_signal"":true,""solid_part_size_mm"":20,""lesion_long_axis_ct_mm"":25,""consent_willingness"":true,""endobronchial_visible_malig"":false,""lesion_within_linear_ebus_reach"":false,""fluorescein_allergy"":false,""hemodynamic_stability"":true,""refractory_hypoxemia"":false,""anticoagulant_use"":false,""tolerates_general_anesthesia"":true,""current_chemotherapy_fluorescent"":true,""chemo_type"":""cisplatin (non-fluorescent)"" ,""pregnant_or_nursing"":false}",true,"Eligible: Peripheral lesion 25mm, solid part 20mm, undergoing non-fluorescent chemotherapy (e.g., cisplatin) which is allowed, meets age and consent criteria, lesion is inaccessible by linear EBUS, and all procedural safety exclusions are avoided."
NCT02117024,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":15,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma (NSCLC) with 3 prior lines (allowed max), disease progression, suitable for chemo, ECOG 1, treated/stable CNS mets allowed, meets 14-day washout, and no history of severe infections, immunodeficiency, or prior cancer vaccine."
NCT02117024,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":2,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":0,""cns_mets_status"":""none"",""washout_systemic_tx_days"":30,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Adenocarcinoma with 2 prior lines (allowed range), good PS (ECOG 0), no CNS involvement, adequate washout, uses effective contraception, and no exclusionary systemic conditions (HIV, severe infection, immunosuppressive drugs)."
NCT02117024,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":2,""cns_mets_status"":""none"",""washout_systemic_tx_days"":20,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma with 3 prior lines, disease progression, PS=2 is explicitly allowed to be considered, washout >14 days, no leptomeningeal disease, and no history of other active malignancy."
NCT02117024,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":2,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":45,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Adenocarcinoma with 2 prior lines, ECOG 1, treated and stable CNS metastases, adequate lab parameters (implied), long washout period, and complies with contraception and other protocol requirements."
NCT02117024,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""NSCLC Adenocarcinoma"",""prior_lines_of_therapy"":3,""suitability_for_chemo"":true,""disease_progression"":true,""ecog_performance_status"":1,""cns_mets_status"":""treated and stable"",""washout_systemic_tx_days"":14,""hiv_hcv_hbv_active"":false,""immunosuppressive_therapy"":false,""immunodeficiency"":false,""leptomeningeal_disease"":false,""other_active_malignancies"":false,""prior_cancer_vaccine"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Adenocarcinoma with 3 prior lines, disease progression, ECOG 1, treated/stable CNS mets, meets minimum washout (14 days), no uncontrolled infections, and no prior cancer vaccine treatment for NSCLC."
NCT00494026,P011,"{""age"":62,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":0,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Histologically confirmed Limited Stage SCLC, measurable disease, excellent performance status (PS 0), no prior chemotherapy or thoracic RT, adequate organ function, no serious disorder/weight loss, and willing to take required supplements/steroids."
NCT00494026,P012,"{""age"":55,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, good PS (PS 1), treatment-naïve for chemo/thoracic RT, adequate organ functions confirmed, no significant weight loss in the preceding 6 weeks, and not pregnant/nursing."
NCT00494026,P013,"{""age"":71,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, good performance status, chemo/RT naïve, all organ functions (BM, Hepatic, Pulmonary, Renal) are adequate, no serious comorbidity, and willing to comply with the medication requirements."
NCT00494026,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":0,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, excellent PS (0), measurable disease, treatment-naïve, no significant weight loss, all organ functions are adequate, and no exclusion criteria (e.g., serious systemic disorder, pregnancy) are met."
NCT00494026,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Limited Stage"",""measurable_disease"":true,""performance_status"":1,""prior_chemo_for_this_cancer"":false,""prior_thoracic_radiotherapy"":false,""adequate_bm_hepatic_pulmonary_renal"":true,""serious_systemic_disorder"":false,""significant_weight_loss_6wks"":false,""willing_to_take_vitamins_steroids"":true,""pregnant_or_nursing"":false}",true,"Eligible: Limited Stage SCLC, measurable disease, PS 1, no prior chemo/thoracic RT, meets all organ function criteria, no severe weight loss in the past 6 weeks, and willing to take all study-required medications."
NCT06963502,P011,"{""age"":65,""gender"":""M"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":0,""life_expectancy_weeks"":15,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C NSCLC, measurable disease, ECOG 0, adequate life expectancy and organ function (Child Pugh A cirrhosis allowed). No prior KRAS G12C inhibitors, active brain mets, high-grade toxicity, or history of other malignancies/severe comorbidities."
NCT06963502,P012,"{""age"":52,""gender"":""F"",""tumor_type"":""Colorectal Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":20,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":true,""hypertension_controlled"":true,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""not applicable"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":true}",true,"Eligible: KRAS G12C CRC, measurable disease, ECOG 1, hypertension is controlled (not 'uncontrolled' exclusion), no Grade $\ge 2$ toxicities, no ILD, no active brain mets, and female patient agrees to contraception."
NCT06963502,P013,"{""age"":71,""gender"":""M"",""tumor_type"":""Pancreatic Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C Pancreatic Cancer, measurable disease, ECOG 1, meets minimum life expectancy (12 weeks), no severe GI issues (can swallow oral meds), no continuous glucocorticoids, and no other exclusion criteria met."
NCT06963502,P014,"{""age"":45,""gender"":""F"",""tumor_type"":""NSCLC"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":true,""effusion_controlled"":true,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""not applicable"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":true}",true,"Eligible: KRAS G12C NSCLC, ECOG 0, effusion is present but controlled (not 'uncontrolled' exclusion), no known non-KRAS approved targeted alterations, and meets all other eligibility requirements."
NCT06963502,P015,"{""age"":68,""gender"":""M"",""tumor_type"":""Colorectal Cancer"",""kras_mutation"":""G12C"",""measurable_lesion"":true,""ecog_performance_status"":1,""life_expectancy_weeks"":25,""prior_kras_g12c_inhibitor"":false,""active_brain_mets"":false,""uncontrolled_effusion"":false,""spinal_cord_compression"":false,""prior_toxicity_grade"":1,""other_targeted_alterations_approved"":false,""history_other_malignancy"":false,""adequate_organ_function"":true,""abnormal_cardiac_exam"":false,""severe_cardiovascular_disorders"":false,""uncontrolled_diabetes"":false,""uncontrolled_hypertension"":false,""bleeding_tendencies"":false,""severe_thrombosis"":false,""serious_infection"":false,""continuous_glucocorticoids"":false,""active_infectious_diseases"":false,""refractory_gi_issues"":false,""cirrhosis_child_pugh_grade"":""A"",""interstitial_lung_disease"":false,""serious_neurological_mental_disorders"":false,""active_autoimmune_diseases"":false,""contraception_agreed"":false}",true,"Eligible: KRAS G12C CRC, measurable disease, Child Pugh A cirrhosis allowed, no active brain mets, no severe cardiovascular/thrombotic/bleeding issues, no active infectious or autoimmune disease, and able to comply with the protocol."
NCT00663689,P011,"{""age"":65,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""alopecia"",""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":20,""anc_x10_9_l"":2.0,""platelets_x10_9_l"":150,""hemoglobin_g_dl"":12.0,""bilirubin_x_uln"":1.0,""alt_ast_x_uln"":1.5,""creatinine_clearance_ml_min"":75,""pt_inr_ptt_x_uln"":1.0}",true,"Eligible: Stage IV NSCLC (non-mixed), SD after 1st line chemo, never received EGFR-TKI/MAB. Asymptomatic brain mets, ECOG 1, life expectancy $\ge 12$wks, all labs adequate, no G3/4 unresolved toxicity (G2 alopecia is resolved/allowed). No GI issues, unstable systemic disease, or severe cardiac events."
NCT00663689,P012,"{""age"":58,""gender"":""F"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":true,""cardio_condition"":""history of MI 2 years ago"",""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":0,""life_expectancy_weeks"":30,""anc_x10_9_l"":3.5,""platelets_x10_9_l"":200,""hemoglobin_g_dl"":10.5,""bilirubin_x_uln"":1.2,""alt_ast_x_uln"":4.0,""liver_mets"":true,""creatinine_clearance_ml_min"":65,""pt_inr_ptt_x_uln"":1.1}",true,"Eligible: Stage IV NSCLC, SD after chemo, treatment-naïve for EGFR inhibitors. MI history $>1$ year ago is allowed. Good PS (ECOG 0), liver mets present (ALT/AST $<5 \times$ ULN acceptable). All labs and procedural requirements met, and brain mets are asymptomatic."
NCT00663689,P013,"{""age"":72,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":2,""unresolved_toxicity_type"":""neuropathy (grade 2)"" ,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":true,""other_malignancy_type"":""cured basal cell carcinoma"",""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":2,""life_expectancy_weeks"":15,""anc_x10_9_l"":1.8,""platelets_x10_9_l"":120,""hemoglobin_g_dl"":11.0,""bilirubin_x_uln"":0.8,""alt_ast_x_uln"":2.0,""creatinine_clearance_ml_min"":80,""pt_inr_ptt_x_uln"":1.0}",true,"Eligible: Stage IV NSCLC, SD after chemo, PS 2 (allowed), asymptomatic brain mets, neuropathy Grade 2 allowed if stable, prior basal cell carcinoma is exempt from 5-year rule. All lab parameters and exclusion criteria met."
NCT00663689,P014,"{""age"":45,""gender"":""F"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":true,""cardio_condition"":""CHF NYHA Class II"",""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":12,""anc_x10_9_l"":1.5,""platelets_x10_9_l"":100,""hemoglobin_g_dl"":10.0,""bilirubin_x_uln"":1.5,""alt_ast_x_uln"":2.5,""creatinine_clearance_ml_min"":60,""pt_inr_ptt_x_uln"":1.1}",true,"Eligible: Stage IV NSCLC, SD after chemo, naive to EGFR inhibitors, PS 1, minimum required labs met (ANC, Plt, Hgb, CrCl, Bilirubin), CHF NYHA Class II is the maximum allowed (not > Class II). Brain mets are asymptomatic, and all washouts are met."
NCT00663689,P015,"{""age"":60,""gender"":""M"",""nsclc_stage"":""IV"",""mixed_histology"":false,""extracerebral_sd_after_chemo"":true,""prior_egfr_tki_mab"":false,""unresolved_toxicity_grade"":1,""exposure_biotherapy_immuno_4wks"":false,""concurrent_anticancer_therapy"":false,""upper_gi_integrity"":true,""malabsorption"":false,""able_to_take_oral_meds"":true,""active_pud"":false,""unstable_systemic_disease"":false,""cardiovascular_event"":false,""brain_mets_symptomatic"":false,""other_malignancy_5yrs"":false,""substance_abuse_or_psych_condition"":false,""pregnant_or_breastfeeding"":false,""ecog_performance_status"":1,""life_expectancy_weeks"":25,""anc_x10_9_l"":4.0,""platelets_x10_9_l"":300,""hemoglobin_g_dl"":13.5,""bilirubin_x_uln"":0.5,""alt_ast_x_uln"":1.0,""creatinine_clearance_ml_min"":90,""pt_inr_ptt_x_uln"":0.9}",true,"Eligible: Stage IV NSCLC, SD after chemo, no prior EGFR-TKI/MAB, excellent PS and lab functions. Asymptomatic brain metastases are present, no current concurrent anti-cancer therapy, no history of GI/absorption issues that would prevent oral medication."
NCT02772107,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":0,""anc_ul"":1800,""platelets_ul"":150000,""hemoglobin_g_dl"":10.0,""ast_alt_xuln"":1.5,""total_serum_bilirubin_xuln"":1.0,""serum_creatinine_xuln"":1.0,""chemo_to_random_weeks"":4,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC with measurable disease (including brain mets), ECOG 0, all hematologic and organ function labs are within limits. Washout period (4 weeks) is within the required 3-7 weeks, and patient is free of exclusionary conditions like leptomeningeal disease, AIDS/HAART, or uncontrolled illness."
NCT02772107,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":false,""ecog_performance_status"":1,""anc_ul"":2500,""platelets_ul"":120000,""hemoglobin_g_dl"":9.5,""ast_alt_xuln"":4.0,""liver_malig_cause"":true,""total_serum_bilirubin_xuln"":1.5,""serum_creatinine_xuln"":1.5,""chemo_to_random_weeks"":7,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Extensive-stage SCLC, ECOG 1, LFTs up to $5 \times$ ULN allowed due to liver malignancy, all other organ/hematologic labs meet criteria. Washout period (7 weeks) is at the maximum limit, and female patient complies with contraception requirements."
NCT02772107,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":1,""anc_ul"":1500,""platelets_ul"":100000,""hemoglobin_g_dl"":9.0,""ast_alt_xuln"":2.5,""total_serum_bilirubin_xuln"":1.2,""serum_creatinine_xuln"":1.0,""chemo_to_random_weeks"":3,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC, measurable brain mets allowed, ECOG 1, all labs meet the minimum required thresholds (ANC $\ge 1500$, Plt $\ge 100k$, Hgb $\ge 9.0$), washout period (3 weeks) is at the minimum limit, and no uncontrolled intercurrent illnesses."
NCT02772107,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":false,""ecog_performance_status"":0,""anc_ul"":3000,""platelets_ul"":250000,""hemoglobin_g_dl"":13.0,""ast_alt_xuln"":2.0,""total_serum_bilirubin_xuln"":0.8,""serum_creatinine_xuln"":0.8,""chemo_to_random_weeks"":5,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":true}",true,"Eligible: Extensive-stage SCLC, measurable disease, ECOG 0, excellent lab values and mid-range washout (5 weeks). No CNS involvement, no investigational agents, and female patient is not pregnant/nursing and uses contraception."
NCT02772107,P015,"{""age"":68,""gender"":""M"",""sclc_stage"":""Extensive-Stage"",""measurable_disease"":true,""brain_metastases"":true,""ecog_performance_status"":1,""anc_ul"":1700,""platelets_ul"":110000,""hemoglobin_g_dl"":10.5,""ast_alt_xuln"":5.0,""liver_malig_cause"":true,""total_serum_bilirubin_xuln"":1.0,""serum_creatinine_xuln"":1.2,""chemo_to_random_weeks"":6,""uncontrolled_intercurrent_illness"":false,""leptomeningeal_involvement"":false,""aids_or_hiv_on_haart"":false,""investigational_agents"":false,""pregnant_or_breastfeeding"":false,""contraception_used"":false}",true,"Eligible: Extensive-stage SCLC with measurable brain mets, ECOG 1, LFTs up to $5 \times$ ULN allowed due to liver involvement, and all other conditions (washout, controlled illness, HIV status) are compliant with the protocol."
NCT03313544,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":55,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC patient currently on Nivolumab, LVEF 55% ($\ge 50\%$), no history of major cardiac exclusion criteria (cardiomyopathy, arrhythmia, prior cardiotoxicity, known coronary disease, recent stroke), not pregnant, and willing to participate with no MRI contraindications (implied from study design)."
NCT03313544,P012,"{""age"":48,""gender"":""F"",""cancer_type"":""Melanoma"",""current_therapy"":""nivolumab"",""lvef_percent"":60,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: Melanoma patient on Nivolumab, excellent LVEF (60%), no prior cardiac issues or cardiotoxicity from previous non-nivolumab treatment, not pregnant/vulnerable, and is willing to participate."
NCT03313544,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":50,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":true,""known_coronary_disease_stable"":true,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC on Nivolumab, LVEF exactly 50% (meets $\ge 50\%$ threshold), known coronary disease is permitted if stable and not meeting the 'history of' exclusion (which is specific to 'known coronary disease' in the exclusion, but the brief summary implies stable/older disease may be allowed if it doesn't meet the exclusion criteria, which focuses on recent instability/history). Assuming stable known coronary disease is not an absolute exclusion if LVEF $>50\%$. The list excludes 'Known coronary disease' without context, but including a stable patient based on the LVEF and the study's focus on new cardiotoxicity risk is appropriate."
NCT03313544,P014,"{""age"":60,""gender"":""F"",""cancer_type"":""Melanoma"",""current_therapy"":""nivolumab"",""lvef_percent"":58,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":false,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: Melanoma on Nivolumab, LVEF 58%, no cardiac history including arrhythmia or prior cardiotoxicity, not pregnant or a vulnerable person, and is willing to participate in the study."
NCT03313544,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""NSCLC"",""current_therapy"":""nivolumab"",""lvef_percent"":52,""cardiomyopathy"":false,""cardiac_arrhythmia_history"":false,""cardiac_toxicity_prior_tx"":false,""known_coronary_disease"":false,""stroke_less_than_3mo"":true,""stroke_time_months"":4,""willing_to_participate"":true,""vulnerable_person"":false,""mri_contraindication"":false,""pregnant"":false}",true,"Eligible: NSCLC on Nivolumab, LVEF 52%, stroke history is $>3$ months ago (4 months), avoiding the exclusion criterion. No other cardiac history or vulnerability issues are present, and the patient is willing to comply."
NCT02349412,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Advanced NSCLC"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":4,""ecog_performance_status"":1,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced NSCLC not for curative intent, informed of incurable diagnosis within the 8-week window, ECOG 1, reads English, receiving care at the enrolling institution under an oncologist."
NCT02349412,P012,"{""age"":52,""gender"":""F"",""cancer_type"":""Mesothelioma"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":8,""ecog_performance_status"":2,""read_respond_english"":false,""english_ability"":""can complete questions with minimal interpreter assistance"",""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Mesothelioma not for curative intent, informed of diagnosis exactly 8 weeks ago (maximum allowed), ECOG 2, does not read English but can complete questions with minimal interpreter assistance (allowed), and meets care location requirement."
NCT02349412,P013,"{""age"":71,""gender"":""M"",""cancer_type"":""Advanced Pancreatic Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":1,""ecog_performance_status"":1,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced Pancreatic Cancer (non-colorectal GI) not for curative intent, recently informed (1 week), ECOG 1, good communication skills, and meets all institutional care and oncologist requirements."
NCT02349412,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Advanced Small Cell Lung Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":6,""ecog_performance_status"":0,""read_respond_english"":true,""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced SCLC not for curative intent, informed 6 weeks ago, excellent PS (ECOG 0), fluent in English, and receiving all cancer care at the enrolling site."
NCT02349412,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Advanced Gastric Cancer"",""curative_intent"":false,""informed_incurable_diagnosis_weeks"":5,""ecog_performance_status"":1,""read_respond_english"":false,""english_ability"":""can read/respond with minimal family member assistance"",""medical_care_at_enrolling_inst"":true,""under_oncologist_care"":true}",true,"Eligible: Advanced Gastric Cancer (non-colorectal GI) not for curative intent, informed 5 weeks ago, ECOG 1, requires minimal family member assistance for communication (allowed), and is under the care of an oncologist at the enrolling institution."
NCT07090499,P011,"{""age"":52,""gender"":""M"",""cancer_type"":""bladder"",""stage"":""advanced metastatic urothelial carcinoma"",""measurable_disease"":true,""ecog"":0,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced bladder cancer with measurable disease, ECOG 0, only 1 prior line in advanced setting, no prior camptothecin-ADC, no GI/pulmonary exclusions, toxicities resolved, tissue consent provided."
NCT07090499,P012,"{""age"":68,""gender"":""F"",""cancer_type"":""non-small cell lung cancer"",""stage"":""stage IV"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":2,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced NSCLC with measurable disease, ECOG 1, ≤2 prior lines in advanced setting, no prior camptothecin-ADC, no active GI or excluded pulmonary disease, prior toxicity resolved, tissue consent feasible."
NCT07090499,P013,"{""age"":61,""gender"":""M"",""cancer_type"":""head and neck squamous cell carcinoma"",""stage"":""recurrent/metastatic"",""measurable_disease"":true,""ecog"":0,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, R/M HNSCC with measurable disease, ECOG 0, 1 prior line in advanced setting, no camptothecin-ADC exposure, no GI obstruction or excluded pulmonary issues, toxicities resolved to ≤Grade 1, tumor tissue available."
NCT07090499,P014,"{""age"":59,""gender"":""F"",""cancer_type"":""esophageal squamous cell carcinoma"",""stage"":""stage IV"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":2,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, advanced esophageal SCC with measurable disease, ECOG 1, max 2 prior systemic lines, never received camptothecin-class ADC, no active anorexia/nausea/obstruction or excluded lung disease12/14/2025, prior therapy toxicities resolved, consent for tumor tissue."
NCT07090499,P015,"{""age"":65,""gender"":""M"",""cancer_type"":""pancreatic adenocarcinoma"",""stage"":""metastatic"",""measurable_disease"":true,""ecog"":1,""prior_lines_advanced"":1,""prior_adc_camptothecin"":false,""active_anorexia_nausea_vomiting"":false,""intestinal_obstruction"":false,""significant_pulmonary_disease"":false,""acute_toxicity_resolved"":true,""tumor_tissue_available"":true}",true,"Eligible: ≥18yo, metastatic pancreatic adenocarcinoma with measurable disease, ECOG 1, only 1 prior line in advanced setting, no prior camptothecin-ADC, no excluded GI or pulmonary conditions, acute effects of prior therapy resolved, tumor tissue submission consented."
NCT01075399,P011,"{""age"":64,""gender"":""M"",""cancer_type"":""head and neck squamous cell carcinoma"",""tumor_size_cm"":4.8,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":1.1,""ast_alt_xuln"":2.1,""serum_creat_xuln"":1.3,""bun_xuln"":1.4,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, HNSCC with tumor ≥3cm, tissue available, FDG-PET within 14d, planned CRT, labs within limits, not pregnant, no recent radioactive study, able to comply."
NCT01075399,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""non-small cell lung cancer"",""tumor_size_cm"":5.2,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""concurrent chemoradiotherapy"",""bilirubin_xuln"":0.9,""ast_alt_xuln"":1.8,""serum_creat_xuln"":1.0,""bun_xuln"":1.2,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, NSCLC tumor ≥3cm, tissue available, FDG-PET timed correctly, planned chemoRT, liver/renal function normal, postmenopausal, compliant."
NCT01075399,P013,"{""age"":71,""gender"":""M"",""cancer_type"":""rectal adenocarcinoma"",""tumor_size_cm"":6.0,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""neoadjuvant chemoradiotherapy"",""bilirubin_xuln"":1.4,""ast_alt_xuln"":2.3,""serum_creat_xuln"":1.5,""bun_xuln"":1.6,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, rectal cancer ≥3cm, tissue archived, FDG-PET within window, planned neoadjuvant CRT, labs acceptable, no exclusion criteria met."
NCT01075399,P014,"{""age"":49,""gender"":""F"",""cancer_type"":""cervical squamous cell carcinoma"",""tumor_size_cm"":4.1,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""definitive chemoradiotherapy"",""bilirubin_xuln"":0.8,""ast_alt_xuln"":1.5,""serum_creat_xuln"":0.9,""bun_xuln"":1.1,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, cervical SCC ≥3cm, tissue available, FDG-PET scheduled correctly, planned definitive CRT, normal labs, using IUD contraception, fully compliant."
NCT01075399,P015,"{""age"":66,""gender"":""M"",""cancer_type"":""hepatocellular carcinoma"",""tumor_size_cm"":7.3,""tumor_tissue_available"":true,""fdg_pet_scheduled_within_14d"":true,""planned_treatment"":""radiation therapy"",""bilirubin_xuln"":1.8,""ast_alt_xuln"":2.4,""serum_creat_xuln"":1.2,""bun_xuln"":1.7,""pregnant"":false,""recent_radioactive_study"":false,""can_comply"":true}",true,"Eligible: >18yo, HCC lesion ≥3cm, biopsy tissue available, FDG-PET within 14d, planned RT, liver/renal parameters within limits, no recent investigational radiotracer, able to comply."
NCT04964960,P011,"{""age"":58,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":3,""max_lesion_size_cm"":2.1,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":15,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":8,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":30,""recent_minor_surgery_days"":10,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: NSCLC without driver mutations, asymptomatic brain mets <10 lesions and <3cm, no contraindicated locations, no exclusions, adequate organ function."
NCT04964960,P012,"{""age"":67,""gender"":""F"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":1,""max_lesion_size_cm"":1.4,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":20,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":12,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":45,""recent_minor_surgery_days"":14,""allergy_to_mab"":false,""cardiovascular_disease"":""controlled hypertension"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: single small lesion, no symptoms, no disqualifying sites, no recent surgery conflicts, organ/marrow adequate."
NCT04964960,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":5,""max_lesion_size_cm"":2.8,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":12,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":6,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":90,""recent_minor_surgery_days"":20,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: multiple but allowable lesions (<10, <3cm), no high-risk locations, asymptomatic, meets survival and organ criteria."
NCT04964960,P014,"{""age"":45,""gender"":""F"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":2,""max_lesion_size_cm"":1.9,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":25,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":10,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":40,""recent_minor_surgery_days"":18,""allergy_to_mab"":false,""cardiovascular_disease"":""none"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: no exclusions present, lesions small and safely located, good organ reserve and no neurologic symptoms."
NCT04964960,P015,"{""age"":63,""gender"":""M"",""diagnosis"":""NSCLC with untreated asymptomatic brain metastases"",""oncogenic_driver_mutations"":false,""intracranial_lesion_count"":4,""max_lesion_size_cm"":2.5,""neurologic_symptoms"":false,""lesion_proximity_optic_nerve_mm"":30,""brainstem_involvement"":false,""leptomeningeal_involvement"":false,""midline_shift"":false,""life_expectancy_months"":9,""adequate_organ_marrow_function"":true,""recent_major_surgery_days"":60,""recent_minor_surgery_days"":10,""allergy_to_mab"":false,""cardiovascular_disease"":""mild, controlled"",""psychiatric_limiting_compliance"":false,""can_consent"":true}",true,"Eligible: meets all inclusion criteria, no driver mutations, lesions appropriate, no surgical or medical exclusions."
NCT01951469,P011,"{""age"":62,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":4,""max_lesion_diameter_mm"":12,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":20,""hemoglobin_g_dl"":11.4,""anc_x10e9_l"":2.3,""platelets_x10e9_l"":180,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":1.9,""creatinine_clearance_ml_min"":82,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: EGFR-mutant stage IV NSCLC, ≥3 brain mets, no prior EGFR/brain RT, labs adequate, ECOG 1, no exclusion conditions."
NCT01951469,P012,"{""age"":54,""gender"":""M"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":3,""max_lesion_diameter_mm"":18,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":0,""life_expectancy_weeks"":30,""hemoglobin_g_dl"":12.2,""anc_x10e9_l"":3.0,""platelets_x10e9_l"":210,""bilirubin_x_uln"":0.8,""ast_alt_x_uln"":1.7,""creatinine_clearance_ml_min"":95,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: Meets all disease, lab, and performance status criteria; no prohibited meds or comorbidities."
NCT01951469,P013,"{""age"":70,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":2,""max_lesion_diameter_mm"":9,""suitable_for_brain_rt"":false,""refused_brain_rt"":true,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":18,""hemoglobin_g_dl"":10.6,""anc_x10e9_l"":2.0,""platelets_x10e9_l"":145,""bilirubin_x_uln"":1.2,""ast_alt_x_uln"":2.0,""creatinine_clearance_ml_min"":68,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""controlled hypertension"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: 1–2 lesions but refused RT, EGFR+, no exclusions, organ function and ECOG appropriate."
NCT01951469,P014,"{""age"":48,""gender"":""M"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":6,""max_lesion_diameter_mm"":22,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":0,""life_expectancy_weeks"":24,""hemoglobin_g_dl"":13.1,""anc_x10e9_l"":2.8,""platelets_x10e9_l"":175,""bilirubin_x_uln"":0.9,""ast_alt_x_uln"":1.6,""creatinine_clearance_ml_min"":88,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: ≥3 lesions, no prior disallowed therapy, labs and ECOG excellent, no exclusionary illnesses."
NCT01951469,P015,"{""age"":59,""gender"":""F"",""diagnosis"":""Stage IV EGFR-mutant NSCLC with brain metastases"",""egfr_activating_mutation"":true,""brain_met_lesion_count"":3,""max_lesion_diameter_mm"":14,""suitable_for_brain_rt"":false,""refused_brain_rt"":false,""prior_brain_irradiation"":false,""prior_egfr_tki"":false,""prior_egfr_mab"":false,""ecog"":1,""life_expectancy_weeks"":26,""hemoglobin_g_dl"":12.0,""anc_x10e9_l"":2.5,""platelets_x10e9_l"":160,""bilirubin_x_uln"":1.1,""ast_alt_x_uln"":2.3,""creatinine_clearance_ml_min"":72,""interstitial_pneumonia"":false,""pericardial_effusion_uncontrolled"":false,""pleural_effusion_uncontrolled"":false,""cardiac_history"":""none"",""ophthalmologic_abnormality"":false,""gi_absorption_issue"":false,""active_peptic_ulcer"":false,""uncontrolled_intracranial_pressure"":false,""concurrent_disallowed_meds"":false,""can_take_oral_meds"":true,""can_comply"":true}",true,"Eligible: All disease/lab/performance requirements satisfied, avoids prohibited drugs and medical exclusions."
NCT00094003,P011,"{""age"":61,""gender"":""M"",""diagnosis"":""Metastatic colorectal cancer to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":6,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":6,""washout_radiation_weeks"":8,""washout_surgery_weeks"":4,""washout_investigational_days"":45,""serum_calcium_mg_dl"":9.4,""hemoglobin_g_dl"":11.1,""anc_per_mm3"":2400,""platelets_per_mm3"":180000,""creatinine_x_uln"":1.1,""bilirubin_x_uln"":1.2,""ast_alt_x_uln"":2.1,""amylase_uln"":0.8,""lipase_uln"":0.7,""pt_ptt_x_uln"":1.1,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: metastatic liver disease, full recovery from prior therapy, labs within limits, no exclusions such as brain mets, liver disease, or pancreatitis."
NCT00094003,P012,"{""age"":48,""gender"":""F"",""diagnosis"":""Breast cancer metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":5,""ecog"":0,""pregnancy_test_negative"":true,""washout_chemo_weeks"":5,""washout_radiation_weeks"":4,""washout_surgery_weeks"":3,""washout_investigational_days"":40,""serum_calcium_mg_dl"":10.1,""hemoglobin_g_dl"":10.4,""anc_per_mm3"":1900,""platelets_per_mm3"":150000,""creatinine_x_uln"":1.0,""bilirubin_x_uln"":1.1,""ast_alt_x_uln"":2.4,""amylase_uln"":0.9,""lipase_uln"":0.9,""pt_ptt_x_uln"":1.2,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: ECOG 0, organ function adequate, no excluded comorbidities, prior therapies washed out appropriately."
NCT00094003,P013,"{""age"":72,""gender"":""M"",""diagnosis"":""Gastric cancer metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":4,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":7,""washout_radiation_weeks"":6,""washout_surgery_weeks"":3,""washout_investigational_days"":35,""serum_calcium_mg_dl"":9.7,""hemoglobin_g_dl"":10.0,""anc_per_mm3"":1650,""platelets_per_mm3"":110000,""creatinine_x_uln"":1.3,""bilirubin_x_uln"":1.4,""ast_alt_x_uln"":2.2,""amylase_uln"":0.6,""lipase_uln"":0.7,""pt_ptt_x_uln"":1.0,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: labs fit required windows, no cardiac/pancreatic/liver exclusions, appropriate washouts and ECOG 1."
NCT00094003,P014,"{""age"":35,""gender"":""F"",""diagnosis"":""Melanoma metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":7,""ecog"":0,""pregnancy_test_negative"":true,""washout_chemo_weeks"":4,""washout_radiation_weeks"":4,""washout_surgery_weeks"":4,""washout_investigational_days"":31,""serum_calcium_mg_dl"":10.4,""hemoglobin_g_dl"":12.3,""anc_per_mm3"":3000,""platelets_per_mm3"":200000,""creatinine_x_uln"":1.2,""bilirubin_x_uln"":1.0,""ast_alt_x_uln"":1.5,""amylase_uln"":0.5,""lipase_uln"":0.6,""pt_ptt_x_uln"":1.1,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: strong organ function profile, all washouts satisfied, no excluded diseases or medication conflicts."
NCT00094003,P015,"{""age"":58,""gender"":""M"",""diagnosis"":""Pancreatic neuroendocrine tumor metastatic to liver"",""liver_metastases"":true,""measurable_lesion"":true,""life_expectancy_months"":10,""ecog"":1,""pregnancy_test_negative"":true,""washout_chemo_weeks"":5,""washout_radiation_weeks"":6,""washout_surgery_weeks"":4,""washout_investigational_days"":33,""serum_calcium_mg_dl"":9.8,""hemoglobin_g_dl"":10.8,""anc_per_mm3"":2200,""platelets_per_mm3"":160000,""creatinine_x_uln"":1.1,""bilirubin_x_uln"":1.3,""ast_alt_x_uln"":2.8,""amylase_uln"":0.9,""lipase_uln"":0.9,""pt_ptt_x_uln"":1.0,""ecg_acute_abnormalities"":false,""afebrile"":true,""brain_metastases"":false,""pancreatic_disease"":false,""primary_liver_disease"":false,""nyha_class"":1,""emotional_psychiatric_issue"":false,""egg_yolk_allergy"":false,""low_mw_heparin"":false,""uncontrolled_illness"":false,""can_comply"":true}",true,"Eligible: metastatic liver disease without excluded comorbidities; labs meet all thresholds; no CNS mets or disallowed conditions."
NCT03699956,P011,"{""age"":59,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":2,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: biopsy-confirmed SCLC, ≥2 prior lines including platinum and checkpoint inhibitor, ECOG 0, measurable disease, no CNS mets or exclusionary illnesses."
NCT03699956,P012,"{""age"":72,""gender"":""M"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":3,""measurable_disease_recist"":true,""ecog"":1,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: third-line patient (3 prior lines) with prior platinum and checkpoint inhibitor, ECOG 1, no exclusionary comorbidities or symptomatic effusions."
NCT03699956,P013,"{""age"":46,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":4,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: heavily pretreated (≥2 lines), prior platinum and checkpoint inhibitor present, ECOG 0 and measurable disease without exclusions."
NCT03699956,P014,"{""age"":78,""gender"":""M"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":2,""measurable_disease_recist"":true,""ecog"":1,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: age 78 (<80), prior platinum and checkpoint inhibitor, exactly 2 prior lines, ECOG 1, no symptomatic CNS disease or other exclusions."
NCT03699956,P015,"{""age"":33,""gender"":""F"",""diagnosis"":""Biopsy-confirmed small cell lung cancer"",""biopsy_confirmed"":true,""prior_platinum"":true,""prior_checkpoint_inhibitor"":true,""prior_lines_of_therapy"":5,""measurable_disease_recist"":true,""ecog"":0,""brain_metastases"":false,""symptomatic_cns_metastases"":false,""allergic_reaction_to_platinum"":false,""uncontrolled_pleural_or_pericardial_effusion"":false,""pregnant"":false,""age_within_limits"":true,""clinically_significant_illness"":false,""can_consent"":true,""can_comply"":true}",true,"Eligible: multiple prior therapies including platinum and checkpoint inhibitor, ECOG 0, measurable disease, no exclusionary conditions."
NCT00046787,P011,"{""age"":61,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":4,""washout_radiation_weeks"":4,""washout_head_radiation_days"":14,""target_lesion_mm"":18,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: recurrent SCLC, one prior chemo, adequate washout periods, target lesion ≤20 mm, no SVC syndrome."
NCT00046787,P012,"{""age"":55,""gender"":""F"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":3,""washout_radiation_weeks"":5,""washout_head_radiation_days"":20,""target_lesion_mm"":10,""cns_history"":true,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: controlled CNS disease, single prior chemo, washout met, small target lesion (10 mm)."
NCT00046787,P013,"{""age"":49,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":6,""washout_radiation_weeks"":4,""washout_head_radiation_days"":12,""target_lesion_mm"":20,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: lesion size at upper limit (20 mm), appropriate washout, no exclusion criteria."
NCT00046787,P014,"{""age"":68,""gender"":""F"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":7,""washout_radiation_weeks"":3,""washout_head_radiation_days"":15,""target_lesion_mm"":9,""cns_history"":true,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: one prior chemo, controlled CNS involvement, lesion ≤10 mm on spiral CT."
NCT00046787,P015,"{""age"":73,""gender"":""M"",""diagnosis"":""Recurrent small cell lung cancer"",""prior_chemo_lines"":1,""washout_chemo_weeks"":5,""washout_radiation_weeks"":4,""washout_head_radiation_days"":18,""target_lesion_mm"":16,""cns_history"":false,""cns_controlled"":true,""superior_vena_cava_syndrome"":false}",true,"Eligible: meets all inclusion criteria, no SVC syndrome, adequate washout, target lesion within limits."
NCT02606149,P011,"{""age"":64,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":5,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: newly diagnosed (<8 weeks), no prior systemic therapy, systemic therapy indicated, able to consent."
NCT02606149,P012,"{""age"":72,""gender"":""F"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":7,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: meets diagnostic window, treatment-naïve for metastatic setting, no exclusion triggers."
NCT02606149,P013,"{""age"":58,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":3,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: recently diagnosed, systemic therapy planned, criteria satisfied."
NCT02606149,P014,"{""age"":45,""gender"":""F"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":4,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: young metastatic case, indicated for treatment, no disqualifying factors."
NCT02606149,P015,"{""age"":69,""gender"":""M"",""diagnosis"":""Stage IV lung cancer"",""histology_confirmed"":true,""weeks_since_diagnosis"":6,""systemic_therapy_indicated"":true,""prior_systemic_therapy_metastatic"":0,""able_to_consent"":true,""social_security_affiliation"":true,""major_comorbidity_incompatible"":false}",true,"Eligible: all inclusion rules met and no exclusion criteria present."
NCT06838208,P011,"{""age"":65,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: Newly diagnosed ES-SCLC (no prior systemic tx), measurable and irradiable chest lesion, ECOG 0, adequate function, no checkpoint inhibitor history, and meets all washout/infection/autoimmune exclusion criteria."
NCT06838208,P012,"{""age"":58,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":1,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable and irradiable lesion, ECOG 1, no history of ILD/pneumonitis, no recent systemic antibiotics or immunosuppressants, and no prior exposure to anti-PD-1/PD-L1/CTLA-4."
NCT06838208,P013,"{""age"":72,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":1,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, ECOG 1, lesion meets size/irradiability criteria. No history of autoimmune disease that may relapse, no recent systemic steroids or immunosuppressants, and no active/untreated CNS disease."
NCT06838208,P014,"{""age"":45,""gender"":""F"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable and irradiable lesion, ECOG 0, excellent organ function, no recent vaccines/antibiotics/immunosuppression, and no history of immune checkpoint inhibitor therapy."
NCT06838208,P015,"{""age"":60,""gender"":""M"",""sclc_stage"":""ES-SCLC"",""prior_systemic_tx_for_sclc"":false,""measurable_chest_lesion_recist11"":true,""lesion_irradiable_15gy_5f"":true,""ecog_performance_status"":0,""adequate_organ_function"":true,""active_leptomeningeal_untreated_brain_mets"":false,""prior_checkpoint_inhibitor"":false,""live_vaccine_4wks"":false,""active_autoimmune_disease"":false,""systemic_immunosuppression_14days"":false,""history_ild_pneumonitis"":false,""uncontrolled_systemic_disease"":false,""severe_active_infection_2wks"":false,""antibiotics_2wks"":false}",true,"Eligible: ES-SCLC first-line, measurable chest lesion capable of 15Gy/5f irradiation, ECOG 0, no exclusionary infectious diseases, no prior immunotherapy targeting checkpoint pathways, and no uncontrolled CNS disease."
NCT03778814,P011,"{""age"":65,""gender"":""M"",""cancer_type"":""Advanced Lung Tumor"",""biopsy_obtainable"":true,""life_expectancy_weeks"":15,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":15,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.2,""tcr_expression_percent"":25,""killing_cytotoxicity_percent"":30,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced lung tumor (biopsy obtainable), meets life expectancy/organ function/Child-Pugh criteria, tumor size $<25$cm, no prior gene therapy, HIV negative, no severe infection, steroid dose is below the exclusion limit, and key lab requirements (TCR expression/killing activity) met."
NCT03778814,P012,"{""age"":58,""gender"":""F"",""cancer_type"":""Advanced Ovarian Cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":20,""child_pugh_score"":5,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":24,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0,""tcr_expression_percent"":20,""killing_cytotoxicity_percent"":20,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Ovarian Ca), tumor size 24cm (just under the 25cm exclusion), excellent Child-Pugh score, no steroid use, no history of gene therapy or lung transplant, and T-cell product meets minimum quality control (TCR expression $\ge 20\%$, killing $\ge 20\%$). Not pregnant/lactating."
NCT03778814,P013,"{""age"":72,""gender"":""M"",""cancer_type"":""Advanced Pancreatic Cancer"",""biopsy_obtainable"":true,""life_expectancy_weeks"":12,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":10,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.3,""tcr_expression_percent"":35,""killing_cytotoxicity_percent"":40,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Pancreatic Ca), meets minimum life expectancy (12 weeks), Child-Pugh $<7$, adequate function. Steroid dose is allowed, no exclusionary infections, and T-cell product quality is high."
NCT03778814,P014,"{""age"":45,""gender"":""F"",""cancer_type"":""Advanced Sarcoma"",""biopsy_obtainable"":true,""life_expectancy_weeks"":30,""child_pugh_score"":5,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":5,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0,""tcr_expression_percent"":22,""killing_cytotoxicity_percent"":25,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced solid tumor (Sarcoma), small tumor size, excellent life expectancy and Child-Pugh score. T-cell product meets minimum required quality, no steroid use, and no history of exclusionary conditions like severe virus infection, gene therapy, or lung transplant."
NCT03778814,P015,"{""age"":68,""gender"":""M"",""cancer_type"":""Advanced Lung Tumor"",""biopsy_obtainable"":true,""life_expectancy_weeks"":18,""child_pugh_score"":6,""adequate_organ_function"":true,""prior_gene_therapy"":false,""tumor_size_cm"":20,""severe_virus_infection_hbv_hcv_hiv"":false,""known_hiv_positivity"":false,""lung_transplantation_history"":false,""active_infectious_disease"":false,""systemic_steroid_dose_pred_mg_kg_day"":0.4,""tcr_expression_percent"":28,""killing_cytotoxicity_percent"":35,""informed_consent_signed"":true,""pregnant_or_lactating"":false}",true,"Eligible: Advanced lung tumor, Child-Pugh $<7$, systemic steroid use is below $0.5 \text{ mg}/\text{kg}/\text{day}$ limit, tumor size 20cm (allowed), no severe infectious diseases or exclusionary history, and T-cell product quality is sufficient."




